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Obesity is associated with dysfunction of adipose tissue due to oxidative stress and 
inflammation, leading to insulin resistance. Thiosulfate sulfurtransferase (Tst) was 
previously identified as an adipose-expressed anti-diabetic gene that protects against 
diet-induced metabolic impairment when upregulated in adipose tissue of mice. TST 
is a mitochondrial enzyme involved in the metabolism of cyanide, reactive oxygen 
species (ROS) and endogenous hydrogen sulfide (H2S). This thesis tested the 
hypothesis that TST maintains metabolic health in the face of dietary obesity. To do 
this, I investigated the adipose-tissue phenotypes and metabolic consequences of Tst 
gene deletion (Tst–/– mice) and of adipose tissue-specific overexpression of human 
TST (Ad-hTST mice) after exposure to high fat diet (HFD). 
After 20 weeks of HFD, Tst–/– mice exhibited impaired glucose tolerance 
despite unchanged adipose tissue inflammatory cell infiltration, protein carbonylation 
and unfolded protein response activation. However, levels of mRNA encoding 
mitochondrial antioxidant enzymes including superoxide dismutase 2 and 
peroxiredoxin 3 were lower in Tst–/– mice on HFD.  Unexpectedly, chow-fed Tst-/- mice 
had lower body weight and fat mass than wild-type controls highlighting a potential 
effect of Tst on fat accumulation with age. 
A new mouse model with high expression of human TST genetically targeted 
to adipose tissue (Ad-hTST) was developed using the LoxP / Cre recombinase 
expression system, with a parent line expressing Cre under the control of the 
adiponectin promoter to confer adipose specificity. The Ad-hTST mice were found to 
gain a similar amount of weight and fat mass to control mice when exposed to 6 weeks 
of HFD. However, Ad-hTST mice had impaired glucose tolerance with no change in 
inflammatory cell infiltration, mRNA levels of antioxidant enzymes or unfolded 
protein response genes. Thus, unexpectedly, overexpression of human TST in adipose 
tissue of mice results in a detrimental metabolic phenotype. 
In vivo and in vitro experiments were conducted to test the hypothesis that TST 
protects against ROS accumulation. Paraquat was tested as an inducer of oxidative 
stress in vivo in wild-type, Tst-/- and Tst+/- mice. At the doses used (25mg/kg and 
under), mice became unwell and lost weight, with no increase in markers of oxidative 
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stress in adipose or lung. The production of mitochondrial ROS in response to 
exogenous hydrogen peroxide (H2O2) exposure was increased in primary adipocytes 
from Tst-/- mice in vitro. However, primary hepatocytes showed reduced mitochondrial 
ROS production in response to H2O2 exposure. ROS production in hepatocytes was 
unaffected by pre-incubation with a H2S donor, an inhibitor of H2S-producing enzyme 
CSE or N-acetyl-cysteine, an antioxidant. TST may therefore influence mitochondrial 
ROS production differently in cell types such as adipocytes and hepatocytes. Disposal 
of exogenous H2O2 was unchanged in primary adipocytes from Tst-/- and Ad-hTST 
mice, and this was not affected by pre-incubation with sodium thiosulfate, a TST 
substrate.  
Metabolic changes in response to HFD may be influenced by alteration in TST 
expression, however the current data suggest it is unlikely to occur through the 
prevention of excessive local ROS accumulation in adipose tissue. Mice lacking the 
Tst gene globally and mice with adipose-specific overexpression of the human TST 
gene have a similarly impaired metabolic response to HFD.  The phenotype of adipose-
specific human TST-overexpressing mice does not recapitulate the protective 
metabolic phenotype produced by overexpression of the endogenous mouse Tst gene. 
In conclusion, TST may influence adipose tissue due to its role in the oxidation of H2S, 
however, by the current means, it does not appear to substantially impact the response 








The prevalence of obesity has increased greatly over the last three decades, and 
because of this, diseases that are associated with increased weight, such as diabetes are 
on the rise. In obesity, fat tissue expands to store excess nutrients, but this can often 
lead to damage to fat cells causing them to make damaging reactive oxygen species 
(ROS), stop functioning properly and die. When this happens, the fat tissue no longer 
responds to insulin which is telling it to absorb sugar from the blood, a state that is 
called insulin resistance that can lead to diabetes. Whether someone who is obese will 
get diabetes or not is often influenced by how well their fat cells survive and respond 
to this large expansion, and genes in the fat cells can affect this. TST is one gene that 
was found to protect mice against gaining weight and becoming diabetic when it was 
increased in fat tissue.  
This project aimed to find out how changing the levels of TST in fat tissue 
could protect against damage of the tissue caused by obesity. It is thought that TST 
could protect fat cells because it might be able to break down ROS, which are made 
by damaged fat cells, and which cause more damage. To test this idea, mice without 
TST and mice with higher amounts of human TST introduced into their fat tissue were 
put on a high fat diet to make them obese. Mice lacking TST became overweight to 
the same level as normal mice that had the gene, but they had slightly more sugar in 
their blood. There were no major differences in damage to their fat tissue however, 
and so lacking TST in fat tissue was probably not causing the diabetes. The other mice 
with higher amounts of TST in their fat tissue, gained weight as normal when given a 
high fat diet. Surprisingly however, these mice showed a slight worsening of their 
diabetes. They also had no major differences in damage to their fat tissue, and so I 
could not confirm that having high amounts of human TST in fat tissue protected the 
mice from becoming diabetic when they were obese. 
Isolated fat cells from mice lacking TST and mice with high TST in fat were 
used to test if these cells made more ROS than normal fat cells, or if they could break 
down ROS better. Fat cells lacking TST made more ROS than normal cells, but when 
repeated with liver cells, the opposite result was found. Fat cells lacking TST and fat 
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cells with more TST broke down ROS at the same rate as normal fat cells. Therefore, 
TST likely does not help protect cells against damaging ROS and so it might not be 
able to protect fat tissue damaged in obesity. 
This project was important because it found out that increasing TST in fat 
tissue probably won’t prevent diabetes in obese people. Future work focusing on 
understanding the functions of TST in other tissues may help us uncover a way to 
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Chapter 1 Introduction 
1.1 OBESITY 
1.1.1 Obesity Prevalence 
Obesity is defined as having a body mass index (BMI) over 30kg/m2, and a BMI over 
25kg/m2 is defined as overweight. A high BMI, particularly if accompanied by 
excessive visceral fat accumulation, is associated with increased risk of non-
communicable diseases such as cardiovascular disease, type two diabetes mellitus and 
cancer (Renehan et al. 2008; Wormser et al. 2011). The world is in the grips of an 
obesity epidemic, with the prevalence of overweight and obesity increasing 27.5% for 
adults and 47.1% for children between 1980 and 2013 (Ng et al. 2014). The 
detrimental effect of this rapid increase in obesity on global health is seen in the 
doubling of diabetes prevalence between 1980 and 2014, and the increased economic 
burden due to healthcare costs and loss of work (Seuring et al. 2015; Zhou et al. 2016). 
The cause of this rapid worldwide increase in obesity is thought to be globalisation of 
a diet high in animal fat and protein, refined grains and added sugar, and a reduction 
in physical activity due to technological advances (Malik et al. 2012). Despite this 
obesogenic environment, a substantial proportion of the population has remained non-
obese indicting that some protection against obesity may lie in the genetic variation of 
the population (Ljungvall and Zimmerman 2012). Understanding the underlying 
mechanisms controlling this variation may lead to the development of new 
interventions – pharmacological or lifestyle – that can be targeted to prevent or reverse 
excess weight gain and diseases associated with it. 
 
1.1.2 Metabolic syndrome 
Excess fat mass characterised by a high BMI or waist circumference is significantly 
associated with the most common non-communicable diseases: cardiovascular 
disease, diabetes and cancer (Chan et al. 1994; Renehan et al. 2008; Wormser et al. 
2011). Central obesity, an excess of intra-abdominal visceral fat, is particularly 
predictive of metabolic and cardiovascular disease risk (Tchernof and Després 2013). 




      
      
The metabolic syndrome is a cluster of risk factors for these diseases, and is defined 
as at least three of the following: dyslipidemia, hyperglycemia, elevated blood 
pressure, and a pro-inflammatory and pro-thrombotic state (Grundy 2016). The 
prevalence of metabolic syndrome is increased in obese and overweight cohorts (Park 
et al. 2003), and excess abdominal fat is positively correlated with many of these risk 
factors (Vega et al. 2006). Pathophysiological changes occur in adipose tissue in 
obesity, including altered secretion of many hormonal factors and pro-inflammatory 
cytokines that directly contribute to these features of the metabolic syndrome, and link 
obesity with diabetes and cardiovascular disease. 
 
1.1.3 Genetics of obesity 
BMI and other measurements of body mass such as waist circumference are heritable 
traits. Twin studies have estimated this heritability to be between 56% and 77% for 
BMI (Silventoinen et al. 2008; Wardle et al. 2008). A long history of experimental 
genetics in mouse lines confirms that body weight and fat mass are influenced by 
genes. The was illustrated by the identification of the hyperphagic ob/ob mouse as far 
back as 1950 (Ingalls et al. 1950). It took almost half a century to finally identify the 
ob gene as an adipose-derived hormone, named leptin from the Greek “lepto” for 
thinness, that signals in the hypothalamus to suppress appetite and energy expenditure 
(Zhang et al. 1994; Satoh et al. 1997). Subsequently, two cases of leptin deficiency in 
humans leading to severe obesity were described, with subsequent successful 
treatment with recombinant leptin (Montague et al. 1997; Farooqi et al. 1999). This 
discovery confirmed that individual susceptibility to weight gain was influenced by 
genetics. Subsequently, the genetic basis of obesity in other rodent models was 
uncovered, including the discovery of neuropeptide Y, pro-opiomelanocortin and the 
melanocortin-4 receptor, leading to the elucidation of neural circuits involved in the 
control of appetite (Dryden et al. 1995; Huszar et al. 1997; Yaswen et al. 1999). Rare 
mutations in these genes were also found to cause morbid obesity in humans (Van Der 
Klaauw and Farooqi 2015). As these monogenic forms of obesity explained only the 
severest cases, accounting for only a small proportion of the obese population, 




      
      
genome-wide associated studies (GWAS) were undertaken to search for common 
variants with less extreme effects on obesity risk. The first gene region with variation 
that has a strong and replicable association with obesity was in the first intron of the 
FTO gene. Single nucleotide polymorphisms (SNPs) in this region associated strongly 
with early-onset and severe obesity, and type 2 diabetes risk through increased BMI 
(Dina et al. 2007; Frayling et al. 2007). A more recent meta-analysis including data 
from more 300,000 individuals from 125 studies identified 97 loci significantly 
associated with BMI (Locke et al. 2015). When grouped by pathway, these common 
obesity-associated variants confirm a major role for neural control of obesity risk, but 
also highlight new pathways such as insulin signalling, energy metabolism and 
adipogenesis. Waist to hip ratio, another surrogate measurement of obesity related to 
fat distribution, was associated with up to 49 loci in a genome wide association meta-
analysis (Shungin et al. 2015). Many of the loci were distinct from those previously 
associated with BMI, and were in or near genes expressed highly in adipose tissue, or 
involved in biological processes necessary for adipose tissue expansion such as 
adipogenesis and angiogenesis. The success of GWAS at finding genetic variants 
associated with obesity has led to a wealth of information about possible causes of 
increased weight gain, especially through the discovery of genes involved in biological 
processes such as appetite regulation and adipose tissue function. However, 
understanding the function of many of these common variants and how, or even 









      
      
1.2 ADIPOSE TISSUE DYSFUNCTION IN OBESITY 
1.2.1 Adipose structure and function 
Adipose tissue had long been thought of as only a storage organ for excess nutrient as 
lipid, with a huge capacity for expansion. However, in recent years the ability of 
adipose tissue to secrete numerous endocrine factors with a myriad of systemic effects 
has been recognised. Adipose tissue is now known to play a role in other vital functions 
including thermogenesis, reproduction and lactation, as well as helping to modulate 
immune responses. The main cellular component of adipose tissue is the adipocyte, a 
cell highly specialised to store a large quantity of triglyceride in lipid droplets, and to 
synthesise and secrete many hormonal factors, called adipokines. Adipose tissue 
contains other cell types, collectively called the stromal vascular fraction (SVF), 
including pre-adipocytes, endothelial cells, fibroblasts and many types of immune 
cells (Rosen and Spiegelman 2014). Different types of adipose tissue are specialised 
for different functions. Brown adipose tissue (BAT) is highly vascularised and 
contains adipocytes with many small lipid droplets and numerous large mitochondria 
with high expression of uncoupling protein 1 (UCP1)(Diaz et al. 2014). During cold 
exposure, UCP1 mediates the biochemical uncoupling of mitochondrial oxidative 
phosphorylation from ATP production, leading to the production of heat. It was 
initially thought that brown fat was only present in humans in infants, however recent 
discoveries of cold-triggered highly metabolically active tissues in adult humans has 
led to the recognition that some BAT depots are retained in adults, and can contribute 
to thermogenesis (Sacks and Symonds 2013). White adipose tissue (WAT) is much 
more abundant than BAT, and carries out the classical function of energy storage, but 
is also a key endocrine organ (Coelho et al. 2013). White adipocytes contain a single 
large lipid droplet, and are highly specialised to take up and convert nutrients to 
triglyceride for storage (lipogenesis), and to release free fatty acids by lipolysis. White 
adipocytes can also expand in times of excess – a process called hypertrophy – or pre-
adipocytes can proliferate and differentiate to add more lipid storage capacity through 
hyperplasia (Rosen and Spiegelman 2014). Different white adipose depots have a 
different capacity to expand without causing detrimental metabolic effects, and it is 




      
      
widely recognised that upper body obesity characterised by excess visceral fat is more 
metabolically harmful than lower-body obesity in which the subcutaneous fat expands 
more (Tchernof and Després 2013). A third type of adipocyte with an intermediary 
phenotype, the beige adipocyte, has also been described (Diaz et al. 2014). Beige 
adipocytes have several lipid droplets and UCP1-expressing mitochondria like brown 
adipocytes, however they are located within white adipose depots. A full 
understanding of their contribution to metabolic health is outside the scope of this 
thesis. 
 
1.2.2 Oxidative stress in adipose tissue 
Reactive oxygen species (ROS) are made during cellular processes and are essential 
for normal physiological activity of the cell. However, ROS can cause oxidative 
damage when produced in excess or when the cellular antioxidant machinery is 
overloaded. Oxidative stress contributes to the pathology of many diseases, including 
obesity. In adipose tissue, ROS are essential for differentiation of pre-adipocytes to 
mature adipocytes (Tormos, Anso and Hamanaka 2011). As well as playing a role in 
the creation of new adipocytes, ROS are produced in the mitochondria and by 
activation of the insulin signalling pathway in mature adipocytes, and are necessary 
for appropriate propagation of the intracellular insulin signal (Mahadev et al. 2004). 
Therefore, maintaining the redox balance of the cell is essential for adipose tissue to 
function normally. In obesity, adipose tissue exhibits oxidative stress due to increased 
production of ROS and overloading of the antioxidant capability of the tissue 
(Furukawa et al. 2004; Huh et al. 2012; Long et al. 2013). This contributes to 
dysfunction of the tissue, and is a key risk factor for metabolic disease. 
 
1.2.2.1 Sources of cellular reactive oxygen species 
Mitochondria are a major source of ROS. Both complex I and III of the electron 
transport chain are significant sites of superoxide anion production, as well as other 
mitochondrial enzymes such as pyruvate dehydrogenase, 2-oxoglutarate 
dehydrogenase and complex II, with the type of substrate used influencing the amount 




      
      
of superoxide produced (Quinlan et al. 2013). Another source of cellular ROS is the 
NADPH oxidases (NOX), with NOX4 being the most abundant in adipose tissue. 
NOX4 produces hydrogen peroxide (H2O2) in response to insulin-stimulation in 
adipocytes, which acts as a second messenger in the insulin signalling cascade, and is 
essential for insulin-induced differentiation of pre-adipocytes (Mahadev et al. 2004; 
Schröder et al. 2009). In normal physiological conditions, superoxide is metabolised 
rapidly to H2O2 by the superoxide dismutase enzymes – SOD1 in the cytosol, and 
SOD2 in the mitochondria. Superoxide and H2O2 act as redox signals, reversibly 
oxidising redox sensitive cysteines on enzymes, and thus changing their activity or 
function and contributing to cellular homeostasis across a physiological range (Sies 
2014). Disruption of the redox balance of the cell by production of excess superoxide 
and H2O2 can result in irreversible oxidation of redox sensitive enzymes, impairing 
their function. As well as direct effects, excess H2O2 in the presence of ferrous iron 
(Fe2+) can be converted to the hydroxyl radical, which oxidatively damages proteins, 
lipids and nucleic acids (Gieseg et al. 1993; Cadet et al. 1999; Ayala et al. 2014). 
These highly reactive hydroxyl radicals cause peroxidation of lipids, resulting in the 
production of damaging lipid hydroperoxides and reactive aldehyde species. Reactive 
aldehydes – 4-hydroxy-2-nonenal (4-HNE) and malondialdehyde (MDA) for example 
– attach to cysteine, histidine and lysine amino acid side chains as carbonyl additions 
(Ruskovska and Bernlohr 2013). Protein carbonylation is increased in adipose tissue 
from obese individuals and causes alterations to many key enzymes, with a potential 
loss of function (Grimsrud et al. 2007). 
 
1.2.2.2 Endogenous antioxidant machinery 
Cells constantly generate ROS, and must be able to quench these ROS or reverse the 
damage they cause to maintain their functionality. Several enzymatic antioxidant 
systems maintain physiological levels of ROS and intracellular redox potential in the 
cytoplasm and mitochondria. These systems are triggered by activation of redox 
sensitive transcription factors, such as nuclear factor (erythroid-derived 2)-like 2 
(NRF2). Under normal cellular conditions NRF2 is bound to Kelch-Like ECH 




      
      
Associated Protein 1 (KEAP1), an actin-bound protein that mediates the ubiquitination 
of the transcription factor marking it for degradation (Vomhof-Dekrey and Picklo 
2012). During oxidative stress, KEAP1 is oxidised at cysteine residues, freeing NRF2 
to translocate to the nucleus and bind to antioxidant response elements in the promoters 
or regulatory regions of target antioxidant genes. 
To maintain cellular ROS levels within a normal range for redox signalling and 
to prevent damage from oxidative stress, maintaining a normal balance of hydrogen 
peroxide is essential. Catalase is the main enzyme responsible for disposing of 
cytoplasmic H2O2 (Okuno et al. 2008). The thioredoxin and glutathione antioxidant 
cytoplasmic and mitochondrial systems are also involved in this process, and both are 
inducible by NRF2 activation. The mitochondrial thioredoxin system, comprising 
thioredoxin reductase 2 (TXNRD2) and thioredoxin 2 (TXN2) contributes to the 
control of H2O2 levels in mitochondria by maintaining peroxiredoxin 3 (PRX3) in its 
reduced form and thus capable of scavenging further H2O2  (Chae et al. 1999; Lu and 
Holmgren 2014). The importance of this ROS scavenging system in metabolism was 
highlighted by recent work which demonstrated reduced Prx3 expression in adipose 
tissue in obesity and metabolic syndrome (Huh et al., 2012). In addition, Prx3 
knockout mice exhibit impaired glucose tolerance, adipocyte hypertrophy and 
increased adipose tissue protein carbonylation and superoxide levels. 
The glutathione antioxidant system is also important for regulating the redox 
environment, quenching ROS and reversing oxidative damage (Quintana-Cabrera and 
Bolaños 2013). Glutathione is produced by the enzyme glutamate-cysteine ligase 
(GCL) and is a tripeptide composed of glutamate, cysteine and glycine. It is maintained 
in its reduced form (GSH) by glutathione reductase (GR) at very high intracellular 
concentrations (10-15mM) (Marí et al. 2009). NRF2 activation can induce expression 
of both GCL and GR, increasing the pool of reduced GSH to counteract damage from 
oxidative stress (Harvey et al. 2009). In the mitochondria and cytosol, GSH is used as 
a cofactor for glutathione peroxidase 1 (GPX1) in the reduction of H2O2 to water 
(Brigelius-Flohé and Maiorino 2013). GSH is also necessary for detoxification of lipid 
peroxides by glutathione peroxidase 4 (GPX4) and the metabolism of reactive 




      
      
aldehydes such as 4-HNE by glutathione-S-transferase A4 (GSTA4)(Yant et al. 2003; 
Curtis et al. 2010). Perturbations of the antioxidant machinery contribute to 
dysfunction of adipose tissue in obesity (Long et al. 2013).  
 
1.2.2.3 Oxidative stress in adipose tissue 
Oxidative stress is a feature of dysfunctional adipose tissue in obesity. Consumption 
of a high fat diet for just one week can cause increased production of mitochondrial 
ROS, increased levels of markers of oxidative stress and impairment of glucose 
tolerance (Paglialunga et al. 2015). Similarly, a high fructose diet can also cause 
adipose oxidative stress and metabolic impairment (Mellouk et al. 2011, 2012). 
Exposure of the 3T3-L1 adipocyte cell line to excess nutrients from glucose and 
palmitate results in increased NOX4 activity and production of excess ROS (Han et 
al. 2012). Molecularly, the rate of production of superoxide is dependent on a number 
of factors including the availability of electron carriers such as NADH, FADH and 
ubiquinone, and the demand for ATP (Murphy 2009). In cells with a high demand for 
ATP, electron carriers are mostly oxidised and superoxide production is low. 
Overnutrition supplies excess electrons to the respiratory chain and lack of physical 
exercise reduces ATP demand, leading to increased superoxide formation (James et 
al. 2012). As well as excess superoxide production from mitochondria, hypoxia due to 
inadequate expansion of adipose vasculature can contribute to oxidative stress through 
reducing the expression of antioxidant enzymes (Lee et al. 2008). Hypoxia and 
increased ROS production can also result in the triggering of the unfolded protein 
response, which contributes to further ROS production and oxidative stress (Harding 
et al. 2003). As well as increased ROS production, adipose tissue from obese 
individuals exhibits reduced expression and activity of many key antioxidant enzymes. 
Superoxide dismutase activity and glutathione peroxidase activity, as well as 
expression of catalase are reduced in adipose tissue of genetically obese mice 
(Furukawa et al. 2004). Peroxiredoxin 3 is also reduced in adipose of obese humans 
and mice (Huh et al. 2012). Excess production of ROS in adipose tissue from obese 
individuals, and consequent overloading of the antioxidant machinery, leads to 




      
      
dysfunction of insulin signalling, adipogenesis and contribute to local and systemic 
inflammation. 
Oxidative stress in adipose tissue can cause irreversible damage to cellular 
components, interfere with normal adipocyte function, and induce local and systemic 
inflammation. One of the main consequences of oxidative stress is the irreversible 
oxidation or carbonylation of proteins leading to impaired function and degradation or 
aggregation. GST4A is responsible for detoxifying the reactive aldehyde 4-HNE and 
is reduced in adipose tissue of obese insulin-resistant individuals, resulting in an 
increase in carbonylation, with many of the target enzymes having roles in cellular 
stress response and insulin signalling (Grimsrud et al. 2007; Curtis et al. 2010). 
Treating 3T3-L1 adipocytes with 4-HNE caused carbonylation and degradation of the 
insulin receptor substrate 1 and 2 (IRS1/2) and thus, impaired insulin-stimulated 
glucose uptake and lipogenesis (Demozay et al. 2008). Oxidative stress also caused a 
reduction in proteasome activity, leading to aggregation of oxidised and ubiquitinated 
proteins, and activation of the unfolded protein response (UPR) and insulin resistance 
(Díaz-Ruiz et al. 2015).  While a physiological level of ROS production by NOX4 is 
induced and required for insulin-mediated differentiation of pre-adipocytes (Schröder 
et al. 2009), excess ROS inhibits both proliferation and differentiation of pre-
adipocytes and thus reduces the availability of new adipocytes to store excess lipid 
leading to hypertrophy (Carrière et al. 2003, 2004). Production of H2O2 by NOX4 
under normal physiological conditions is also necessary for insulin-stimulated glucose 
uptake (Mahadev et al. 2004), however prolonged exposure to a high concentration of 
H2O2 impairs insulin-induced translocation of the glucose transporter GLUT4 to the 
plasma membrane and reduced glucose uptake and lipogenesis (Rudich and Kozlovsky 
1997; Rudich et al. 1998).  
Increased oxidative stress, as well as having direct effects on insulin signalling 
in the adipocyte, is implicated in induction of inflammatory signalling pathways and 
infiltration of macrophages. Oxidative stress caused an alteration in the secretome of 
adipokines towards a more pro-inflammatory phenotype, with a reduction observed in 
the anti-inflammatory, insulin-sensitising hormone adiponectin and an increase in 




      
      
monocyte chemotactic protein 1 (MCP1), plasminogen activator inhibitor 1 (PAI1), 
and interleukin-6 (IL-6), a pro-inflammatory cytokine (Furukawa et al. 2004). This 
alteration in the adipokine secretion profile was induced in 3T3-L1 adipocytes in vitro 
by exposure to exogenous H2O2 or high concentrations of glucose and palmitate, which 
induced excess ROS production (Chen et al. 2009; Han et al. 2012). As well as direct 
effects of excess ROS, lipid aldehydes such as 4-HNE produced by peroxidation of 
lipids can also trigger activation of local inflammatory pathways (Zarrouki et al. 2007), 
and the detoxification of 4-HNE by the addition of glutathione allows it to be secreted 
from the cell, where it subsequently induces infiltration and activation of macrophages 
(Frohnert et al. 2014). Therefore, inflammation of adipose tissue triggered by oxidative 




While excess production of ROS leads to oxidative stress and cellular damage, at lower 
physiological levels, ROS can act as signalling molecules to induce cellular changes 
that promote resistance to stress. This concept, named mitochondrial hormesis, or 
mitohormesis, theorises that low doses of ROS protect cells from damage through 
induction of antioxidant and stress defence mechanisms, and can thus promote health 
and increase lifespan (Ristow and Schmeisser 2014). An understanding of the 
mitohormetic response is essential when considering the implications of ROS 
production in obesity, as variation in the ability to upregulate protective mechanisms 
may underlie individual susceptibility to metabolic dysfunction (Kolb and Eizirik 
2012). 
The mitohormetic response can be induced by various stimuli that are relevant 
when discussing the impact of ROS on metabolic health. Exercise, calorie restriction 
and hypoxia have all been shown to increase ROS production, and produce beneficial 
outcomes at a cellular and systemic level in certain contexts (Ristow and Schmeisser 
2014). Physical activity is a long recognised trigger of the mitohormetic response, with 
exercise-induced ROS production leading to mitochondrial biogenesis and increased 




      
      
mitochondrial function (Davies et al. 1982). Exercise reduces risk of diabetes, 
cardiovascular disease and cancer, as well as potentially delaying onset of 
neurodegenerative diseases (Radak et al. 2008), and increases lifespan in rodents 
(Boveris and Navarro 2008). This adaptive effect is abrogated if antioxidants such as 
vitamins C and E are administered prior to exercise, indicating the importance of ROS 
in this process (Ristow and Zarse 2009). Another trigger of the mitohormetic response 
proven to promote health and increase lifespan is calorie restriction (CR). Reducing 
nutrient intake by up to 50% without malnutrition increases lifespan in many species, 
including mammals, and reduces risk of age-related diseases in humans (Heilbronn et 
al. 2006; Ristow and Schmeisser 2014). CR in yeast and glucose restriction in the 
nematode Caenorhabditis elegans (C. elegans) increase ROS production, leading to 
increased antioxidant activity and prolonged lifespan (Agarwal et al. 2005; Schulz et 
al. 2007). Hypoxia occurs in adipose tissue in obesity due to poor vascularisation of 
the expanding tissue (discussed in paragraph 1.2.5 on page 33). However, transient 
hypoxia has also been shown to extended lifespan in C. elegans through ROS-
mediated mechanisms (Lee et al. 2010). These triggers of a mitohormetic response 
mediate their beneficial effects through activation of various stress-response 
mechanisms including NRF2, a transcriptional regulator of many antioxidant genes 
(described in paragraph 1.2.2.2 on page 23) , AMP-activated protein kinase (AMPK), 
a sensor of nutrient shortage and sirtuins, histone deacetylases involved in regulation 
of expression of DNA repair enzymes, protein folding chaperones and autophagy 
(Ristow and Schmeisser 2014).  
 Increased production of ROS in adipose tissue in obesity is generally 
recognised as being detrimental to the function of the tissue, leading to impairment of 
insulin signalling, dysregulation of adipokines and metabolic syndrome (Rudich et al. 
1998; Furukawa et al. 2004). However, early adaptation to a high fat diet may lead to 
induction of a mitohormetic response, which may reduce metabolic impairment in a 
mouse model of diet-induced obesity. 
 




      
      
1.2.3 Inflammation 
1.2.3.1 Immune cell populations in adipose tissue 
As well as the lipid-storing adipocytes and their precursors, adipose tissue contains 
many other cell types that greatly affect the tissue microenvironment and its 
dysfunction in obesity. The stromal vascular fraction (SVF) of adipose tissue contains 
endothelial cells, fibroblasts, smooth muscle cells and immune cells. Nearly all cells 
of the innate and adaptive immune system have been identified in adipose tissue. Many 
immune cell types play roles in the maintenance of a healthy anti-inflammatory 
environment, and others have been found to contribute to local inflammation during 
the development of obesity. In a lean state, immune cells play a key role in adipose 
tissue homeostasis, tissue remodelling and maintenance of an anti-inflammatory 
environment through secretion of anti-inflammatory cytokines. Adipose tissue 
macrophages (ATMs) are the most common immune cell in the tissue, with both 
resident cells and infiltrating monocyte-derived macrophages present. In a lean 
individual, ATMs are mostly polarised towards an alternatively activated or M2 
phenotype (Lumeng et al. 2007), although recent evidence indicates that macrophage 
activation states exist as a spectrum rather than a branched set of phenotypically 
distinct states (Xu et al. 2013; Ginhoux et al. 2015). ATMs in adipose tissue from non-
obese individuals are characterised by anti-inflammatory cytokine production, such as 
increased expression of IL-10 and its receptor, and increased arginase 1 expression, 
which dampens down inflammatory T cell activation and prevents fibrosis (Lumeng 
et al. 2007; Pesce et al. 2009). A role for M2 macrophages has also been suggested in 
clearing apoptotic adipocytes to facilitate tissue remodelling during cold exposure and 
because of increased lipolysis (Lee et al. 2013). 
This beneficial M2 cell type is supported by signals from other immune cells 
such as eosinophils and invariant-chain natural killer T cells (iNKT). Eosinophils are 
the main source of the cytokine IL-4 which is necessary for the maintenance of the 
ATM M2 phenotype, and they are subsequently sustained by IL-5 secretion from 
innate lymphoid type 2 cells (ILC2)  (Wu et al. 2011; Molofsky et al. 2013). The anti-
inflammatory ATM population is also regulated by iNKT cells. These are unusual T 




      
      
cells in that they recognise lipids presented by CD1d antigen-presenting cells rather 
than peptides presented using the major histocompatibility complex (MHC)(Lynch 
2014). iNKT cells mediate the function of other immune cells by rapid cytokine 
production, including the anti-inflammatory IL-4 and IL-10 (Lynch et al. 2012). 
Another subset of T cells, regulatory T cells (Treg) are also present in adipose tissue 
from non-obese individuals and secrete IL-10, helping to maintain an anti-
inflammatory insulin-sensitive environment (Feuerer et al. 2009). 
 
1.2.3.2 Variations in adipose tissue immune cell populations in obesity. 
Chronic low-grade inflammation in adipose tissue in obesity is thought to be one of 
the main drivers of local and systemic insulin resistance. Inflammation can be 
triggered by hypoxia due to adipocyte hypertrophy, subsequent adipose tissue fibrosis 
and necrotic adipocyte death (Ye et al. 2007; Khan et al. 2009). Activation of the UPR 
and increased production of ROS in adipose tissue also lead to activation of 
inflammatory signalling (Furukawa et al. 2004; Özcan et al. 2004). These features of 
dysfunctional adipose tissue can exist simultaneously in obesity, and all result in the 
modification of the normal immune cell population of adipose tissue, and an increase 
in pro-inflammatory cytokine production leading to systemic insulin resistance. 
Obesity associated with a high fat diet induces an accumulation in immune 
cells in adipose tissue, as well as a switch towards more pro-inflammatory cell types. 
These directly contribute to local insulin resistance and are responsible for increases 
in plasma pro-inflammatory cytokine levels. Adipose tissue in obesity lacks or has 
reduced numbers of many of the cell types responsible for maintaining an anti-
inflammatory environment in the non-obese state. Eosinophils, ILC2 cells and Treg 
cells are all reduced in obesity resulting in less anti-inflammatory cytokine production 
(Feuerer et al. 2009; Wu et al. 2011; Brestoff et al. 2015), which is required to maintain 
the M2 ATM population (Molofsky et al. 2013). In contrast, neutrophil content in 
adipose tissue increases quickly after exposure to a high fat diet (Elgazar-Carmon et 
al. 2008). Activated neutrophils secrete elastase, a protease that has been found to 
degrade insulin receptor substrate 1 (IRS1) and induce insulin resistance in adipocytes 




      
      
and hepatocytes, as well as activating toll-like receptor 4 (TLR4) pro-inflammatory 
signalling (Talukdar et al. 2012). CD8+ effector T cells are also increased and activated 
in adipose tissue after high fat feeding (Nishimura et al. 2009). When activated, these 
cells secrete MCP1, encouraging the migration of monocytes into adipose tissue and 
their differentiation into macrophages (Kamei et al. 2006; Nishimura et al. 2009). 
Natural killer (NK) cells in adipose tissue increase in number with high fat feeding and 
act as sensors of cellular stress or infection (Wensveen et al. 2015). In response to 
upregulation of stress signals from adipocytes, NK cells increase interferon-γ (IFN-γ) 
production, triggering polarisation of ATM to an M1 phenotype.  
 Pro-inflammatory macrophages in visceral adipose tissue are thought to be the 
main source of the excessive production of pro-inflammatory cytokines and insulin 
resistance. ATMs are the most abundant immune cell in adipose tissue, and their 
population size is greatly increased in the obese state (Weisberg et al. 2003; Xu, 
Barnes, et al. 2003), due to increased expression of chemoattractant signals from 
adipocytes, both alive and necrotic, and other immune cells (Cinti et al. 2005; 
Nishimura et al. 2009; Arner et al. 2012). M1-polarised ATMs in obesity are found 
mostly around dying or dead adipocytes in clusters called crown-like structures (CLS), 
where they scavenge free lipid and form giant multinucleated cells (Cinti et al. 2005; 
Lumeng et al. 2007; Murano et al. 2008). The pro-inflammatory phenotype of these 
ATMs is characterised by increased expression of the cell surface marker CD11c, 
lysosome biogenesis and expression of pro-inflammatory cytokines (Wentworth et al. 
2010; Xu et al. 2013). These activated ATMs are the primary source of many 
damaging pro-inflammatory cytokines that are increased systemically in obesity, 
including tumour necrosis factor alpha (TNFα), the first cytokine found to be 
upregulated in obese adipose tissue and associated with insulin resistance 
(Hotamisligil et al. 1993; Nguyen et al. 2007). ATMs also increase expression of 
interleukin 1 beta (IL-1β) in diet-induced obesity, leading to a rise in plasma levels of 
the cytokine and increased production of monocytes and neutrophils in bone marrow, 
a prevalent feature of obesity-associated insulin resistance (Nagareddy et al. 2014). As 
well as its systemic effects, IL-1β induces inflammatory gene expression and insulin 




      
      
resistance in primary adipocytes, potentially increasing local inflammation further 
(Gao et al. 2014).  The damaging local and systemic effects of these pro-inflammatory 
macrophages have been confirmed by ablation of CD11c+ cells in obese mice 
(Patsouris et al. 2008). Without M1 macrophages, adipose expression as well as serum 
levels of pro-inflammatory cytokines were reduced, and whole body insulin sensitivity 
was restored, with a reduction in liver lipid content and macrophage markers in 
muscle. A reduction in adipose tissue macrophage content was also associated with 
improved insulin sensitivity in humans after thiazolidinedione treatment (Koppaka et 
al. 2013).  
 
1.2.4 Endoplasmic reticulum stress 
The endoplasmic reticulum (ER) is a large membranous organelle involved in protein 
and lipid synthesis, and with the Golgi apparatus, ensures the secretion of correctly 
folded proteins. Within the lumen of the ER, chaperone proteins aid in the correct 
folding of proteins and formation of disulfide bonds. Adipocytes are potent endocrine 
cells, secreting many endocrine and paracrine factors, some of which are found 
abundantly in serum. The ER also plays a role in triglyceride formation in adipocytes, 
as the enzymes required to join three fatty acids and one glycerol molecule are located 
in the ER lumen (Wolins et al. 2006) and it has been suggested to be integral to the 
formation of lipid droplets (Blanchette-Mackie et al. 1995). The ER is very sensitive 
to changes in the cell including glucose deprivation, increased demand for protein 
synthesis and secretion, excess lipid and hypoxia (Koumenis et al. 2002; Gregor and 
Hotamisligil 2007). If stressed, the ER triggers an adaptive response called the 
unfolded protein response (UPR). The UPR is characterised by reduced protein 
synthesis, enhanced secretory capability and increased expression of chaperone 
proteins to aid in folding proteins in the ER (Gregor and Hotamisligil 2007). As well 
as its effects on protein synthesis, the UPR increases production of reactive oxygen 
species through increased activity of endoplasmic reticulum oxidoreductase 1 
(ERO1)(Harding et al. 2003). UPR activation has also been shown to activate pro-




      
      
inflammatory pathways and directly inhibit insulin signalling in liver cells through 
inhibition of insulin-stimulated phosphorylation of downstream targets  (Özcan et al. 
2004). In adipose tissue of obese mice and humans, the UPR is activated contributing 
to metabolic dysfunction (Özcan et al. 2004; Sharma et al. 2008).  
 
1.2.5 Adipose expansion, hypoxia and fibrosis 
Excess nutrients are stored by hypertrophy of the adipocyte population and recruitment 
of adipocyte precursors to differentiate and cause hyperplastic growth of the fat pad. 
With rapid expansion of the fat depot, the vasculature can fail to expand accordingly 
and adequate blood flow is not maintained, resulting in local areas of hypoxia. Obesity 
has been shown to reduce oxygenation of adipose tissue in humans, dogs and mice (Di 
Girolamo et al. 1971; Kabon et al. 2004; Hosogai et al. 2007). Hypoxia causes 
stabilisation of hypoxia inducible factor 1α (HIF1α), the key transcriptional regulator 
of the hypoxia response. In a classical hypoxic response, HIF1α stimulates the 
expression of proangiogenic genes such as vascular endothelial growth factor A 
(VEGFa) and its receptor. However, in adipose tissue from obese individuals, HIF1α 
fails to trigger this pro-angiogenic response, and instead upregulates components of 
the extracellular matrix (ECM) leading to deposition of fibrillar collagen and reduction 
of tissue plasticity (Halberg et al. 2009). This abnormal fibrotic response causes stress 
to increasingly large adipocytes, resulting in necrotic cell death, infiltration of 
macrophages and local inflammation and subsequently impaired glucose tolerance 
(Khan et al. 2009). As well as enacting a damaging fibrotic program of gene 
expression, hypoxia can also trigger activation of the UPR, reduce gene expression of 
antioxidant enzymes, dysregulate adipokine production and promote inflammation 
(Koumenis et al. 2002; Hosogai et al. 2007; Ye et al. 2007; Lee et al. 2008). Through 
its many detrimental effects on cellular function, and direct metabolic impairment of 
adipocyte function, hypoxia is a key player in the pathophysiology of dysfunctional 
adipose tissue in metabolic disease. 




      
      
1.2.6 Altered adipokine secretion 
Adipose tissue is an endocrine organ, producing many hormones and cytokines that 
signal the metabolic and inflammatory state of the tissue. Adipocytes and cells of the 
stromal vascular fraction, including pre-adipocytes and immune cells make and secrete 
these signals, collectively called adipokines. In obesity, secretion of beneficial 
adipokines such as adiponectin are reduced and pro-inflammatory adipokines, like 
PAI1 and TNFα are increased, and it is through disruption of the balance of these 
signals that dysfunctional adipose tissue can lead to systemic insulin resistance, 
cardiovascular disease and the metabolic syndrome.  
 
1.2.6.1 Anti-inflammatory adipokines 
Several beneficial adipokines have been identified which have pleotropic effects on 
insulin sensitivity, cardiovascular health, inflammation, neuroendocrine activity and 
food intake. Adiponectin is the most abundant adipokine in human plasma. It is 
expressed in all white adipose tissue and levels in plasma are reduced with obesity (Hu 
et al. 1996) and further reduced in diabetic patients (Yu et al. 2002). Hypoxia and 
oxidative stress in adipose tissue in obesity reduce adiponectin expression, and in diet-
induced obesity in mice, adiponectin protein is sequestered in adipose tissue rather 
than secreted (Furukawa et al. 2004; Chen et al. 2006; Nakatsuji et al. 2014). 
Adiponectin is a peptide hormone produced by white adipocytes with a structure 
similar to complement factor C1q (Scherer et al. 1995). Two known receptors for this 
adipokine, AdipoR1 and AdipoR2, are found in both humans and rodents in many 
tissues and cell types including adipocytes (Blüher et al. 2005), hepatocytes (Neumeier 
et al. 2005),  skeletal muscle cells (Staiger et al. 2004), cardiomyocytes (Ding et al. 
2007), osteoblasts (Berner et al. 2004), immune cells (Chinetti et al. 2004; Alberti et 
al. 2007), pancreatic β cells (Kharroubi et al. 2003) and in the hypothalamus (Kubota 
et al. 2007). The widespread expression of adiponectin receptors gives some indication 
of its importance as an insulin-sensitising hormone and anti-inflammatory signal. In 
mouse models, recombinant adiponectin replacement improves insulin sensitivity and 
reduces hepatic steatosis (Yamauchi et al. 2001; Xu, Wang, et al. 2003). Adiponectin 




      
      
enhances insulin signalling in both liver and skeletal muscle, inhibiting 
gluconeogenesis and increasing glucose uptake respectively (Berg et al. 2001; Stefan 
et al. 2002). Adiponectin also functions in an autocrine manner on adipocytes, 
increasing insulin-mediated glucose uptake and lipogenesis (Fu et al. 2005). As well 
as its insulin-sensitising effects, adiponectin acts as an anti-inflammatory hormone, 
encouraging macrophage M2 polarisation, and inhibiting pro-inflammatory cytokine 
production (Okamoto et al. 2008; Ohashi et al. 2010). It also supresses proliferation 
of monocytic precursors, phagocytosis and cytokine production in mature 
macrophages (Yokota et al. 2000), and importantly for cardiovascular risk, it prevents 
macrophage to foam cell transformation by preventing lipid accumulation (Ouchi et 
al. 2001). The anti-inflammatory effects of adiponectin on macrophages are suggested 
to be protective against atherosclerosis, along with its beneficial effects on endothelial 
cells through decreasing TNFα expression (Ouchi et al. 2000),  and down-regulating 
leukocyte adhesion (Komura et al. 2013). In apolipoprotein E knockout mice, 
supplementation of adiponectin by adenoviral delivery reduces the formation of  
atherosclerotic lesions (Okamoto et al. 2002). Therefore, the reduced level of 
circulating adiponectin in obesity is directly implicated as a cause of systemic insulin 
resistance and cardiovascular disease. 
 Other beneficial adipokines are expressed and secreted by adipose tissue, 
although a full understanding of their mechanisms of action and regulation remains to 
be elucidated. The C1q/TNF-related protein (CTRP) family are structurally similar to 
adiponectin, and some members are mainly expressed in adipose tissue, and their 
expression is reduced with obesity (Wong et al. 2008). These CTRP proteins are 
associated with enhanced insulin signalling, reduced macrophage activation and 
improved revascularisation after cardiac ischaemic injury (reviewed in Ohashi et al. 
2014). Other adipokines with beneficial metabolic and cardiovascular effects are 
secreted frizzled-related protein 5 (SFRP5) and omentin. Both are reduced in adipose 
tissue in mouse models of obesity and in visceral fat from obese human individuals 
(De Souza Batista et al. 2007; Ouchi et al. 2010). Mice lacking SFRP5 have worsened 
insulin sensitivity after a high fat feeding challenge, and are susceptible to  increased 




      
      
cardiac damage after myocardial ischemia/reperfusion injury (Ouchi et al. 2010; 
Nakamura et al. 2016). Omentin overexpression in apolipoprotein E knockout mice 
attenuated atherosclerotic lesion formation, reducing macrophage infiltration and pro-
inflammatory cytokine expression in plaques (Hiramatsu-Ito et al. 2016). These and 
other beneficial adipokines exert positive effects throughout the body, and 
dysregulation of their expression in dysfunctional adipose tissue in obesity directly 
contributes to whole-body insulin resistance and other characteristics of the metabolic 
syndrome.  
 
1.2.6.2 Pro-inflammatory adipokines in obesity 
Leptin was the first adipokine to be discovered, and it was initially known to act as a 
satiety signal, with its absence leading to reduced energy expenditure, hyperphagia and 
extreme obesity (discussed in paragraph 1.1.3 on page 19)(Friedman and Halaas 1998). 
Leptin also plays a role in many peripheral processes including reproduction (Chehab 
et al. 1996), bone metabolism (Ducy et al. 2000), angiogenesis (Sierra-Honigmann et 
al. 1998), hematopoiesis (Bennett et al. 1996) and glucose homeostasis (Berti and 
Gammeltoft 1999). Leptin also influences the activity of the immune system 
contributing to systemic inflammation in obesity. Plasma leptin is increased in obesity, 
and correlates with fat mass in mice and humans (Frederich et al. 1995; Considine et 
al. 1996). Although leptin is known to signal in the hypothalamus to inhibit food 
intake, in most cases of severe obesity, high leptin levels fail to act as an appetite 
suppressant, a state that has been described as “leptin resistance”. Leptin has a similar 
structure to the long chain helical family of cytokines, and its receptor is a member of 
the class I cytokine receptor family (Tartaglia et al. 1995; Zhang et al. 1997). This 
receptor is expressed in the hypothalamus and other neural regions, but it is also 
expressed by many cells of the immune system, including monocytes, neutrophils and 
lymphocytes (Tartaglia et al. 1995; Lord et al. 1998; Zarkesh-Esfahani et al. 2001; 
Caldefie-Chezet et al. 2003). Leptin induces proliferation and expression of pro-
inflammatory cytokines and chemokines in monocytes and macrophages (Gabay et al. 
2001; Zarkesh-Esfahani et al. 2001; Kiguchi et al. 2009). It also increases chemotaxis 




      
      
and ROS production in neutrophils (Caldefie-Chezet et al. 2003). In CD4+ T cells, 
leptin has been found to induce proliferation and increase expression of pro-
inflammatory cytokines and adhesion molecules (Lord et al. 1998). Leptin also 
increases platelet aggregation and ROS production and cytokine expression by 
endothelial cells, as well as encouraging macrophage to foam cell differentiation 
(Konstantinides et al. 2001; Yamagishi et al. 2001; O’Rourke et al. 2002). Therefore, 
these effects of leptin contribute to the chronic pro-inflammatory state in obesity, and 
increase the risk of developing atherosclerosis or suffering a thrombotic stroke. 
Macrophages in adipose tissue are a source of many pro-inflammatory 
adipokines that have detrimental local and systemic effects. Dysfunctional adipose 
tissue in obesity overexpresses many factors that cause macrophage infiltration and 
activation. Tumour necrosis factor alpha (TNFα) was the first cytokine found to be 
expressed in adipose tissue, and this discovery established the association of 
inflammation  with severe obesity and insulin resistance (Hotamisligil et al. 1993). 
TNFα, produced by adipocytes and macrophages, inhibits insulin signalling, as well 
as maintaining pro-inflammatory cytokine production, including its own production, 
thus creating a chronic inflammatory state (Hotamisligil et al. 1994; Nguyen et al. 
2005).  Monocyte chemotactic protein 1 (MCP1) is also upregulated in adipose tissue 
in obesity and contributes to insulin resistance in adipose tissue, liver and muscle 
(Kamei et al. 2006; Kanda et al. 2006a; Sell et al. 2006). MCP1 also acts as a 
chemokine, encouraging monocyte infiltration into adipose tissue. Macrophages also 
produce interleukin-6 (IL-6) which is associated with insulin resistance (Pradhan et al. 
2001; Fain et al. 2004). Blocking IL-6 in cases of genetic or diet-induced obesity 
improved hepatic insulin sensitivity and prevented macrophage recruitment to adipose 
tissue (Klover et al. 2005; Kraakman et al. 2015). However, the function of IL-6 in 
metabolic processes is complex, as mice genetically lacking the gene (IL-6-/- mice) are 
more prone to developing hepatic inflammation and systemic insulin resistance than 
wild type controls on a standard or high fat diet (Matthews et al. 2010). 
An increase in the expression of some adipokines is associated with 
cardiovascular disease. Plasminogen activator inhibitor 1 (PAI1) is increased in 




      
      
plasma of obese and diabetic patients. (Landin et al. 1990; McGill et al. 1994). PAI1 
is an inhibitor of fibrinolysis, a process that prevents blood clot formation, and it is 
produced by adipocytes and SVF cells, with its expression induced by TNFα, as well 
as other inflammatory factors (Alessi et al. 1997; Samad et al. 1999). Another player 
in the control of haemostasis, tissue factor (TF) is also dysregulated in adipose tissue 
in obesity. TF is a major initiator of the coagulation cascade and its expression is 
increased in adipose depots of ob/ob mice (Samad et al. 1998). Leptin increases 
expression of TF in neutrophils and monocytes (Rafail et al. 2008). Inhibition of 
fibrinolysis by PAI1 and increased risk of coagulation by TF, coupled with increased 
platelet activity (Konstantinides et al. 2001), likely underpins the increased risk for 
thrombotic and cardiovascular complications associated with obesity (Borch et al. 
2011; Wormser et al. 2011). Adipose tissue also produces angiotensinogen, a key 
factor in the renin-angiotensin system (RAS) of blood pressure control. Activation of 
RAS is found in hypertension associated with diet-induced obesity in rats, and 
upregulation of angiotensinogen in adipose tissue is thought to be responsible for the 
increased blood pressure (Boustany et al. 2004). 
Other adipokines increased in obesity have been associated with insulin 
resistance or inflammation, although less is known about their mechanisms of action. 
Resistin is secreted by adipocytes in mice, its plasma levels are increased in obesity 
and there is evidence that it impairs glucose tolerance and induced insulin resistance 
(Steppan et al. 2001). In humans, resistin is expressed by macrophages rather than 
adipocytes (Savage et al. 2001), however the development of a “humanised” mouse 
expressing resistin only in macrophages supported a causal link between this adipokine 
and adipose tissue inflammation and insulin resistance in WAT and skeletal muscle 
(Qatanani et al. 2009). Chemerin is another adipokine associated with glucose 
intolerance and worsened measurements of metabolic health. Chemerin is expressed 
in adipose tissue, enriched in the adipocytes, and its receptor is most highly expressed 
in adipose tissue suggesting a paracrine action (Goralski et al. 2007). Plasma chemerin 
is increased in obese individuals, and is correlated with features of the metabolic 
syndrome such as fasting insulin, plasma triglycerides and HDL cholesterol (Bozaoglu 




      
      
et al. 2009). In obese mice, chemerin exacerbated glucose intolerance and reduced 
serum insulin levels (Ernst et al. 2010). Retinol binding protein 4 (RBP4) is also 
upregulated in adipose tissue of obesity mice, with increased plasma levels associated 
with insulin resistance (Yang, Graham, et al. 2005). Its role in human obesity is more 
controversial, as results from clinical studies measuring RBP4 in obese and diabetic 
subjects have given conflicting results (Kotnik et al. 2011), despite mouse studies 
showing that RBP4 increases adipose inflammation, impairs insulin signalling, and 
increases hepatic gluconeogenesis (Yang, Graham, et al. 2005; Moraes-Vieira et al. 
2014). These and many more adipokines underlie the varied detrimental effects of 
obesity on metabolic health. 
 
To summarise, in obesity adipose tissue expansion with inadequate angiogenesis leads 
to hypoxia, endoplasmic and oxidative stress and inflammation, impairing the ability 
of the tissue to store excess lipid, make and secrete adipokines and respond to insulin. 
These consequences of adipose dysfunction lead to an increase in systemic pro-
inflammatory cytokine circulation, and a reduction in insulin sensitivity locally and in 
other organs.  
  




      
      
1.3 THIOSULFATE SULFURTRANSFERASE 
1.3.1 Discovery of Tst as a lean gene 
Recent work from our laboratory sought to discover a genetic basis for healthy 
leanness comparing the Lean and Fat mouse lines (L and F mice), created by divergent 
selection for more than 60 generations for low and high body fat content (Horvat et al. 
2000). One gene was found to be overexpressed in white adipose tissue of the L mice, 
thiosulfate sulfurtransferase (Tst) (Morton et al. 2016). Elevated Tst expression in 
adipose tissue co-segregated with leanness in subsequently derived congenic lines with 
increasingly refined “lean” chromosomal regions back-crossed onto the divergently 
selected counterpart F line.  Conversely, adipose TST levels are low in mice with diet-
induced or genetic obesity. Direct evidence that elevated TST is metabolically 
protective was provided by the phenotype of transgenic mice overexpressing Tst in 
adipose tissue under the adiponectin promoter, the Adipoq-Tst mouse. In response to 
high fat diet, these mice had reduced weight gain, elevated plasma adiponectin and 
improved glucose tolerance (Morton et al. 2016). In addition to a genetic increase in 
Tst expression, pharmacological activation by treatment with a TST substrate, sodium 
thiosulfate ameliorated diabetes in high fat diet-fed wild-type mice and genetically 
obese mice. Investigation of the relevance of TST to human biology found that TST 
mRNA was higher in adipose depots from lean compared to obese subjects in an 
Austrian cohort, and adipose TST mRNA correlated negatively with BMI in two other 
human cohorts from Iceland and Spain. Several polymorphisms in and around the TST 
gene were identified in a small Caucasian cohort, some of which were predicted to 
alter the function or stability of the enzyme or impact promoter activity, however no 
metabolic phenotypes were reported in these papers (Billaut-Laden et al. 2006; Libiad 
et al. 2015). A full understanding of the role of TST in adipose tissue function, 
including an investigation of the effects of common TST polymorphisms on obesity 
and metabolic syndrome risk has yet to be elucidated. 
  




      
      
1.3.2 Function of thiosulfate sulfurtransferase 
TST was first described as early as the 1950s as a cyanide detoxification enzymatic 
activity called rhodanese (Baskin et al. 1992). Rhodanese domain-containing proteins 
have since been found in all phyla, including bacteria and plants (Bordo and Bork 
2002). As a sulfurtransferase, TST’s main function is to catalyse the transfer of sulfane 
sulfur (R-S-SH) from a donor to an acceptor. TST shares up to 66% sequence 
similarity with another sulfutransferase, 3-mercaptopyruvate sulfurtransferase 
(MPST) which was first identified as the source of hydrogen sulfide (H2S) in the brain 
(Nagahara et al. 1995; Shibuya et al. 2009). In the detoxification of cyanide, 
thiosulfate is administered as an antidote, and is used by TST as a substrate to drive 
the addition of sulfur to cyanide, making the less toxic thiocyanate ion. This reaction 
is also used as the basis of an assay to measure rhodanese activity in vitro as shown in 
Figure 1.1. Decades of research linked TST to a number of cellular processes such as 
donation of sulfane sulfur to iron-sulfur clusters of the respiratory complexes of the 
mitochondrial electron transport chain, detoxification of mitochondrial ROS, transport 
of ribosomal 5S RNA into mitochondria and metabolism of the endogenously-
produced gasotransmitter H2S (Bonomi et al. 1977; Nandi et al. 2000; Hildebrandt and 
Grieshaber 2008; Smirnov et al. 2010). The central role of TST in many mitochondrial 
processes suggests a number of potential biochemical mechanisms linking it to the 
adipose tissue-intrinsic control of fat accumulation and insulin sensitivity, and fits with 
evidence that oxidative stress, mitochondrial dysfunction, hydrogen sulfide signalling 
and inflammation play key roles in the pathogenesis of obesity and diabetes (Koh et 
al. 2007; Gregor and Hotamisligil 2011; Ruskovska and Bernlohr 2013). 




      
      
 
Figure 1.1: Catalytic mechanism of TST activity in the detoxification of 
cyanide and in the assay used to measure rhodanese activity. 
(a) Thiosulfate becomes sulfite by donating a sulfur to the active site cysteine 
(Cys-248) of TST. (b) This sulfur is then transferred to cyanide making 
thiocyanate. (Image created using ChemDraw Std). 
  




      
      
1.3.2.1 TST in hydrogen sulfide metabolism 
In humans and mice, TST is implicated in the oxidation of hydrogen sulfide (H2S) in 
the mitochondria, however its role and the mechanism of its action is not fully clarified. 
H2S is a gasotransmitter with varied physiological effects, including vasodilation and 
redox and inflammatory mediation, and it may play a role in adipose tissue dysfunction 
in obesity (discussed in section 1.3.3 on page 48).  
 H2S is metabolised in the mitochondria by enzymes of the sulfide oxidation 
pathway (Figure 1.2). The initial oxidation of H2S by sulfide quinone oxidoreductase 
(SQR) which is bound to the inner mitochondrial membrane, results in the transfer of 
two electrons from sulfide to the electron transport chain (Hildebrandt and Grieshaber 
2008). The remaining sulfane sulfur is transferred to glutathione, making glutathione 
persulfide (GSSH). This is then further oxidised to sulfite (SO32-) by a sulfur 
dioxygenase, also known as ethylmalonic encephalopathy protein 1 (ETHE1) due to 
its discovery as the causative mutation in that fatal inherited disease (Tiranti et al. 
2009). TST catalyses the transfer of sulfur from another molecule of glutathione 
persulfide to this highly reactive sulfite, neutralising it and making thiosulfate (SSO32-
) (Libiad et al. 2014). Sulfite can also be disposed of by sulfite oxidase (SO), which 
turns it into sulfate (SO42-). Thiosulfate and sulfate are the two main products of the 
sulfide oxidation pathway, although the ratio of their production varies in different 
tissues and depending on the concentration of substrates and expression of the enzymes 
of the pathway. Red blood cells, lacking mitochondria, employ an alternative 
mechanism of sulfide metabolism using methemoglobin to oxidise sulfide, producing 
thiosulfate and polysulfides, which can also act as signalling molecules (Vitvitsky et 
al. 2015). 




      
      
 
Figure 1.2: Mitochondrial sulfide oxidation pathway 
Proposed model of mitochondrial sulfide oxidation. Hydrogen sulfide (H2S); 
sulfide quinone oxidoreductase (SQR); Ethymalonic encephalopathy protein 1 
(ETHE1); Thiosulfate sulfurtransferase (TST); Sulfite oxidase (SO); 
Glutathione +/- persulfidation (GSH/GSSH); Sulfite (SO32-); Thiosulfate 
(SSO32-); Sulfate (SO42-); Complex III (CIII); Electron (e-); Outer mitochondrial 
membrane (OMM); Intermembrane space (IMS); Inner mitochondrial 
membrane (IMM). [Protein images licenced under Creative Commons 
Attribution 3 from Servier Medical Art by Servier at smart.servier.com]. 
 
Some controversy exists about whether TST can directly metabolise sulfide, or 
whether it must first be oxidised to sulfane-sulfur, such as in glutathione persulfide 
and thiosulfate. This controversy is based on investigation of sulfide oxidation in the 
colon, where levels of sulfide can reach or exceed toxic concentrations due to 
production by bacteria (Macfarlane et al. 1992; Leschelle et al. 2005). Rhodanese 
activity (encompassing TST and MPST activity) has been measured throughout the 
gastroinstestinal tract, with highest activity in the colon (Picton et al. 2002). This study 
concluded that rhodanese was capable of metabolising H2S, and was the main activity 
responsible for sulfide oxidation in the colonic muscosa. However, this was 




      
      
subsequently challenged by another group that found that the H2S-metabolising rate of 
rhodanese was up to twenty times lower than the capacity of mixed protein 
homogenate of colonic muscosa, and it is likely rhodanese requires the initial oxidation 
of H2S by another enzyme, such as SQR, before rhodanese can use it as a substrate 
(Wilson et al. 2008). Although this was challenged by the authors of the first paper 
(Eggo et al. 2008), more recent investigations, such as that by Libiad et al. (2014), do 
not support the claim that rhodanese/TST can directly metabolise H2S. 
Preliminary results from our lab using liver tissue homogenate of Tst-/- mice 
have indicated that TST is involved in the breakdown of H2S, as liver homogenate 
lacking Tst shows a lower rate of H2S breakdown than wild type (Roderick Carter, 
unpublished). Also the Tst–/– mouse has increased plasma sulfide, indictating a 
profound alteration in sulfide oxidation (Morton et al. 2016). The presence of TST in 
many other tissues including adipose tissue, the liver and immune cells indicates a 
broad role for this enzyme in the metabolism of H2S, and hence its importance in 
regulating the myriad physiological effects proposed for H2S as a signalling molecule 
and ROS and inflammatory mediator (see 1.3.3). A full understanding of the role of 
TST in H2S metabolism is still lacking, however evidence linking H2S to oxidative 
stress, inflammation and insulin resistance highlights a potential mechanism for the 
impact of altered adipose Tst expression in the polygenic Lean mouse line. 
 
1.3.2.2 TST in ROS metabolism 
As well as its role in sulfur metabolism, TST may interact with antioxidant enzymes 
to aid in metabolism of reactive oxygen species (ROS). Thioredoxin, one of the main 
antioxidant enzymes reverses oxidation of cysteine groups by high ROS levels 
(described in section 1.2.2.2 on page 23). Thioredoxin is in turned recycled to its 
reduced form by thioredoxin reductase using NADPH. TST can be oxidised by H2O2 
at its active site cysteine forming a sulfenic acid, and prolonged exposure to excess 
H2O2 can result in further oxidation and the formation of a disulfide bond, permanently 
inactivating the enzyme (Costa et al. 1977). However, in a cell-free system, the 
oxidation of one isoform of TST by the formation of a sulfenic acid at its active site 




      
      
was reversed by thioredoxin, resulting in the oxidation of NADPH and the 
neutralisation of the attacking ROS (Nandi et al. 2000). Thioredoxin, thioredoxin 
reductase and TST are found in the mitochondrial matrix, and so excess mitochondrial 
ROS production as observed in dysfunctional adipose tissue may be neutralised by this 
pathway. While this interaction has not yet been directly observed in mammalian cells, 
sulfurtransferases of the plant Arabidopsis thaliana interacted with thioredoxins which 
are in close proximity within subcellular locations (Henne et al. 2015). In mammalian 
cells, the evolutionarily similar sulfurtransferase MPST can be oxidised and 
inactivated by H2O2, and this oxidation is reversed by interaction with thioredoxin 
(Nagahara and Katayama 2005). This inactivation of MPST by oxidative stress 
indirectly contributes to the restoration of the redox balance by reducing the amount 
of cysteine consumed by MPST and allowing it to be used as a reducing agent instead. 
Due to the similarity of MPST and TST, it is conceivable that TST may also be 
inactivated by oxidation, leading to the build-up of H2S or glutathione persulfide, both 
of which may help to restore the redox balance of the cell, however this has not been 
investigated. 
 Some evidence indicating a link with TST and ROS metabolism in vivo in 
mammals has been found, although a definite role has yet to be described. TST gene 
and protein expression was reduced in blood monocytes of hemodialysis patients, and 
was negatively correlated with superoxide levels, and low levels predicted greater 
mortality risk (Krueger et al. 2010). In rats exposed to long-term low-dose radiation, 
TST expression was increased in liver, potentially in response to increased ROS 
production, however the authors failed to confirm the presence of oxidative stress 
(Nakajima et al. 2008). Our lab found that siRNA-mediated knockdown of TST in 
3T3-L1 adipocytes led to increased mitochondrial ROS production after exposure to 
H2O2 (Morton et al. 2016). The contribution of TST to the control of ROS in vivo 
remains uncertain, but in vitro evidence of its ability to interact with thioredoxin 
suggests that the enzyme may play a part in reducing mitochondrial ROS levels, and 
thus could help to prevent oxidative stress and subsequent inflammation and insulin 
resistance.  




      
      
 
1.3.2.3 Other functions of TST 
Several other roles for TST that could impact the function of the mitochondria have 
been suggested. Early investigation of the sulfur-transfer function of TST led 
biochemists to conclude that it could increase the function of iron-sulfur cluster-
containing enzymes. NADH dehydrogenase, complex I of the electron transport chain 
and succinate dehydrogenase, complex II can receive sulfur from TST, allowing them 
to function in vitro (Pagani et al. 1975; Bonomi et al. 1977; Pagani and Galante 1983). 
As well as this, a role for TST in transportation of 5S ribosomal RNA from the 
cytoplasm to the mitochondria has been suggested. TST was found to bind ribosomal 
RNA and silencing of the gene lead to a reduction in mitochondrial protein translation 
(Smirnov et al. 2010), which may impact the phenotype of genetically altered mice 
used in this thesis. 
 
  




      
      
1.3.3 Hydrogen sulfide 
1.3.3.1 H2S is an endogenously produced gasotransmitter 
Hydrogen sulfide (H2S) was long recognised as a toxic gas with the smell of rotten 
eggs. Its toxicity lies in its ability to inhibit cytochrome c oxidase, complex IV, thus 
stopping respiration and causing cell death (Nicholls and Kim 1982). However in 
recent decades, H2S has been recognised as an endogenously produced 
gasotransmitter, with many pleotrophic physiological effects. At estimated 
endogenous levels, H2S can donate electrons to the electron transport chain, thus acting 
as substrate for oxidative phosphorylation (Goubern et al. 2007). H2S may exert 
biological effects by directly interacting with ROS to make thiol intermediates, but it 
can also change protein function by persulfidation, a post-translational modification 
characterised by the addition of sulfur to the thiol side chain of cysteine residues 
forming a persulfide group (Li et al. 2011). H2S  has also been shown to mediate the 
beneficial effects of calorie restriction (Hine et al. 2015). Through direct chemical 
interaction or through protein modification, H2S has been identified as a modulator of 
inflammation and oxidative stress, thus linking it to progression of metabolic disease 
in obesity. 
H2S was first discovered to be produced endogenously in mammalian brain by 
cystathionine β-synthase (CBS), and to modulate brain function by enhancing 
neurotransmitter receptor activity (Abe and Kimura 1996). Susequently, another H2S-
producing enzyme, cystathionine γ-lyase (CSE) was identified in the vasculature, and 
it was found that H2S could cause vasorelaxation through inhibition of potassium ATP 
channel function (Zhao et al. 2001; Hosogai et al. 2007). CBS and CSE are dependant 
on a co-factor, pyridoxal 5’ phosphate (PPP), and use L-cysteine or homocysteine as 
substrates. H2S can also be made by a third enzyme, the rhodanese domain-containing 
3-mercapopyruvate sulfurtransferase (MPST) which uses 3-mercaptopyruvate as a 
substrate and has high similarity to TST (Nagahara et al. 1995; Shibuya et al. 2009). 
In adipose tissue, CSE is recognised as the main source of local H2S production (Feng 
et al. 2009). The tissue-specific expression and activity of these enzymes, as well as 




      
      
substrate and co-factor availability determines the rate of H2S production in different 
tissues. 
Our understanding of the role of H2S in vivo has been hampered by inaccurate 
methods of measuring and delivering the gas experimentally. It was discovered that 
measurements of endogenous H2S levels in tissue were likely to be much lower than 
initially thought (Furne et al. 2008), and modern methods of sulfide measurement have 
been developed which substantiate this (Wintner et al. 2010). The most commonly 
used H2S donor compounds such as disodium sulfide (Na2S) and sodium hydrosulfide 
(NaHS), rapidly release large non-physiological amounts of H2S which is quickly 
metabolised, putting in doubt any long-term effects. New slow-release H2S donor 
compounds such as GYY4137 and the mitochondrially-targeted AP39 are being used 
to deliver physiological levels of the gas and to investigate its biological effects in 
many diseased and non-diseased states (Li et al. 2008; Szczesny et al. 2014). It is likely 
that improvements in our ability to measure and control delivery of H2S will lead to a 
deeper understanding of its myriad physiological roles as an endogenously produced 
gasotransmitter and its potential as a therapeutic target for many diseases, including 
the metabolic syndrome. 
 
1.3.3.2 H2S as an antioxidant mediator 
Hydrogen sulfide can help to maintain a normal cellular redox balance through several 
mechanisms. It may directly act to scavenge reactive species, thus preventing or 
reversing damage to proteins, DNA and lipids. It is likely that persulfidation of some 
antioxidant enzymes may increase their activity during oxidative stress. Persulfidation 
of specific proteins within mitochondria can also lead to reduced production of 
mitochondrial ROS. As well as these direct antioxidant effects, H2S-mediated 
persulfidation of key transcription factors can lead to upregulation of antioxidant and 
anti-inflammatory genes. 
H2S can directly scavenge ROS and reactive products of their reaction with 
other cellular components, and may be able to reduce mitochondrial ROS production 
during oxidative stress. H2S can directly scavenge superoxide in vitro, as well as 




      
      
inhibiting superoxide production from NADPH oxidase (NOX) in aortic rings (Al-
Magableh et al. 2014). Superoxide reacts with nitric oxide to form a reactive nitrogen 
compound, peroxynitrite with strong oxidising and nitrating capabilities. H2S inhibits 
peroxynitrite-mediated nitration of proteins and protects against cytotoxicity in a 
neuronal cell line (Whiteman et al. 2004). Lipid hydroperoxides are found in oxidised 
low density lipoprotein (oxLDL) and are formed by the attack of lipids by highly 
reactive species such as the hydroxyl radical. These reactive lipids can be destroyed 
by H2S, potentially reducing damage to the vasculature by oxLDL, which can lead to 
atherosclerosis (Muellner et al. 2009). Damage due to 4-HNE, another product of lipid 
peroxidation, is also inhibited by H2S, preventing carbonylation of proteins and 
protecting against cell death (Schreier et al. 2010). H2S can also reduce the formation 
of ROS from mitochondria through inhibitory persulfidation of p66Shc, a protein 
involved in upregulation of mitochondrial ROS (Xie et al. 2014). These ROS and their 
damaging products are found in dysfunctional adipose tissue in obesity, (discussed in 
paragraph 1.2.2 on page 22), therefore it is possible that local H2S production or 
delivery from the blood may reduce obesity-associated oxidative stress. 
H2S can also directly modulate the function of some antioxidant enzymes. 
Superoxide dismutase (SOD) has cytosolic and mitochondrial forms that incorporate 
different metal ions. H2S reduces the manganese ion in SOD2, the mitochondrial form, 
causing the inactivation of the enzyme due to release of its manganese core (Bolic et 
al. 2015). However, H2S may lead to an overall increase in SOD2 activity during 
oxidative stress, as it is thought to cause an increase in its protein expression (Sun et 
al. 2012). Expression of the cytosolic form of SOD (SOD1 or CuZn-SOD) is 
unchanged by H2S, but its activity is directly increased by binding of H2S to its copper 
ion (Sun et al. 2012; Bolic et al. 2015). H2S enhances protein expression and activity 
of other antioxidant enzymes such as catalase, glutathione S-transferase and 
glutathione peroxidase in response to an oxidative stress challenge (Wen et al. 2013). 
Exogenous H2S mediates the activity of NRF2, inducing the expression of 
many antioxidant enzymes. Normally NRF2 is bound to KEAP1, but increased 
oxidation from ROS allows its dissociation (see paragraph 1.2.2.2 on page 23). H2S 




      
      
can also cause the disassociation of NRF2 from KEAP1 through persulfidation of 
KEAP1 (Yang et al. 2013). This leads to an increase in GSH through the upregulation 
of GCL and GR. H2S also decreases oxidative stress through NRF2-mediated 
upregulation of the antioxidant enzymes thioredoxin 1 and heme oxygenase 1 in a 
mouse model of cardiac ischemia reperfusion injury (Calvert et al. 2009). 
 
1.3.3.3 H2S as an inflammatory mediator 
H2S plays a role in the inflammatory process, however it is still debated whether it is 
anti- or pro-inflammatory. H2S synthesising enzymes are expressed in many cells of 
the immune system, and their expression is increased in some inflammatory disease 
states. H2S can influence many of the cardinal features of acute inflammation – 
increased blood flow, oedema, pain and immune cell infiltration and activation – 
however, some of these effects are also key to the resolution of inflammation. As a 
signalling molecule, H2S can upregulate or downregulate key inflammatory and 
apoptotic pathways in different contexts, muddying the water further. Recent 
development of slow-releasing H2S donor compounds and research on their effects on 
inflammatory disease models has helped bring some clarity to this complicated and 
contradictory field of research, and highlights a potential therapeutic role for this 
gasotransmitter. 
 H2S can directly influence the cardinal signs of inflammation, increasing blood 
flow, altering leukocyte adhesion and survival (Hosoki et al. 1997; Pan et al. 2011). 
While the role of H2S in mediating blood flow in inflammation has not been well-
characterised, the vasodilatory effect of this gas through persulfidation of potassium 
ATP channels highlights a potential mechanism for increased blood flow in pathogenic 
states (Hosoki et al. 1997). This increased blood flow may contribute to oedema during 
inflammation, as observed in a model of limb oedema in which H2S synthesis and 
plasma levels were increased, and administration of a CSE-inhibitor reduced swelling 
(Bhatia et al. 2005). However, in other studies of limb inflammation, administration 
of a H2S donor reduced inflammation and blood flow, indicating a more complicated 
effect of this gasotransmitter on oedema (Andruski et al. 2008; Ekundi-Valentim et al. 




      
      
2010). The adhesion of leukocytes to the endothelium is a key step in allowing 
infiltration of cells towards a site of inflammation, and H2S suppressed this process by 
reducing expression of adhesion molecules in HUVEC endothelial cells, leading to 
reduced adhesion of monocytes (Pan et al. 2011). Also in limb ischemia-reperfusion, 
neutrophil infiltration was inhibited by treatment with H2S (Ball et al. 2013). H2S can 
also impact the activity of leukocytes, as well as reducing their adhesion and 
infiltration. Macrophages treated with H2S show reduced expression of a chemokine 
CXCL1 and its receptor, and this effect was reproduced in an in vivo model of 
atherosclerosis in which H2S treatment reduced plaque formation (Zhang, Guo, Wu, 
et al. 2012). H2S suppressed uptake of oxLDL by macrophages in vitro, preventing 
their conversion to lipid-laden foam cells (Zhao et al. 2011). These effects of H2S 
mediate its protective effect against atherosclerosis  development (Wang et al. 2009). 
The ability of H2S to modulate leukocyte adhesion and function is now widely 
accepted and has led to an understanding of the signalling pathways underlying this 
effect. 
 A deeper understanding of the mechanism of H2S mediation of inflammatory 
pathways has led to a better understanding of its role in inflammatory diseases, and to 
the development of H2S donor compounds that are better able to influence these 
pathways. Patients with inflammatory bowel diseases (IBD) such as ulcerative colitis 
and Crohn’s disease were found to have reduced sulfide detoxification, which led to 
the hypothesis that accumulating H2S is causative for these diseases (De Preter et al. 
2012; Arijs et al. 2013). However, a H2S-releasing derivative of mesalamine, a first-
line therapy for IBD, reduced disease severity, neutrophil activity and pro-
inflammatory cytokine expression in a mouse model of colitis, indicating that the 
reduced sulfide metabolism observed in these patients may be compensatory (Fiorucci 
et al. 2007). Other evidence for the benefit of H2S in reducing gut inflammation came 
from the development of H2S-releasing non-steroidal anti-inflammatory drugs 
(NSAIDs). This class of anti-inflammatory drug includes the common painkillers 
aspirin and ibuprofen, which increase risk of gastric injury, especially with long-term 
use. NSAIDs were found to inhibit H2S synthesis in the gastric mucosa, highlighting 




      
      
a potential mechanism of gastric injury (Fiorucci et al. 2005). A H2S-releasing 
derivative of the NSAID diclofenac, showed a similar ability to reduce oedema and 
neutrophil activity as its parent drug, but with greatly reduced intestinal damage 
(Sidhapuriwala et al. 2007; Wallace et al. 2007). H2S-releasing derivatives of aspirin 
protected against gastric injury, while also reducing plaque size in a model of 
atherosclerosis and hypertension and insulin levels in a model of metabolic syndrome, 
as well as maintaining the anti-thrombotic benefits of aspirin (Rossoni et al. 2010; 
Zhang, Guo, Zhang, et al. 2012). Compounds which release H2S slowly have also been 
developed, such as GYY4137 which inhibited pro-inflammatory macrophage 
activation and supressed cytokine production in a model of endotoxic shock (Li et al. 
2009; Whiteman, Li, et al. 2010). A mitochondrially-targeted H2S donor – AP39 – has 
also recently been developed, and initial testing in vivo has shown beneficial effects in 
reducing neutrophil infiltration, markers of oxidative stress and tissue damage in 
kidney after ischaemia/reperfusion injury (Ahmad et al. 2016).  
The potent anti-inflammatory effects of H2S-based therapies in pre-clinical 
disease models has transformed our understanding of the role of H2S in the complex 
biology of inflammation, and highlighted this simple molecule as a promising new 
target in numerous inflammatory conditions, including the chronic inflammation 
observed in dysfunctional adipose tissue in obesity. 
 
1.3.3.4 H2S in obesity and diabetes 
One study found that hydrogen sulfide was reduced in the plasma of diabetic patients 
and obese individuals (Whiteman, Gooding, et al. 2010). This reduction may 
contribute to the metabolic consequences of these diseases, due to the loss of H2S-
mediated suppression of oxidative stress and inflammation. H2S also exerts direct 
effects on metabolically important tissues such as the adipose, liver, and insulin-
producing β-cells, which may be diminished due to the reduction of H2S in obesity.  
 Adipose tissue expresses the enzymes responsible for H2S production, and this 
gaseous signalling molecule may influence adipogenesis, insulin signalling and 
lipolysis, as well a potentially impacting upon the production of adipokines. A role for 




      
      
H2S in adipogenesis has been suggested, as expression of H2S-generating enzymes is 
increased during adipocyte differentiation (Tsai et al. 2015). H2S can also influence 
differentiation through persulfidation of the transcription factor Peroxisome 
proliferator-activated receptor gamma (PPAR-γ), a master regulator of adipogenesis 
(Cai et al. 2016a). Supplementation of differentiation media of the adipocyte cell line 
3T3-L1 with H2S or the slow-release donor GYY4137 increased nuclear translocation 
of PPAR-γ, with increased lipid accumulation and expression of adipocyte biomarkers. 
In vivo evidence of an important role for H2S in adipogenesis came from studies of 
CBS deficient and CSE knockout mice, which both exhibited reduced fat mass (Gupta 
and Kruger 2011; Mani et al. 2011). H2S also influences mature adipocyte function 
through modulation of insulin signalling and lipolysis. While initial research found 
H2S inhibits insulin-mediated glucose uptake (Feng et al. 2009), results from more 
recent investigations have shown that H2S improves insulin action in adipose through 
upregulation of PPAR-γ activity, and through increasing GLUT4 translocation to the 
membrane via activation of phophatidylinositide 3-kinase (PI3K) (Manna and Jain 
2011; Xue et al. 2013; Cai et al. 2016a). H2S inhibits basal and adrenergic-stimulated 
lipolysis in many models, including in our own Tst-/- mouse which has increased 
plasma sulfide levels  (Morton et al. 2016). Inhibition of lipolysis by H2S has also been 
observed in 3T3-L1 cells and in wild-type mice treated with the slow-release donor 
GYY4137, with beneficial effects on glucose tolerance when administered during a 
high fat diet regime (Geng et al. 2013; Tsai et al. 2015). H2S may also impact the 
secretion of adipokines in adipose tissue, although this has yet to be observed in vivo. 
In 3T3-L1 adipocytes exposed to a high glucose concentration, secretion of the pro-
inflammatory cytokine MCP1 was increased, and adiponectin was reduced, but these 
effects were partially normalised by exposure to H2S (Manna and Jain 2011; Pan et al. 
2014). As well as impacting the function of adipocytes, the depletion of H2S in obesity 
may increase the phenotypic switching of macrophages from the tissue resident pro-
resolution M2 type to the M1 pro-inflammatory type with increased production of pro-
inflammatory cytokines (Velmurugan et al. 2015). H2S also has pro-angiogenic and 
anti-fibrotic effects which may help to limit damage caused by local hypoxia during 




      
      
expansion, although these are yet to be fully investigated in adipose tissue 
(Papapetropoulos et al. 2009; Zhang et al. 2015). These beneficial effects of H2S on 
adipose tissue function may help to prevent dysfunction of the tissue, but the reduction 
of H2S in obesity may contribute to the link between obesity and metabolic syndrome. 
 The activity of insulin in liver is influenced by H2S levels, although current 
evidence suggests it has the opposite effects to H2S in adipose tissue. The liver 
responds to insulin by increasing glucose uptake and its conversion to glycogen or 
lipid, as well as inhibiting gluconeogenesis. H2S has the opposite effects on 
hepatocytes, inhibiting glucose uptake and increasing glucose production via 
gluconeogenesis and glycogenolysis, as well as enhancing lipid β-oxidation and 
inhibiting lipid synthesis (Zhang et al. 2013; Wu et al. 2015). While insulin reduces 
the expression of CSE in a hepatocyte cell line grown under normal conditions, when 
insulin resistance was induced by pre-exposure to high glucose and high insulin 
concentrations, CSE expression was increased, potentially contributing to the impaired 
insulin-responsiveness of these cells (Zhang et al. 2013). This insulin-mediated 
suppression of H2S production by the liver may be counter-intuitively protective 
against liver damage by high fat diet. Exogenous H2S administration reduced lipid 
synthesis and lipid droplet accumulation in mice fed a high fat diet, as well as reducing 
markers of oxidative stress (Wu et al. 2015). In human obesity, the observed reduction 
in plasma H2S concentration may therefore contribute to ectopic lipid storage in the 
liver, contributing to the development of non-alcoholic fatty liver disease, although 
this has yet to be investigated.  
 The jump from insulin resistance to overt type 2 diabetes occurs due to failure 
of the pancreatic insulin-producing β cells. A protective role for H2S has been 
suggested in this process, although with some controversy. In isolated primary mouse 
islets exposed to a high glucose concentration or oxidative stress, exogeneous H2S 
exposure protected against apoptosis and preserved insulin secretion (Kaneko et al. 
2009; Taniguchi et al. 2011). CSE knockout mice with reduced H2S production were 
susceptible to β cell damage when put on a high fat diet, but only when older than 6 
months (Okamoto et al. 2013). These mice exhibited impaired glucose tolerance due 




      
      
to reduced insulin secretion caused by increased apoptosis in pancreatic islets, 
suggesting that H2S production improves β cell survival. However, other research on 
CSE knockout mice concluded that H2S contributed to β cell failure in mice exposed 
to streptozotocin, a commonly used model of type 1 diabetes (Yang et al. 2011). The 
contradictory effects of H2S in these studies may be due to the differing mechanisms 
of β cell damage caused by high glucose and streptozotocin, indicating that H2S may 
be either protective or damaging depending on the level of cellular damage caused by 
outside factors. In human obesity, which is more closely modelled by high fat diet 
exposure in rodents, the progression to type 2 diabetes may be facilitated by the 
reduction in H2S observed in patients leading to β cell damage. As well the potential 
effect of H2S on β cell survival, increased intracellular H2S levels in β cells has been 
directly linked to suppression of insulin secretion due to H2S-mediated activation of 
KATP channels and inhibition of calcium channels (Yang, Yang, et al. 2005; Tang et 
al. 2013). Therefore, H2S reduction in diabetes may be a compensatory mechanism to 
increase insulin secretion, but ultimately contributing to β cell death. 
 
1.3.3.5 H2S and calorie restriction 
Recently, a role for H2S in modulating the beneficial effects of calorie restriction (CR) 
has been suggested. CR is a trigger of mitohormesis, with beneficial effects on health, 
including glucose tolerance, and lifespan (Heilbronn et al. 2006; Ristow and 
Schmeisser 2014)(described in paragraph 1.2.2.4 on page 27). CR in mice leads to 
increased hepatic expression of the H2S -producing enzyme CSE, and increased 
production of H2S  in liver extracts (Hine et al. 2015). This increase in H2S  was shown 
to be essential for the protective effects of CR on a model of hepatic ischaemia 
reperfusion injury in mice, and it was associated with lifespan extension in fruit flies, 
yeast and the nematode, C. elegans. As the Tst–/– mouse used in this thesis has 
increased plasma sulfide levels (Morton et al. 2016), the potential for H2S to impact 
the metabolic phenotype of these mice must be considered. 
 




      
      
1.3.4  TST function summarised 
To summarise, the mitochondrial enzyme TST may influence adipose tissue function 
through its ability to neutralise ROS, by enabling persulfidation of target proteins, by 
donating sulfur to iron-sulfur clusters of complexes of the electron transport chains, 
via transport of mitochondrial ribosomal RNA and through metabolism of H2S. This 
gasotransmitter has anti-inflammatory and antioxidant effects, and influences the 
response of metabolically active tissues to insulin, and so may mediate or counteract 




In a polygenic model of healthy leanness, TST was found to be upregulated in white 
adipose tissue. A subsequent mouse model with TST specifically over-expressed in 
adipose under the control of the adiponectin promoter, the Adipoq-Tst mouse, was 
found to be protected against weight gain and metabolic impairment on a high fat diet. 
It has been suggested that TST has antioxidant capabilities through interaction with 
thioredoxin. As oxidative stress is a key feature of adipose tissue dysfunction in 
obesity, leading to inflammation, altered adipokine secretion and insulin resistance, 
the local antioxidant effect of TST may underlie its protective effects in this mouse 
model. TST also contributes to the oxidation of hydrogen sulfide, and in our Tst-/- 
mouse line, systemic sulfide levels are increased. H2S can act as an antioxidant and 
anti-inflammatory mediator and maintain insulin action in adipose tissue, therefore its 
effects on metabolic parameters were considered.  
 
  




      
      
1.5 HYPOTHESIS AND AIMS 
Overarching hypothesis:  
Thiosulfate sulfurtransferase in adipose tissue maintains metabolic health by 
preventing excessive local reactive oxygen species accumulation and subsequent 
oxidative stress and inflammation.  
 
The sub-hypotheses of this PhD are: 
• Thiosulfate sulfurtransferase gene knockout impairs metabolic health after a 
high fat challenge due to increased adipose oxidative stress and inflammation. 
• Thiosulfate sulfurtransferase over-expression in adipose tissue protects against 




To test these hypotheses, the aims of this thesis were: 
• To measure oxidative stress and inflammation in adipose of Tst knockout mice 
after a high fat challenge, and assess metabolic impairment. 
• To characterise TST expression in a new mouse line with over-expression of 
human TST in adipose. 
• To evaluate metabolic phenotype of Ad-hTST mice after a high fat challenge. 
• To investigate response to exogenous oxidative stress in primary adipocytes 
from Tst-/- and Ad-hTST mice in vitro and in vivo.  
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Chapter 2 Materials and Methods 
 
See Appendix for manufacturers’ details and addresses (Table 7.2 on page 221). 
 
2.1 IN VIVO PHYSIOLOGY 
2.1.1 Animal models and maintenance 
2.1.1.1 Maintenance conditions 
Mice were housed in standard conditions of 12hrs light/dark (7am to 7pm) and room 
temperature (21oC) with ad libitum access to food, either standard chow (RM1; Special 
Diet Services) or experimental diets (see Table 2.2 on page 63 for experimental diet 
composition). All experiments and procedures were carried out in accordance with the 
UK Animals (Scientific Procedures) Act 1986 under a valid and active project licence 
(N Morton, PPL: 70/8117) and personal licence (C. Mc Fadden, PIL: IF3546C87). 
Approval of the named veterinary surgeon was given for all procedures. Mice were 
culled by CO2 followed by cervical dislocation (schedule 1 method) or by decapitation 
(regulated procedure) when blood plasma was required. 
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2.1.1.2 Tst−/− mouse 
The Tst−/− mouse is a homozygous knockout that was previously described (Morton et 
al. 2016). Briefly, this line was generated by the University of California at Davis 
knockout-mouse project (https://www.komp.org/geneinfo.php?geneid=85272; project 
VG13928; model Tsttm1(KOMP)Vlcg, representing a definitive null allele with the whole 
Tst gene replaced by a neo gene). Sperm from viable heterozygote mice were used to 
fertilize C57BL/6N embryos at the University of Edinburgh Genetic Intervention and 
Screening technologies (GIST) facility. The mice were initially bred with C57BL/6J 
wild-type mice, and subsequently the genotypes were separated for use as wild-type 
and Tst-/- lines on a mixed 6N/6J genetic background for high fat-feeding experiments 
and paraquat administration (chapter 3 and chapter 5). Backcrossing was subsequently 
performed to C57BL/6J, and these mice were used for isolation of primary adipocytes 
for in vitro reactive oxygen species experiments (chapter 5). 
 
2.1.1.3 Ad-hTST mouse 
The Ad-hTST line overexpresses the human TST gene in adipose tissue. This mouse 
was produced using the cre-loxP recombination system to target overexpression to 
adipose tissue alone. The parent line (Rosa26LSLhTST) was generated by Cyagen 
Biosciences by using homologous recombination to target the constitutively active 
Rosa26 locus in C57BL/6N embryonic stem cells for insertion of an expression 
cassette containing the human TST cDNA preceded by a stop cassette flanked by loxP 
sites (loxP-STOP-loxP: LSL) (Figure 2.1a). To excise the stop region, the 
Rosa26LSLhTST mice were bred with Adiponectin-cre (Adip-cre) mice, expressing cre 
recombinase in adipose tissue only (Eguchi et al. 2011). Offspring of this cross were 
genotyped for the presence of cre recombinase (see 2.1.1.4). Cre-positive mice were 
presumed to have excision of the stop region (Figure 2.1b), and were called Ad-hTST. 
Cre-negative littermates were used as controls, and were called wild-type-loxP-STOP-
loxP (WT-LSL). These mice were genetically indistinguishable from the parent line 
Rosa26LSLhTST. 
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Figure 2.1: Map of gene expression cassette at Rosa26 locus of 
Rosa26LSLhTST mice (a) before and (b) after Cre-mediated recombination.  
CAG promoter: adapted from chicken β-actin promoter (Jun-ichi et al. 1989); 
loxP: DNA recognition sites for cre recombinase; Stop region: contains 
premature stop codon; hTST cDNA: open reading frame of human TST cDNA; 
IRES: internal ribosome entry site; mCherry: open reading frame of the 
mCherry fluorescence gene; PolyA: polyadenosine coding sequence; Frt: DNA 
recognition sites for Flp recombinase; ROSA Locus 5’/3’: 5 prime and 3 prime 
regions of the ROSA locus. (Created using SnapGene Viewer software). 
 
2.1.1.4 Genotyping (carried out by Transnetyx®) 
At the age of three weeks, mice were weaned and ear clips were taken for identification 
and genotyping by animal facility staff. Ear clips were placed in 96-well plates and 
sent to Transnetyx (Memphis, TN, USA) for genotyping. Transnetyx used a high-
throughput fully automated process to extract and purify DNA, and carry out real-time 
PCR with custom probes. To genotype for the presence of the cre recombinase gene, 
Transnetyx used the following primer sequences for forward and reverse primers: 
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2.1.1.5 Surwit high fat and control diet composition 
To induce obesity by high fat diet, mice were fed a high fat, high sucrose diet (HFD) 
for the length of the experiment, starting from 6 to 8 weeks of age (Surwit et al. 1995). 
Standard RM1 chow (Table 2.1) was used as a control diet in Tst-/- cohorts, however 
in later experiments using Ad-hTST mice it was decided to change to the comparable 
Surwit low fat diet (LFD) with corn-starch as the main carbohydrate source (Table 
2.2). 
 
Table 2.1: Composition of RM1 maintenance diet 






Wheat Soya oil 
Barley Whey powder 
Wheatfeed Amino acids 
Vitamins Soya protein concentrate 
Micro minerals De-hulled extracted toasted soya 
Macro minerals  
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Table 2.2: Composition of Surwit high fat and low fat diets. 
 Surwit D12331 Surwit D12328  
 
High fat /  
High sucrose 
Low fat /  
High corn starch 
Composition Gram% kcal% Gram% kcal% 
Protein 23 16.4 16.8 16.4 
Carbohydrate 35.5 25.5 74.3 73.1 
Fat 35.8 58 4.8 10.5 
Ingredients Gram kcal Gram kcal 
Casein 228 912 228 912 
DL-Methionine 2 0 2 0 
Maltodextrin 10 170 680 170 680 
Corn starch - - 835 3340 
Sucrose 175 700 - - 
Soybean oil 25 225 25 225 
Coconut oil 333.5 3001.5 40 360 
Mineral mix S10001 40 0 40 0 
Sodium bicarbonate 10.5 0 10.5 0 
Potassium citrate 4 0 4 0 
Vitamin mix V10001 10 40 10 40 
Choline bitartrate 2 0 2 0 
FD&C red dye #4 0.1 0 - - 
FD&C yellow dye #5 - - 0.1 0 
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2.1.2 Experimental procedures 
2.1.2.1 Glucose tolerance test 
Mice were fasted for 4hrs prior to the start of the glucose tolerance test (GTT). A sterile 
glucose/saline solution was made consisting of 25% glucose and 0.9% sodium 
chloride.  A tail vein incision was made and basal blood glucose levels measured using 
OneTouch Ultra® glucometer and test strips. Blood samples were also collected using 
Microvette CB300 EDTA-containing tubes and stored on ice. A glucose bolus (2mg 
per gram body weight) was administered by intraperitoneal (IP) injection at time 0. 
Blood glucose and a blood sample were collected at time 15mins, 30mins, 60mins and 
120mins. Blood samples were centrifuged at 4oC, 3,000rpm for 8mins to separate 
plasma, which was removed and stored at -80oC for future measurement of insulin (see 
section 2.2.3.2 on page 74) 
 
2.1.2.2 Insulin tolerance test 
Mice were fasted for 4hrs prior to the start of the test. Fasting blood glucose was 
measured as in the GTT (section 2.1.2.1 above) before administration of insulin 
(Humulin® U-100, 1mU per gram body weight) by IP injection. Blood glucose was 
then measured at 15, 30, 60 and 120mins post-injection. 
 
2.1.2.3 Measurement of lean and fat mass by time domain-NMR 
Fat and lean mass were measured in awake mice using the Bruker minispec LF50 
(7.5MHz, 0.175T) system. This used time domain nuclear magnetic resonance (TD-
NMR) relaxometry to measure fat, lean and free body fluid (water) content while the 
mouse was restrained to minimise movement (Künnecke et al. 2004). Data was 
represented as a percentage of total body weight. 
 
2.1.2.4 Paraquat administration 
Paraquat dichloride in saline solution (0.9% sodium chloride) was made in Milli-Q® 
filtered water and filtered to sterilise. Paraquat or saline were injected by IP injection, 
and mice were monitored for up to 1hr before being returned to their home cages for 
the duration of the exposure. 
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2.2 MOLECULAR BIOLOGY 
2.2.1 Measurement of gene expression 
2.2.1.1 RNA extraction 
RNA was extracted from tissues according to the following method. Frozen tissue was 
put in a 2ml microcentrifuge tube with a stainless steel grinding ball and kept on dry 
ice. For each 100mg of tissue, 1ml of QIAzol was added and the sample immediately 
homogenised by shaking in a Mixer Mill MM301 homogeniser at a speed of 30 shakes 
per second for 1min at RT. Samples were transferred to ice before being centrifuged 
at 12,000g for 5mins in a centrifuge 5415R at 4oC to settle debris. For adipose tissue, 
this spin also caused lipid to form a clear colourless layer on top. The samples were 
transferred to new 1.5ml microcentrifuge tubes, avoiding the settled debris and the 
colourless top-layer in the case of adipose tissue. Samples were left at RT for 5min. 
Chloroform was added at a ratio of 200µl for every 1ml of QIAzol, and samples were 
shaken vigorously for 15s, then left at RT for 2mins. Samples were then centrifuged 
at 12,000g for 15min at 4oC. The top aqueous layer was transferred to a new tube, 
isopropanol was added (500µl for every 1ml of QIAzol) and samples were vortexed 
for 10s before incubating at RT for 10mins. Samples were then centrifuged at 12,000g 
for 10-30mins to pellet RNA, and the pellets were washed in 1ml of 75% ethanol 
(100% ethanol diluted with RNAase/DNAase-free water) by centrifuging at 7,500g for 
5mins. The wash was carried out twice and after the second wash the pellet was 
allowed to dry at RT for ~5mins before being resuspended in 20-30µl of 
RNAase/DNAase-free water. RNA quantity was assessed using the NanoDrop ND-
1000 spectrophotometer by the absorbance at 260nm wavelength. The ratio of 
RNA/protein (A260/280) and RNA/organic compounds (A260/230) were used to 
assess purity of the sample. 
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2.2.1.2 cDNA synthesis and dilution 
RNA was cleared of genomic DNA and transcribed into cDNA using QuantiTect 
Reverse Transcription Kit. To remove contaminating genomic DNA, RNA (750 – 
1000ng) was incubated with gDNA wipeout buffer for 2mins at 42oC. To transcribe 
the remaining RNA to cDNA, 1µl of QuantiTect reverse transcriptase, 1µl of RT 
primer mix and 3µl of RT buffer were added, and this was incubated for 15mins at 
42oC, followed by 3mins at 95oC to inactivate the reverse transcriptase. All incubations 
were carried out in a thermal cycler. cDNA samples were diluted 1:20 in RNase-free 
water, unless otherwise states. 5µl of each sample was pooled to make a standard curve 
of serial dilutions ranging from 1:4 to 1:256. Standard curves were made from a pool 
of all samples in the group unless otherwise stated. 
 
2.2.1.3 Real-time quantitative polymerase chain reaction 
Gene expression was measured by quantifying cDNA levels using a Roche 
LightCycler® 480. Reactions were carried out in a white 384-well plate with the 
following added: 2µl of diluted cDNA, 5µl of buffer, 2.5µl of RNase-free water and 
0.5µl of TaqMan® assay probe. For every gene measured, a standard curve of seven 
standards was also measured, as well as a negative control containing no cDNA. Plates 
were sealed using a clear plastic sticker and centrifuged at 2,000rpm for 2mins prior 
to being placed in the LightCycler®. A program for hydrolysis reaction was run as 
follows: Pre-incubation at 95oC for 10mins, followed amplification for 50 cycles of 
95oC for 10s, 60oC for 30s and 72oC for 1s, before a final cooling at 40oC for 30s. 
Reactions were performed in triplicate, and wells were excluded if standard deviation 
varied more than 0.2. The standard curve generated by LightCycler® software was log 
of concentration (X axis) against crossing point (Y axis), and it was deemed acceptable 
if reaction efficiency factor was between 2.8 and 3.2. Relative concentration was 
interpolated from the standard curve. Data is represented at relative to endogenous 
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Table 2.3: Gene names and TaqMan IDs for probes used for RT-PCR. 
Gene Taqman ID Gene Taqman ID 
Adipoq Mm00456425_m1 Pai1 (AKA. Serpine1) Mm00435858_m1 
Atf4 Mm00515325_g1 Pparg Mm00440940_m1 
Cbs Mm00460654_m1 Prx1 Mm01621996_s1 
Chop 
(AKA. Ddit3) Mm01135937_g1 Prx3 Mm00545848_m1 
Cse (AKA. Cth) Mm00461247_m1 Sod1 Mm01344233_g1 
Eef2 Mm01171435_gH Sod2 Mm01313000_m1 
Ethe1 Mm00480916_m1 Sqrdl Mm00502443_m1 
Gpx1 Mm00656767_g1 Tbp Mm01277042_m1 
Gpx4 Mm00515041_m1 Tnfa Mm00443258_m1 
Hmox1 Mm00516005_m1 TST (human) Hs00361812_m1 
Mcp1 
(AKA. Ccl2) Mm00441242_m1 Tst (mouse) Mm01195231_m1 
Mpst Mm00460389_m1 Txn2 Mm00444931_m1 
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2.2.2 Measurement of protein expression  
2.2.2.1 Protein extraction from adipose tissue 
Samples were kept cold at all times, on ice or in a cooled centrifuge at 4oC. Fat samples 
were weighed and cut on dry ice to make all samples a similar weight. Ice-cold fat 
lysis buffer (described in paragraph 2.2.2.2 below) was added to each sample (2µl for 
every microgram) in a 2ml microcentrifuge tube containing a stainless steel grinding 
ball. Samples were homogenised for 1min in a Mixer Mill MM301 homogeniser. 
Samples were centrifuged at 4oC for 1min at 13,000rpm to settle debris, and transferred 
to new tube.  They were centrifuged at the same speed and tempterature for 10mins 
and aqueous phase was removed to a new tube. Adipose samples formed a solid fat 
layer which was avoided when transferring to a new tube. This was repeated a 
minimum of 3 times until no fat remained on top of the sample. Protein concentration 
was measured in samples diluted 1 in 20 using DCTM Protein assay from Bio-Rad 
according to the manufacturer’s protocol, using bovine serum albumin (0.1mg/µl to 
1.41mg/µl) in 1:20 lysis buffer to make a standard curve. Samples were then diluted 
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2.2.2.2 Protein lysis buffer for adipose tissue 
Lysis buffer to extract protein from adipose tissue was made using the following 
protocol. To 800ml Milli-Q® filtered water, the components in Table 2.4 were added. 
When all components were dissolved, the pH was adjusted to 7.4 using concentrated 
hydrochloric acid (1M). The volume was adjusted to 1 litre with filtered water, before 
the final addition of Triton X-100. On the day of use, the final components in were 
added to a volume of either 50ml or 10ml as required. 
 
Table 2.4: Components of lysis buffer for extraction of protein from 
adipose tissue. 
Component Concentration 
Tris base 50mM  
Sucrose 270mM 
Sodium fluoride 50mM 




• After pH and volume adjustments: 
Triton X-100 1% 
  
Added on day of use:  
β-mercaptoethanol 0.1% 
cOmplete ULTRA Tablet (mini tablets for 10ml) 1 tablet 
β-glycerophosphate 10mM 
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2.2.2.3 Polyacrylamide gel electrophoresis and Western blotting 
Protein samples were separated using sodium dodecyl sulfate polyacrylamide gels for 
electrophoresis (SDS-PAGE), transferred to PVDF membrane followed by Western 
blotting to visualise bands. 
 
2.2.2.3.1 Separation of proteins by SDS-PAGE: 
The stacking gel to hold the samples, and separating gel in which the separation of 
proteins occurred were made according to the protocol in Table 2.5. Separating gel 
was added to gel plates and methanol was put on top to give an even surface and 
remove air bubbles. When the gel was set, the methanol was poured off and the 
stacking gel was added to the top with a comb inserted to create wells. Gel plates were 
assembled in gel running apparatus and cold PAGE running buffer (described in Table 
2.6) was added until the space between the plates was full and the tank was filled to 
the necessary level. Protein samples (20µg in 10µl) were mixed with protein loading 
buffer (1:6) and added to the wells in the stacking gel. Pre-stained protein ladder was 
added to at least one well on every gel. Proteins were separated by running the gel at 
100V for 2hrs. 
 
Table 2.5: Components of SDS-polyacrylamide gels 
Component Separating Gel Stacking Gel 
Milli-Q® filtered water 8ml 5.7ml 
1.5M / 0.5M Tris pH 8.8 - 5ml pH 6.8 - 2.5ml 
10% (w/v) Sodium Dodecyl Sulfate (SDS) in 
water 
200µl 100µl 
30% Acrylamide/ Bis Acrylamide 6.7ml 1.7ml 
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2.2.2.3.2 Transfer of proteins to PVDF membrane 
Protein was transferred to Amersham Hybond P 0.45 PVDF membrane using a Bio-
Rad wet transfer system. Briefly, for each gel 4 rectangles of blotting filter paper were 
prepared and a piece of PVDF membrane the size of the gel was cut. The membrane 
was soaked in methanol for 1min, then filtered water for 1min, and finally transfer 
buffer (described in Table 2.6) for at least 2mins or until ready to use. Two pieces of 
filter paper were soaked in transfer buffer and placed in the transfer “sandwich” 
equipment. The gel was removed from the plates and put on top of these, then the 
membrane was put on top of the gel making sure to exclude air bubbles. Two more 
pieces of filter paper soaked in transfer buffer were added. The transfer sandwich was 
then placed in the transfer tank. An ice block was placed in the tank to keep apparatus 
cool and the tank was topped up with cold transfer buffer. The transfer was run at 
200mA for 2hrs (or overnight at 125mA in the cold room at 4oC). 
 
2.2.2.3.3 Visualisation of proteins by Western blot 
The membrane was removed from the transfer sandwich and rinsed in tris-buffered 
saline with tween (TSB-T), described in Table 2.5. It was then incubated on a shaker 
at RT for 1hr in blocking solution (5% skimmed milk powder in TBS-T). Membranes 
were washed for 15min three times in TBS-T, then incubated in primary antibody in 
5% bovine serum albumin for 2hrs at RT or overnight at 4oC. After a further three 
washes, membranes were incubated for 2hrs in fluorescent secondary antibody at a 
1:10,000 dilution in 5% milk, washed three times in TBS-T. Details of antibodies are 
shown in Table 2.7. Fluorescence was visualised using a LI-COR Odyssey scanner 
and quantified using Image Studio Lite. Quantification of proteins was expressed 
relative to an internal control protein. 
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Table 2.6: Components of buffers for SDS-PAGE and Western blots. 
PAGE Running Buffer 
(10x) 
Transfer Buffer (10x) Tris-buffered Saline 
(TBS, 10x)  
1.9M Glycine 1.9M Glycine 500mM Tris base 
250mM Tris base 250mM Tris base 1.5M NaCl 
pH to 8.3 (before SDS) pH to 8.3 pH to 7.6 
1% Sodium Dodecyl 
Sulfate (SDS) 
1x made with 20% 
Methanol 
1x made with 0.1% Tween 
(TBS-T) 
 
Table 2.7: Primary and secondary antibodies for Western blots. 
Primary antibodies Raised in: Secondary Antibody 
Anti-4 Hydroxynonenal 
polyclonal antibody 
Rabbit IRDye® 800RD Goat Anti-Rabbit 
Anti-GAPDH polyclonal 
antibody 
Mouse IRDye® 680RD Donkey Anti-Mouse 
Anti-TST polyclonal 
antibody 
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2.2.3 Biochemical and enzyme assays 
2.2.3.1 Measurement of total and HMW adiponectin in plasma by ELISA 
Total and high molecular weight (HMW) adiponectin was measured in plasma from 
control and high fat-fed mice using the mouse HMW and total adiponectin enzyme-
linked immunosorbent assay (ELISA) from Alpco. Plasma samples were collected by 
decapitation using Microvette CB300 tubes (as in GTT, paragraph 2.1.2.1 on page 64) 
and stored at -80oC until use. For HMW measured, samples were pre-treated with a 
protease that specifically digests medium and low molecular weight adiponectin. 
Undigested samples were diluted to the same degree but without protease. 50µl of 
adiponectin standards and diluted digested and undigested samples were then added to 
a 96-well plate coated with monoclonal adiponectin antibody and incubated for 1hr at 
RT. Wells were then washed twice with wash buffer. 50µl of biotin-conjugated 
polyclonal adiponectin antibody was then added to each well and the plate was 
incubated for 1hr at RT. The plate was washed three times before addition of 50µl of 
enzyme-labelled streptavidin for 30min at RT. After a further wash (x3), 50µl of the 
substrate solution was added and incubated for 10min at RT before addition of 50µl of 
the stop solution. The absorbance was then measured at a wavelength of 492nm using 
the Infinite® M1000 PRO microplate reader. The absorbance of the blank standard 
containing assay buffer only was subtracted from all other measurements. 
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2.2.3.2 Measurement of insulin in plasma by ELISA 
Plasma samples from mice collected during GTT (section 2.1.2.1 on page 64) were 
used to measure insulin using the Ultra Sensitive Mouse Insulin ELISA kit. Insulin 
standard curve and plasma samples were measured according to the manufacturer’s 
protocol, however samples from high fat-fed mice were diluted 1 in 5 to ensure they 
fell within the range of the wide-range assay. 95µl of sample diluent was added to each 
well of the antibody-coated microplate. 5µl of either sample or insulin standard was 
added and the plate was incubated at 4oC for 2hrs. All wells were washed 5 times with 
wash buffer, ensuring excess solution was removed after each wash. 100µl anti-insulin 
enzyme conjugate was added to each well and the plate was incubated at RT for 30min, 
followed by 7 washes with wash buffer. 100µl of enzyme substrate solution was then 
added to each well and the plate was incubated at RT for 40min in the dark. To stop 
the reaction 100µl stop solution was added and absorbance was measured at 450nm, 
with 630nm absorbance subtracted, using the Infinite® M1000 PRO microplate reader. 
Insulin concentrations were interpolated from the standard curve. 
 
2.2.3.3 Rhodanese activity measurement in tissue homogenates 
Rhodanese activity was measured in adipose tissue homogenates using the principle 
described in Figure 1.1 (page 42).  Adipose samples were homogenised as described 
previously (paragraph 2.2.2.1 on page 68) in potassium phosphate (500mM, pH5.5). 
Homogenate (10µl) was incubated with potassium phosphate (10µl), sodium 
thiosulfate (10µl; 500mM) and Milli-Q® filtered water (60µl) for 2mins. Potassium 
cyanide (10µl; 500mM) was then added to start the production of thiocyanate, and 
incubated for 5-15mins. The reaction was stopped by adding 11µl of 
paraformaldehyde (38%). To the stopped reaction, iron (III) nitrate (125µl; 250mM) 
in 26% nitric acid was added, and absorbance was measured at 460nm using the 
Infinite® M1000 PRO microplate reader. This measurement of rhodanese activity was 
expressed relative to protein concentration, as measured by the DCTM Protein assay 
from Bio-Rad using bovine serum albumin (0.1mg/µl to 1.41mg/µl) in potassium 
phosphate to make a standard curve. 
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2.2.3.4 Measurement of thiobarbituric acid reactive substances (TBARS) 
The reactive lipid aldehyde malondialdehyde (MDA) was measured in adipose and 
lung homogenate using the OxiSelect TBARS Assay Kit from Cell Biolabs. MDA 
reacts with thiobarbituric acid (TBA) to form a compound that can be measured by 
spectrometry. Frozen tissue was homogenised in phosphate buffered saline (PBS) 
containing an antioxidant, butylated hydroxytoluene using stainless steel grinding 
balls and a Mixer Mill MM301 homogeniser as described previously for RNA and 
protein extraction. In microcentrifuge tubes, 100µl of sample homogenate or control 
was added to 100µl of SDS lysis solution and incubated for 5mins at RT. TBA reagent 
(250µl) was then added and the tubes incubated at 95oC for 45mins. The tubes were 
then placed in an ice bath for 5mins to cool before centrifuging at 3000rpm for 15mins. 
Supernatants (200µl) were transferred to a 96-well plate, and absorbance was 
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2.3 CELL BIOLOGY 
2.3.1 Primary cell isolation 
2.3.1.1 Isolation of primary adipocytes and stromal vascular fraction (SVF) 
from adipose tissue 
Adipose depots were dissected and collected into ~10ml of warmed full Krebs buffer 
(described in Table 2.8). The digestion was carried out by putting the fat pad into full 
Krebs containing Collagenase I at a concentration of 2mg/ml. The fat was cut into 
small pieces using scissors and was incubated for approximately 45 minutes in a 5% 
CO2, 37°C incubator, mixing every 10mins. The digestion was then filtered through 
plastic mesh of 500µM aperture into a falcon tube containing 10ml of fresh warm full 
Krebs or media. To separate the adipocytes from the SVF, the cells were centrifuged 
at RT for 5mins at 1500 rpm. The adipocytes settled to form a white floating layer 
which was removed to a 7ml bijoux containing fresh full Krebs or media using a 1ml 
pipette, with a cut off tip to ensure cells did not burst. SVF cells formed a pellet which 
was resuspended in media or phosphate buffered saline as required. 
 
Table 2.8: Components of Full Krebs phosphate buffer (Full Krebs). 
Component Concentration 
Milli-Q® filtered water Make up to 1 litre 
Sodium chloride 118mM 
Potassium chloride 5mM 
Magnesium sulfate heptahydrate 1.2mM 
100mM Disodium hydrogen phosphate (Na2HPO4): Add 120ml PO4 approx.. 15-
20mM 
100mM Sodium dihydrogen phosphate (NaH2PO4):  
Used to adjust pH to 7.4 
PO4 approx.. 15-
20mM 
Added on day of use:  
Calcium chloride 1.265mM 
Glucose 1mg/ml 
Bovine serum albumin 1% 
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2.3.1.1 Primary hepatocyte isolation (carried out by Matthew Gibbins) 
Mice were culled by CO2 followed by cervical dislocation, the abdomen was opened 
and the portal vein nicked to release blood. The thoracic vena cava was then cannulated 
by puncturing the atrium with a needle attached to tubing. Warm (37oC) liver perfusion 
media (LPM, Table 2.9) was then perfused through the tubing using a peristaltic pump 
for 10min, clearing red blood cells and blanching the liver. The liver was then digested 
by perfusing with liver digestion media (LDM, Table 2.9) for approximately 7min or 
until the appearance of clear sinusoidal spaces that remained after applying pressure. 
The digestion was then stopped by perfusing LPM for a further 10min. The liver was 
dissected and put into a petri dish containing warm LPM, and the gall bladder, the 
diaphragm and any other non-liver tissue were removed. In a cell culture hood, the 
liver was manually disrupted using forceps and the cells put into a 50ml centrifuge 
tube through a 40µm cell strainer with hepatocyte media (Table 2.10). The cells were 
settled by centrifuging at 500rpm for 5min and resuspended in DMEM. 50% 
equilibrated Percoll solution (described below) was then added underneath the cell 
suspension in an equal volume, and the sample centrifuged at 1000rpm for 15min to 
separate live hepatocytes in the pellet from dead and non-hepatocyte cells in the 
interface. The pellet was then washed twice in DMEM as above, and counted in a 1:1 
mix with trypan blue using a haemocytometer. Cells were then plated onto collagen-
coated plates and allowed to settle overnight before use. 
 
Equilibrated Percoll was prepared in advance by making a 1 in 10 dilution of Percoll 
in 10X DMEM (Table 2.11). This was then diluted 1 in 2 in 1X DMEM (1:10 dilution 
of 10X DMEM in Milli-Q® filtered water, sterile filtered) to make 50% equilibrated 
Percoll solution. 
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Liver Digestion Media 
Sodium chloride 140mM Base media plus: Base media plus: 
Potassium chloride 2.6mM EGTA  0.5mM Calcium chloride 5mM 
Disodium hydrogen 
phosphate 0.28mM  
pH 7.4 
Collagenase type 1 
100U/ml 





Table 2.10: Components of primary hepatocyte media 
Hepatocyte media 
Dulbecco’s Modified Eagle Medium with Low glucose 1000g/L  
10% (v/v) HyClone™ foetal bovine serum 
1% (v/) Penicillin/streptomycin  
2mM glutamine  
 
Table 2.11: Components of 10X DMEM used to make equilibrated Percoll. 
10X DMEM  
Milli-Q® filtered water 100ml 
DMEM 10g 
Sodium bicarbonate 2.438g 
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2.3.2 In vitro cell analysis 
2.3.2.1 Analysis of immune cell types in SVF by flow cytometry 
Cells of the stromal vascular fraction (SVF) of digested epididymal adipose tissue were 
resuspended in 1ml cold phosphate buffered saline with bovine serum albumin (PBS-
BSA, 0.1%) and filtered through a 100μm cell strainer. Cells were pelleted by 
centrifuging at 1500rpm for 5min in a centrifuge cooled to 4oC. Cells were 
resuspended in PBS-BSA containing anti-mouse CD16/CD32 antibody at a dilution of 
1 in 300 to block FC receptors. Samples were transferred to a V-bottomed 96-well 
plate and incubated on ice for at least 20min. To pellet samples, the plate was 
centrifuged for 3min at 1700rpm. Pellets were resuspended in PBS-BSA with 10% 
mouse/rat serum with antibodies diluted as indicated concentrations (Table 2.12 and 
Table 2.13). The plate was then incubated on ice and protected from light for 30min. 
Samples were centrifuged and washed three times in cold PBS before being transferred 
into flow cytometry tubes. If secondary antibodies were needed, they were incubated 
for 10min before washing again. 1μl of DAPI (4',6-diamidino-2-phenylindole, 
1:10,000) was added to each sample to stain dead cells just before analysis by flow 
cytometry using BD LSRfortessa™ cell analyser with BD FACSDiva™ software. 
Further analysis was carried out using FlowJo® software, following the gating strategy 
shown in Figure 2.2. Cells were gated in the order indicated by the black arrows. Side 
scatter (SSC-A) and forward scatter (FSC-A) were used to exclude debris. Single cells 
were gated using FSC-H (height) and FSC-A (area). From the single cells gate, live cells 
were identified as DAPI-negative. Hematopoetic cells were then identified as CD45+, and 
within this population, eosinophils were distinguished based on SiglecF expression. From 
the SiglecF- population, macrophages (Mac) were identified as F4/80+ and CD11b+ 
initially, followed by Ly6C- and MHCII+ (Ad-hTST cohort only). CD11c+ cells were then 
identified as M1-macrophages (M1). 
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Table 2.12: Flow cytometry antibodies used in Chapter 3 
Chapter 3: Tst-/- mice on HFD for 20 weeks 
Cell type Antigen Fluorophore Dilution Antigen Name 
Hematopoietic CD45 Pacific Blue 1:200 Protein tyrosine 
phosphatase receptor C 
Eosinophil Siglec F PE 1:200 Sialic acid binding IG-
like lectin F 
Neutrophil Gr1 APC Cy7 1:100 Lymphocyte antigen 6 
complex, locus G 
Myeloid F4/80 FITC 1:100 Adhesion G protein-
coupled receptor E1 
Macrophage CD11b PerCP Cy5.5 1:1200 Integrin alpha M 
Monocytes Ly6C APC 1:400 Lymphocyte antigen 6 
complex, locus C 




1:400 Integrin alpha X 
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Table 2.13: Flow cytometry antibodies used in Chapter 4 
Chapter 4: Ad-hTST mice on HFD for 6 weeks 
Cell type Antigen Fluorophore Dilution Antigen Name 
Hematopoietic CD45 FITC 1:100 Protein tyrosine 
phosphatase receptor C 
Eosinophil Siglec F PE 1:200 Sialic acid binding IG-
like lectin F 
Antigen-
presenting 
MHCII eFlour 450 1:800 Major histocompatibility 
complex 2 
Myeloid F4/80 PE Cy7 1:200 Adhesion G protein-
coupled receptor E1 
Macrophage CD11b PerCP Cy5.5 1:1200 Integrin alpha M 
Monocytes Ly6C AlexaFluor 
700 
1:200 Lymphocyte antigen 6 
complex, locus C 
M1 Mac CD11c Pacific Blue 1:50 Integrin alpha X 
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Figure 2.2: Gating strategy for analysis of SVFs from epididymal adipose 
tissue from Tst–/– and Ad-hTST mice. 
Cells were gated in the order indicated by the black arrows. SSC-A: side 
scatter-area; FSC-A: forward scatter-area; FSC-H: forward scatter-height; DAPI: 
4',6-diamidino-2-phenylindole; Mac: macrophages; M1: M1 macrophages. 
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2.3.2.2 Measurement of mitochondrial reactive oxygen species production 
Mitochondrial ROS production was measured in primary adipocytes and primary 
hepatocytes. Cells were incubated with hydrogen peroxide (H2O2) in suitable media 
(full Krebs solution or hepatocyte media) for up to 2hrs to stimulate mitochondrial 
ROS production. This was then washed using Hank’s balanced salt solution (HBSS) 
three times. Mitochondrial ROS was then stained using the fluorescent probe 
MitoSOX™ Red mitochondrial superoxide indicator by incubating for 10min in a 
concentration of 5µM in HBSS. The cells were then washed three times as before, and 
fluorescence measured using the Infinite® M1000 Pro plate reader, using 
excitation/emission wavelengths of 510/580nm. Fluorescence measurements for 
adherent cells were normalised to protein concentration as measured by SRB assay 
(section 2.3.2.4 on page 84). 
 
2.3.2.3 Measurement of H2O2 disposal in primary adipocytes 
Primary adipocytes were exposed to 100µM H2O2 in full Krebs media for 5 minutes, 
with or without pre-incubation in thiosulfate 2mM for 1hr. H2O2 remaining after this 
time period was measured using the fluorometric H2O2 assay kit. After incubation, 
10µl of media was removed from each sample and control and added to 490µl assay 
buffer to make a 1 in 50 dilution. 50µl of these dilutions were put into wells of a 96-
well plate and a matching volume of Master Mix was added for 30min at RT, 
protecting the plate from light. Master Mix contained red peroxidase substrate, 
horseradish peroxidase and assay buffer per the manufacturer’s protocol. The 
fluorescence intensity was then measured using excitation/emission wavelengths of 
540/590nm. H2O2 concentration was calculated using a standard curve. 
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2.3.2.4 Sulforhodamine B colorimetric assay for cellular protein content 
Protein concentration of primary hepatocytes in a 96-well plate was measured using 
the sulforhodamine B (SRB) assay as described by Skehan et al. (Skehan et al. 1990). 
To wells containing 200µl of media, 50µl of 50% trichloroacetic acid (TCA, diluted 
from 100% TCA with filtered water) was added to fix cells, and the plate was 
incubated at 4oC for 1hr. The wells were then washed with tap water ten times and air-
dried. 50µl of SRB solution (SRB 0.4%w/v solution in 1% acetic acid) was added for 
30min at RT to stain cells. The dye was washed out by four washes in 1% acetic acid 
(diluted from 100% with filtered water), and the plate was air-dried. Cell-bound dye 
was re-dissolved in Tris solution (10mM Tris solution pH 10.5) and absorbance was 
measured at 540nm. 
 
2.3.2.5 Lactate dehydrogenase assay 
Lactate dehydrogenase (LDH) activity was measured in media as a marker of cellular 
toxicity using the Pierce™ LDH Cytotoxicity assay kit from ThermoFisher. This kit 
uses NADH, which is formed by the LDH-catalysed conversation of lactate to 
pyruvate, to reduce a tetrazolium salt to a red formazan product, which is directly 
proportional to the amount of LDH in the media. For each experiment, a triplicate of 
wells was used as a maximum measurement of LDH activity by adding lysis buffer 
before the start of LDH measurement. LDH was measured by adding 50µl of each 
sample or control to 50µl of reaction mixture. This was incubated for 30mins at RT 
protected from light before 50µl of stop solution was added. Absorbance was measured 
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2.4 IMAGING 
2.4.1 Whole-mount staining of tissue explants 
Small pieces of adipose and other tissues (10-20μg) were placed in about 500μl PBS 
at RT. DAPI was added at a concentration of 1 in 10,000 and incubated for 10mins at 
RT. Samples were washed in 1-2ml PBS three times, and pieces of tissue were then 
placed on plain microscope slides and mounted using Fluoromount™ Aqueous 
Mounting Medium. A coverslip was attached using clear nail polish, and this was left 
to dry overnight before imaging. 
 
2.4.2 Imaging 
Fluorescence and brightfield imaging was performed with a Hamamatsu Orca II CCD 
camera attached to an Olympus AX-70 Provis epifluorescence microscope, kindly 
provided by Prof. Margarete Heck with assistance from Dr. Kanishk Abhinav. Images 




GraphPad Prism 5 was used for analysis with data presented as mean ± SEM. 
Comparison between two groups was done using unpaired Student’s t-test. 2-way 
analysis of variance (ANOVA) was used to compare between genotypes and diets, and 
Bonferroni multi-comparison post-hoc test was included where appropriate. Data from 
GTT and ITT experiments were compared using 2-way repeated measures ANOVA 
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Chapter 3 The effects of Tst gene knockout on glucose 




Previous evidence suggests that increasing Tst expression in adipose tissue protects 
mice from the metabolic impairment of a high fat diet (HFD) (Morton et al. 2016). 
The aim of this chapter was to investigate the impact of a lack of Tst on adipose 
function and metabolic outcome after a HFD. It was hypothesised that mice with a 
global knockout of the Tst gene would be more susceptible to oxidative stress in 
adipose tissue, and thus more metabolically impaired. To investigate this hypothesis, 
two cohorts of Tst–/– mice were exposed to HFD for 6 and 20 weeks, and subsequent 
effects on metabolic parameters and markers of adipose tissue dysfunction were 
assessed. 
 Our group showed previously that moderate overexpression of mouse Tst in 
adipose tissue protects these mice (Adipoq-Tst mouse)  from gaining weight after a 6-
week HFD, and prevents glucose intolerance (Morton et al. 2016). It was hypothesised 
that the antioxidant capability of TST contributed to the improved metabolic 
phenotype through prevention of local oxidative stress in adipose tissue, as Adipoq-
Tst mice had increased SOD2 protein and Prx3 mRNA in adipose tissue. Whilst there 
is evidence that TST interacts with and may neutralise ROS directly (Nandi et al. 
2000), this has not been fully elucidated in mammals in vivo. However, some evidence 
indicating a link with TST and ROS metabolism has been found in vitro, as a siRNA-
mediated knockdown of Tst expression in 3T3-L1 adipocytes results in increased 
mitochondrial ROS levels (Morton et al. 2016). One of the aims of this chapter is 
therefore to investigate if altered Tst expression influences the antioxidant machinery 
of adipocytes during oxidative stress.  
 To induce oxidative stress in adipose tissue, Tst–/– mice were exposed to HFD 
for either 6 or 20 weeks. WT mice on HFD typically gain weight faster than control-
fed mice, and exhibit features of adipose tissue dysfunction such as increased carbonyl 
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content, immune cell infiltration and metabolic impairment (Matsuzawa-Nagata et al. 
2008). This model of diet-induced obesity is commonly used to assess the impact of 
altered gene expression on risk of metabolic impairment. A short-term HFD challenge 
of only one week can increase adipose ROS production and impair insulin signalling 
without any difference in body weight (Paglialunga et al. 2015). A long-term 
challenge, such as for twenty-four weeks causes overt obesity, whole-body insulin 
resistance, an increase in adipose carbonyl content and upregulation of antioxidant 
enzyme expression (Matsuzawa-Nagata et al. 2008). The Tst–/– mouse was previously 
shown to have worse glucose tolerance than WT mice after 6 weeks of HFD (Morton 
et al., 2016), and so this time-point was chosen to carry out an intial investigation of 
adipose tissue dysfunction. However, it was decided to focus on the longer duration of 
20 weeks of HFD to ensure chronic oxidative stress and adipose tissue dysfunction 
was achieved in this model.   
 To investigate the hypothesis of this chapter, the metabolic phenotype and 
adipose tissue dysfunction were assessed in Tst–/– mice after exposure to HFD. A 
duration of 6 weeks was initially carried out to measure immune cell infiltration, as 
this was thought to be good early marker for different susceptibility to adipose tissue 
dysfunction. This did not uncover any major differences between WT and Tst–/– mice, 
and so a longer duration of 20 weeks was chosen to induce greater adipose tissue 
dysfunction including oxidative stress and chronic inflammation, as well as further 
impair insulin sensitivity. Metabolic phenotype was assessed by carrying out a glucose 
tolerance test, insulin tolerance test and by measuring levels of the insulin-sensitising 
hormone adiponectin. Adipose tissue dysfunction was investigated by measuring a 
marker of oxidative stress and altered expression of antioxidant genes, as well as 
evaluating the inflammatory phenotype of the tissue. Tst–/– mice have increased plasma 
sulfide levels (Morton et al., 2016) which may impact the effect of HFD on both 
adipose function and systemic insulin sensitivity. While it was not possible to control 
for this potential factor in the experiments carried out in this chapter, the impact of Tst 
knockout and HFD exposure on the expression of genes that code for H2S-producing 
enzymes and enzymes involved in H2S breakdown was assessed. 
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 This chapter describes the results of these two experiments for which Tst–/– 
mice were fed a HFD for 6 or 20 weeks. Evidence for or against the hypothesis is 
discussed, as well as potential limitations of this evidence. Future avenues of research 
for further investigating the impact of Tst on metabolic health are suggested, including 
work that followed on from these experiments and will be described in chapter 5. 
 
3.1.1 Hypothesis & aims 
 
In this chapter, it was hypothesised that thiosulfate sulfurtransferase gene knockout 
would impair metabolic health after a high fat challenge due to increased adipose 
oxidative stress and inflammation. 
 
The aims of this chapter were: 
• To evaluate metabolic impairment of Tst knockout mice after a high fat 
challenge. 
• To assess oxidative stress and inflammation in adipose of Tst knockout mice 
after a high fat challenge. 
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3.2 METHOD 
Male Tst–/– mice (as described in paragraph 2.1.1.2 on page 60) were used in this 
chapter to investigate the impact of Tst knockout on metabolic health when exposed 
to HFD for either 6 or 20 weeks. These mice were maintained as a homozygous line, 
having previously been maintained as heterozygotes (Tst+/–) breeding with C57BL/6J 
wild-types (WT). Homozygous Tst–/– and control mice (WT) were generated by 
breeding heterozygous littermates, selecting for homozygous knockouts and WTs, and 
maintaining these as separate lines for 10+ generations. At the age shown in Figure 
3.1 and Figure 3.2 below, Tst–/– and WT mice were separated into two groups with one 
maintained on RM1 standard chow (Chow; see Table 2.1 on page 62) and the other 
group received Surwit D12331 high fat, high sucrose diet (HFD; see Table 2.2 on page 
63).  Mice were maintained on these diets until the end of the study period (6 or 20 
weeks), at which point they were culled by decapitation, and blood and organs were 
harvested. 
 
Figure 3.1: Timeline of WT and Tst–/– mice on chow or HFD for 6 weeks. 
 
 
Figure 3.2: Timeline of WT and Tst–/– mice on chow or HFD for 20 weeks. 
Glucose tolerance test (GTT) and insulin tolerance test (ITT) were carried out 
after 18 and 19 weeks of HFD. 
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3.3 RESULTS 
3.3.1 The effect of Tst gene knockout after 6 weeks of high fat diet. 
3.3.1.1 Body weight was not different in Tst–/– versus WT on HFD for 6 weeks, 
but Tst–/– mice had reduced body weight on chow diet. 
After 6 weeks of HFD, an increase in body weight was observed in Tst–/– mice, 
however WT mice were largely unchanged (Figure 3.3). On chow diet, Tst–/– mice 
























Figure 3.3: Body weight of Tst–/– and WT mice on chow or HFD for 6 
weeks.  
Data are mean ± SEM, analysed by 2-way ANOVA: ** P < 0.01, ns = not 
significant; with Bonferroni post-hoc test comparing between genotypes for 
each diet: # P < 0.05; (chow: n = 6; HFD: n=11). 
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3.3.1.2 Epididymal adipose tissue depot weight was not different in Tst–/– 
versus WT on HFD for 6 weeks. 
6 weeks of HFD increased epididymal adipose weight to a similar extent in WT and 































Figure 3.4: Epididymal white adipose weight of Tst–/– and WT mice on 
chow or HFD for 6 weeks. 
Data are mean ± SEM, analysed by 2-way ANOVA: *** P < 0.001, ns = not 
significant; (n = 6/11). 
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3.3.1.3 Immune cell populations in stromal vascular fraction of adipose tissue 
were not different in Tst–/– versus WT mice on HFD for 6 weeks. 
Adipose stromal vascular fraction (SVF) was isolated from control diet or HFD-fed 
mice by collagenase digestion of epididymal fat pads, stained with fluorescent 
antibodies to differentiate cell types, and analysed by flow cytometry. Macrophage 
(F480+ CD11b+ Ly6C-) number as a percentage of total hematopoietic cell population 
(CD45+ population) was unchanged by HFD in both genotypes (Figure 3.5a). The 
percentage of hematopoietic cells expressing the pro-inflammatory macrophage 
marker CD11c was increased by HFD, but no significant differences were observed 
between genotypes, despite a trend for increased CD11c+ cells in Tst–/– mice on chow 
diet (Figure 3.5b). The percentage of eosinophils (SiglecF+) was not significantly 
altered by HFD (Figure 3.5c). 
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Figure 3.5: Immune cell populations in stromal vascular fraction (SVF) of 
epididymal adipose tissue in Tst–/– and WT mice on chow or HFD for 6 
weeks. 
(a) Macrophages (F4/80+ CD11b+ Ly6C-), (b) M1 macrophages (F4/80+ 
CD11b+ Ly6C- CD11c+), and (c) eosinophils (SiglecF+) measured in SVF of 
epididymal fat by flow cytometry. Results are expressed as percentage of 
hematopoietic population (CD45+). Data are mean ± SEM, analysed by 2-way 
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3.3.1.4 Conclusion after 6 weeks of HFD. 
After exposure to HFD for 6 weeks, WT mice had not gained a significant amount of 
weight, and while adipose tissue had expanded, there was no significant increase in 
macrophage cell number in adipose tissue, a key marker of inflammation. As there 
were no significant differences in Tst–/– mice, which while gaining weight on HFD, 
largely followed the same pattern as WT on HFD in terms of fat mass gain and immune 
cell infiltration, it was decided to carry out a longer exposure to HFD to induce a 
greater extent of metabolic impairment and adipose tissue dysfunction. 
  
Chapter 3  
95 
 
      
      
3.3.2 The effect of Tst gene knockout after 20 weeks of high fat diet. 
3.3.2.1 Body weight was not different in Tst–/– versus WT on HFD for 20 
weeks. 
After 20 weeks of HFD, all mice gained a significant amount of weight, with no 
difference in body weight between Tst–/– and WT groups (Figure 3.6a). Chow-fed mice 
also gained weight, but to a lesser extent than those on HFD (Figure 3.6b). Chow-fed 











































Figure 3.6: Body weights of Tst–/– and WT mice on chow or HFD for 20 
weeks. 
(a) Body weight at cull, and (b) Weight gain between week 0 and week 20. 
Data are mean ± SEM, analysed by 2-way ANOVA: *** P < 0.001, ns = not 
significant; (n = 7-8). 
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3.3.2.2 Adipose tissue depots weights were not different in Tst–/– versus WT 
on HFD for 20 weeks, but Tst–/– mice had less fat mass on chow diet. 
Three white adipose depots were weighed after 20 weeks on chow or HFD and 
normalised to body weight. Epididymal, mesenteric and subcutaneous adipose depots 
were increased with HFD in both Tst–/– and WT mice. However, on chow diet, Tst–/– 
mice had less adipose tissue in all three depots than WT mice (Figure 3.7).  
 
Figure 3.7: White adipose depot weights in Tst–/– and WT mice on chow 
or HFD for 20 weeks. 
(a) Epididymal, (b) mesenteric and (c) subcutaneous white adipose depots, 
normalised to body weight at cull. Data are mean ± SEM, analysed by 2-way 
ANOVA: * P < 0.05, ** P < 0.01, *** P < 0.001, ns = not significant; with 
Bonferroni post-hoc test comparing between genotypes for each diet: ## P < 
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3.3.2.3 Glucose tolerance was impaired after 18 weeks of HFD in Tst–/– and 
WT mice, but insulin was lower in in Tst–/– mice. 
A glucose tolerance test was carried out on WT and Tst–/– mice after 18 weeks of chow 
or HFD to assess the impact of Tst gene knockout. WT mice did not have significantly 
higher glucose levels on HFD compared to chow at any timepoint. This suggests that 
the control group were glucose intolerant, and is supported by these mice having a 
glucose peak of 30mmol/L 30-minutes after glucose administration. There was no 
significant difference between WT and Tst–/– mice, however Tst–/– mice had 
significantly higher glucose on HFD than on chow at 30, 60 and 120 minutes after 
glucose administration (Figure 3.8a). Overall plasma glucose levels during the GTT 
measured by area under the curve were increased by HFD in both WT and Tst–/– mice, 
although there was no significant difference between genotypes (Figure 3.8b).  
 
Plasma insulin was measured at each timepoint before and after glucose 
administration. WT mice on HFD had significantly higher fasting insulin than Tst–/–  
mice on HFD (mean 5.4 vs. 2 ng/ml) (Figure 3.8c). No differences were observed 
between genotypes on chow diet.  HFD led to a significant increase (P < 0.01-0.001) 
in plasma insulin at all timepoints after glucose administration in both WT and Tst–/– 
compared to chow-fed controls (mean, WT: 18 ng/ml; Tst–/–: 11.3 ng/ml). Overall 
plasma insulin levels during the GTT measured by area under the curve were increased 
by HFD in both WT and Tst–/– mice, although insulin was significantly lower in Tst–/– 
mice (Figure 3.8d). [Insulin ELISA was carried out by Rhona Aird, Molecular 
Metabolism Group]. 
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Figure 3.8: Plasma glucose and insulin levels of Tst–/– and WT mice on 
chow or HFD for 18 weeks after administration of a glucose bolus. 
(a) Plasma glucose levels during a glucose tolerance test (GTT); (b) area 
under the curve (AUC) of glucose levels during GTT; (c) plasma insulin levels 
during GTT; (d) AUC of insulin levels during GTT. Data are mean ± SEM, (a) 
and (c) analysed by 2-way repeated measures ANOVA with Bonferroni post-
hoc test comparing each group at each timepoint: Tst–/– chow versus Tst–/– 
HFD: &&& P < 0.001; WT HFD vs. Tst–/– HFD: $$ P < 0.01; (b) and (d) analysed 
by 2-way ANOVA: * P < 0.05, *** P < 0.001, ns = not significant (n = 6-8). 
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3.3.2.4 Insulin tolerance was impaired after 19 weeks of HFD in Tst–/– and WT 
mice. 
An insulin tolerance test was carried out on WT and Tst–/– mice after 19 weeks of HFD 
to assess the impact of Tst gene knockout on the responsiveness of glucose levels to 
insulin. There were no significant differences between WT and Tst–/– mice. WT mice 
had significantly higher glucose levels on HFD compared to chow at only the 15-
minute timepoint. Tst–/– mice on HFD diet had significantly higher glucose at all 
timepoints after insulin injection compared to chow-fed Tst–/– mice (Figure 3.9a). 
Overall plasma glucose levels during the ITT measured by area under the curve were 
increased on HFD in both WT and Tst–/– mice, but no significant difference was found 
between genotypes (Figure 3.9b).   
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Figure 3.9: Plasma glucose levels of Tst–/– and WT mice on chow or HFD 
for 19 weeks after administration of an insulin bolus. 
(a) Plasma glucose levels during an insulin tolerance test (ITT); (b) area under 
the curve (AUC) of glucose levels during GTT. Data are mean ± SEM, (a) 
analysed by 2-way repeated measures ANOVA with Bonferroni post-hoc test 
comparing each group at each timepoint: WT chow versus WT HFD: # P < 
0.05; Tst–/– chow versus Tst–/– HFD: && P < 0.01, &&& P < 0.001; (b) analysed 
by 2-way ANOVA: *** P < 0.001, ns = not significant; (n = 7-8). 
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3.3.2.5 Plasma adiponectin was reduced in Tst–/– mice on chow diet, and in 
both Tst–/– and WT mice on HFD for 20 weeks. 
Total and high molecular weight (HMW) adiponectin were measured in the plasma of 
WT and Tst–/– mice after 20 weeks of HFD by ELISA. Total and HMW adiponectin 
were significantly reduced by HFD in WT mice (Figure 3.10a and Figure 3.10b). 
However, Tst–/– mice had lower total and HMW adiponectin compared to WT mice on 
chow diet. HFD did not cause a further reduction in total or HMW adiponectin in Tst–
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Figure 3.10: Plasma adiponectin levels in Tst–/– and WT mice on chow or 
HFD for 20 weeks. 
(a) Total adiponectin, (b) high molecular weight (HMW) adiponectin, and (c) 
HMW as a percentage of total adiponectin. Data are mean ± SEM, analysed 
by 2-way ANOVA: * P <0.05, ** P <0.01, *** P < 0.001, ns = not significant; 
with Bonferroni post-hoc test comparing between genotypes for each diet: ## 
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3.3.2.6 Gene expression of adiponectin was unchanged in adipose tissue of 
Tst–/– mice versus WT mice on chow or HFD for 20 weeks. 
Gene expression of adiponectin (Adipoq) was measured in mesenteric adipose tissue 
of WT and Tst–/– mice after 20 weeks of HFD. There was no significant effect of Tst 
gene knockout or HFD on Adipoq expression in adipose tissue, however there was a 






















Figure 3.11: Gene expression of adiponectin in mesenteric white adipose 
tissue of Tst–/– and WT mice on chow or HFD for 20 weeks. 
Data are mean ± SEM, analysed by 2-way ANOVA: not significant; (n=4-6). 
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3.3.2.7 Gene expression of some key antioxidant enzymes was reduced in 
adipose tissue of Tst–/– versus WT mice on HFD for 20 weeks. 
The expression of mitochondrial and cytoplasmic antioxidant enzymes in mesenteric 
white adipose tissue from Tst–/– and WT mice fed HFD or chow for 20 weeks was 
measured. Expression of many of the nuclear-encoded mitochondrial antioxidant 
enzymes were reduced in Tst–/– mice, particularly when on HFD. Superoxide dismutase 
2 (Sod2) and peroxiredoxin 3 (Prx3) expression was lower in adipose of Tst–/– mice. 
This was largely accounted for by a failure to increase Sod2 and Prx3 expression in 
response to HFD, as seen in the WT mice (Figure 3.12a and Figure 3.12b). Overall 
expression of glutathione peroxide 1 (Gpx1) and thioredoxin 2 (Txn2) was lower in 
Tst–/– mice compared to WT (Figure 3.12c and Figure 3.12d). Thioredoxin reductase 2 
(Txnrd2) and glutathione peroxidase 4 (Gpx4) were unchanged by Tst gene knockout 
or HFD (Figure 3.12e and Figure 3.12f). Superoxide dismutase 1 (Sod1) was 
unchanged by Tst gene knockout or HFD (Figure 3.12g), however peroxiredoxin 1 
(Prx1) showed reduced expression in adipose from Tst–/– mice, with significant 
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Figure 3.12: Gene expression of key antioxidant enzymes in mesenteric 
adipose tissue in Tst–/– and WT mice on chow or HFD for 20 weeks. 
(a) Superoxide dismutase 2 (Sod2), (b)peroxiredoxin 3 (Prx3), (c) glutathione 
peroxidase 1 (Gpx1), (d) thioredoxin 2 (Txn2), (e) thioredoxin reductase 2 
(Txnrd2) and (f) glutathione peroxidase 4 (Gpx4), (g) superoxide dismutase 1 
(Sod1), and (h) peroxiredoxin 1 (Prx1) mRNA abundance normalised to 
housekeeping gene Tbp. Data are mean ± SEM, analysed by 2-way ANOVA: 
* P <0.05, ** P < 0.01, ns = not significant; with Bonferroni post-hoc test 
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NRF2 is a transcription factor that regulates the expression of many antioxidants genes 
in response to oxidative stress (section 1.2.2.2 on page 23). To assess activation of 
NRF2-mediated transcription, the expression of two NRF2-target genes was measured. 
No difference was found in the expression of heme oxygenase 1 (Hmox1) or NAD(P)H 
quinone oxidoreductase 1 (Nqo1) in mesenteric adipose tissue of Tst-/- mice on chow 
or HFD (Figure 3.13). 
 
Figure 3.13: Gene expression of NRF2-responsive antioxidant enzymes 
in mesenteric adipose tissue in Tst-/- vs. WT mice on chow or HFD for 20 
weeks. 
(a) Heme oxygenase 1 (Hmox1) and (b) NAD(P)H:quinone acceptor 
oxidoreductase 1 (Nqo1) abundance normalised to housekeeping gene Tbp. 
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3.3.2.8 Carbonyl content of adipose tissue was unchanged in Tst–/– versus 
WT mice on chow or HFD for 20 weeks. 
Carbonylation of proteins is a marker of oxidative stress in adipose tissue of obese 
mice and humans. Protein lysate from mesenteric white adipose tissue was separated 
by SDS-PAGE, and an antibody against 4-hydroxynonenal (4-HNE) was used to 
visualise proteins with carbonyl adducts (Figure 3.14a). Carbonyl content was found 
to be unchanged in Tst–/– mice on chow and HFD (Figure 3.14b). 
 
 
Figure 3.14: Carbonyl content of mesenteric adipose tissue of Tst–/– and 
WT mice on chow or HFD for 20 weeks. 
(a) Representative images of protein lysates separated by SDS-PAGE and 
blotted with anti-4-HNE and anti-GAPDH antibodies; (b) quantification of 
intensity of all bands relative to GAPDH control. Data are mean ± SEM, 
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3.3.2.9 Immune cell populations in stromal vascular fraction of adipose tissue 
were not different in Tst–/– versus WT mice on HFD for 20 weeks. 
Macrophage number as a percentage of total hematopoietic cell population (CD45+ 
population) was increased by HFD in both Tst–/– and WT mice (Figure 3.15a). 
However, on chow diet, Tst–/– mice had a lower percentage of macrophages than WTs, 
with post-hoc testing revealing significant reduction in Tst–/– mice compared to WT on 
chow diet (Figure 3.15a). The percentage of hematopoietic cells expressing the pro-
inflammatory macrophage marker CD11c was increased by HFD in both Tst–/– and 
WT mice (Figure 3.15b). The percentage of eosinophils was significantly reduced by 
HFD in both genotypes (Figure 3.15c). 
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Figure 3.15: Immune cell populations in stromal vascular fraction (SVF) 
of epididymal adipose tissue in Tst–/– and WT mice on chow or HFD for 
20 weeks. 
(a) Macrophages (F4/80+ CD11b+ Ly6C-), (b) M1 macrophages (F4/80+ 
CD11b+ Ly6C- CD11c+), and (c) eosinophils (SiglecF+) measured in SVF of 
epididymal fat by flow cytometry. Results are expressed as percentage of 
hematopoietic population (CD45+). Data are mean ± SEM, analysed by 2-way 
ANOVA: ** P > 0.01, *** P < 0.001, ns = not significant; with Bonferroni post-
hoc test comparing between genotypes for each diet: # P < 0.05; (n = 6). 


















































































Chapter 3  
110 
 
      
      
3.3.2.10 Gene expression of pro-inflammatory adipokines was not different in 
adipose tissue of Tst–/– versus WT mice on HFD for 20 weeks. 
Gene expression of pro-inflammatory adipokines was measured in mesenteric fat to 
assess the impact of Tst gene deficiency on adipose tissue inflammatory markers with 
HFD. Plasminogen activator inhibitor 1 (Pai1) was greatly increased by HFD in both 
WT and Tst–/– mice (Figure 3.16a). Monocyte chemotactic protein 1 (Mcp1) was also 
increased by HFD in both genotypes (Figure 3.16b). Tumour necrosis factor α (Tnfα) 
was not significantly different with Tst gene deficiency or HFD (Figure 3.16c). 
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Figure 3.16: Gene expression of pro-inflammatory adipokines in 
mesenteric adipose tissue of Tst–/– and WT mice on chow or HFD for 20 
weeks. 
(a) Plasminogen activator inhibitor 1 (Pai1), (b) monocyte chemotactic protein 
1 (Mcp1), and (c) tumour necrosis factor α (Tnfα) abundance normalised to 
housekeeping gene Tbp. Data are mean ± SEM, analysed by 2-way ANOVA: 
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3.3.2.11 Gene expression of an endoplasmic reticulum stress marker was 
increased in adipose tissue of Tst–/– versus WT mice on chow diet, 
but unchanged on HFD for 20 weeks. 
To assess activation of the unfolded protein response, the expression of two key genes 
involved in this process was measured in mesenteric fat of Tst–/– after 20 weeks of 
HFD. Expression of activating transcription factor 4 (Atf4) was unchanged by Tst gene 
knockout or HFD (Figure 3.17a). C/EBP-Homologous Protein (Chop) was increased 
in Tst–/– mice, with a greater increase observed on chow diet only (Figure 3.17b). 
 
 
Figure 3.17: Gene expression of endoplasmic reticulum stress markers 
in mesenteric adipose tissue of Tst–/– and WT mice on chow or HFD for 
20 weeks. 
(a) Activating transcription factor 4 (Atf4) and (b) C/EBP-Homologous Protein 
(Chop) mRNA abundance normalised to housekeeping gene Tbp. Data are 
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3.3.2.12 Gene expression of thiosulfate sulfurtransferase was reduced in 
adipose tissue of WT mice on HFD for 6 weeks, and chow and HFD 
for 20 weeks. 
Tst mRNA was not detected in Tst–/– mice. After 6 weeks of HFD, Tst mRNA levels 
were greatly reduced in WT mice (Figure 3.18a). However, at the end of the 20-week 
HFD challenge, Tst mRNA levels were unchanged between chow and HFD mice 
(Figure 3.18b). This was due to already low Tst mRNA levels in adipose of WT mice 
on chow diet for 20 weeks. 
 
 
Figure 3.18: Comparison of Tst gene expression in mesenteric adipose 
tissue in WT mice after (a) 6 weeks and (b) 20 weeks of chow or HFD. 
Tst mRNA abundance normalised to housekeeping gene Tbp. Tst gene 
expression was undetectable in RNA from Tst–/– mesenteric adipose tissue. 
Data are mean ± SEM, analysed by Student’s t-test: ** P < 0.01; (6 weeks, 
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3.3.2.13 Gene expression of sulfide production enzymes were reduced in 
adipose tissue of in Tst–/– versus WT mice on chow or HFD for 20 
weeks. 
To assess the effect of Tst gene knockout and HFD on hydrogen sulfide production, 
gene expression of the three enzymes responsible for producing sulfide (section 1.3.3.1 
on page 48) were measured in mesenteric white adipose tissue. Cystathionine γ lyase 
(Cse) was reduced in Tst–/– mice on chow diet only, with no significant difference 
observed between high fat-fed groups (Figure 3.19a). Cystathionine β synthase (Cbs) 
was reduced in both WT and Tst–/– mice fed HFD, however no difference was found 
between genotypes (Figure 3.19b). Mercaptopyruvate sulfurtransferase (Mpst) was 
reduced in adipose of Tst–/– compared to WT mice, however no effect of diet was 
observed (Figure 3.19c). 
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Figure 3.19: Gene expression of H2S-producing enzymes in mesenteric 
adipose tissue of Tst–/– and WT mice on chow or HFD for 20 weeks. 
(a) Cystathionine γ lyase (Cse) (b) cystathionine β synthase(Cbs) and (c) 
mercaptopyruvate sulfurtransferase (Mpst) abundance normalised to 
housekeeping gene Tbp. Data are mean ± SEM, analysed by 2-way ANOVA: 
* P <0.05, *** P < 0.001, ns = not significant; with Bonferroni post-hoc test 
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3.3.2.14 Gene expression of sulfide oxidation enzymes was unchanged in 
adipose tissue of Tst–/– versus WT mice on chow or HFD for 20 
weeks. 
The gene expression of enzymes involved in the oxidation of sulfide was measured. 
Sulfide-quinone oxidoreductase (Sqrdl) and ethylmalonic encephalopathy protein 1 
(Ethe1) were unchanged by Tst gene deficiency or HFD (Figure 3.20). 
 
 
Figure 3.20: Gene expression of sulfide oxidation genes in mesenteric 
adipose tissue of Tst–/– and WT mice on chow or HFD for 20 weeks. 
(a) Sulfide:quinone oxidoreductase (Sqrdl) and (b) ethylmalonic 
encephalopathy protein 1 (Ethe1) abundance normalised to housekeeping 
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3.4 DISCUSSION 
Thiosulfate sulfurtransferase, when over-expressed in adipose tissue, was previously 
found to be protective against metabolic impairment due to exposure to a high fat diet 
(Morton et al. 2016). For this chapter, Tst knockout mice were used to test the 
hypothesis that the absence of this gene would lead to increased adipose oxidative 
stress and inflammation, and subsequently, a worse metabolic profile after exposure 
to high fat diet. The findings show that Tst–/– mice are potentially more prone to 
metabolic impairment on high fat diet due to a failure to induce adipose antioxidant 
genes in response to high fat diet and reduced high molecular weight adiponectin in 
plasma. However, there was no clear evidence of functional oxidative damage, perhaps 
due to limitations in the carbonyl measurement method, and no clear evidence for the 
expected increase in macrophage infiltration and inflammatory cytokine contribution 
to this phenotype. Indeed, in chow fed Tst–/– mice, macrophage infiltration was lower, 
consistent with reduced fat mass. It is also likely that other factors and organs that are 
affected by Tst gene knockout are important for the overall phenotypic outcome of 
exposure to high fat diet. Some surprising differences uncovered in older chow-fed 
Tst–/– mice highlighted a previously unobserved interaction of Tst gene knockout and 
age-related fat accumulation which remains to be investigated in future studies. 
 
3.4.1 Metabolic impairment of Tst–/– mice on HFD. 
The data presented here confirmed previous findings that Tst–/– mice are metabolically 
impaired after exposure to HFD. Tst–/– mice on high fat diet for 20 weeks gained a 
comparable amount of weight to WT mice. This comparable weight gain on HFD was 
observed in previous experiments with these mice (Morton et al. 2016), and was likely 
due to increased fat mass, as all adipose depots measured increased with HFD in both 
genotypes. High fat feeding for 6 weeks caused a reduction in Tst gene expression in 
adipose of WT mice, and by 20 weeks, Tst expression was reduced in both chow-fed 
and high fat-fed WT mice. This reduction in Tst in adipose may explain the 
convergence of body weight and fat accumulation in WT and Tst–/– groups fed HFD, 
as the impact of local Tst expression was reduced in adipose of WT mice. 
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A well-characterised effect of high fat feeding on 6J mice is a reduction in 
plasma concentration of the insulin-sensitising hormone adiponectin due to adipose 
tissue dysfunction (Furukawa et al. 2004; Hosogai et al. 2007). While WT mice on 
HFD showed this expected reduction in total adiponectin and the most biologically 
active high-molecular weight (HMW) form, adiponectin levels of Tst–/– mice were 
reduced on chow diet, but were resistant to further reduction on HFD. Tst–/– mice on 
chow diet weighed less and had less fat mass than their WT counterparts, and therefore, 
higher adiponectin levels would be expected (Pannacciulli et al. 2003). This 
unexpected reduction in plasma adiponectin in chow-fed Tst–/– mice could be due to 
unfolded protein response (UPR) activation or oxidative stress. The UPR activation 
marker C/EBP homologous protein (Chop) is implicated in reducing adiponectin 
expression in adipose tissue (Hosogai et al. 2007), and this gene was upregulated in 
mesenteric adipose tissue of Tst–/– mice on chow diet. While this does not confirm full 
activation of the UPR, increased Chop expression could contribute to reduced levels 
of circulating adiponectin in chow-fed Tst–/– mice. Adiponectin expression in adipose 
tissue is also reduced by excess H2O2 and oxidative stress (Furukawa et al. 2004), 
therefore, in adipose tissue from Tst–/– mice, lower expression of key antioxidant 
enzymes such as Sod2, Prx3, Txn2 and Gpx1 could impact adiponectin synthesis and 
secretion. While adiponectin gene expression in mesenteric adipose tissue was 
unchanged, there was a trend for lower expression of this gene in adipose of Tst–/– 
mice, and it is possible that its expression in other adipose depots is also impacted by 
Tst gene knockout. As adiponectin is an insulin-sensitising hormone, a reduction in 
plasma concentration usually leads to reduced insulin sensitivity (Stefan et al. 2002), 
however this was not the case in chow-fed Tst–/– mice, which cleared glucose in a 
manner comparable to WT mice during an insulin tolerance test (ITT).  
Despite a similar amount of weight gain, Tst–/– mice on HFD for 20 weeks were 
more susceptible than WT mice to metabolic impairment. A glucose tolerance test 
(GTT) did not find significant differences between WT and Tst–/– mice on HFD. It was 
revealed however that Tst–/– mice had impaired glucose clearance after 20 weeks of 
HFD compared to chow diet. This impairment in glucose clearance could be due to 
increased insulin resistance, as the results of the ITT suggest that HFD impairs the 
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ability of Tst–/– mice to clear glucose, however not to a significantly greater degree 
than in WT mice. A more likely factor affecting glucose clearance may be insulin 
secretion during the GTT, which was significantly lower in Tst–/– mice on HFD 
compared to WT mice. This failure to increase insulin secretion to compensate for 
increased plasma glucose indicates progression to diabetes in Tst–/– mice on HFD. WT 
mice on HFD had significantly higher plasma insulin during the GTT than HFD-fed 
Tst–/– mice, indicating a more robust β-cell response to increased glucose than Tst–/– 
mice. Despite HFD-induced insulin resistance in WT mice as observed by ITT, there 
was no difference in glucose clearance between chow- and HFD-fed WT mice, which 
likely to be due to compensation by higher insulin secretion. A confounding factor in 
the metabolic assessment of WT mice was the extensive weight gain in control-fed 
animals, which may have contributed to glucose intolerance in these mice. Increased 
weight gain and glucose intolerance without obesogenic diet has been recently 
observed in C57BL/6N (6N) mice, which were found to gain more weight and have 
increased plasma glucose during a GTT than 6J mice on a low-fat diet for 18 weeks, 
(Hull et al. 2017). Based on this finding, Tst–/– mice were backcrossed to 6J for future 
experiments to limit any effect of a mixed background containing an unknown and 
variable amount of genetic information from the 6N sub-strain. Despite the potential 
cofounding factor of glucose intolerance in control-fed WT mice, Tst–/– mice showed 
metabolic impairment during the GTT by failing to induce insulin secretion. However, 
to confirm that Tst–/– mice were more susceptible to metabolic impairment than WT 
mice, this experiment must be repeated using a specific low-fat diet to reduce age-
related fat accumulation and metabolic impairment in control-fed WT mice.  
I have confirmed that Tst–/– mice are susceptible to metabolic impairment on 
HFD. Tst–/– mice gained a similar amount of weight and fat mass to WT mice after 20 
weeks of HFD, and their ability to clear glucose, as measured by glucose and insulin 
tolerance tests was impaired by HFD. This agrees with our previously reported 
findings of glucose intolerance in Tst–/– mice after 6 weeks of HFD (Morton et al. 
2016). An investigation of adipose tissue dysfunction of Tst–/– mice was carried out to 
uncover the physiological basis for the metabolic phenotype of these mice on HFD.  
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3.4.2 Adipose tissue dysfunction of Tst–/– mice on HFD. 
An investigation of adipose tissue dysfunction was carried out to uncover the 
physiological basis of the impaired metabolic phenotype of Tst–/– mice on HFD. It was 
hypothesised that Tst–/– mice were more susceptible to oxidative stress and 
inflammation in adipose tissue. As well as the reduction in plasma adiponectin 
discussed above, Tst–/– mice had lower expression of key antioxidant enzymes in 
adipose tissue, especially on HFD, without overt changes in a marker of oxidative 
stress, immune cell infiltration or expression of proinflammatory adipokines.  
 
3.4.2.1 Oxidative stress 
Expression of key antioxidant genes in adipose tissue can be altered by high fat feeding 
(Furukawa et al. 2004; Long et al. 2013), and overexpression or knockout of some of 
these key genes have been associated with altered susceptibility to obesity and insulin 
resistance in mice (Loh et al. 2009; Han et al. 2016). Key antioxidant enzymes, Sod2, 
Prx3, Txn2, Gpx1 and Prx1, were lower in mesenteric adipose of Tst–/– mice, due to an 
increase in their expression in adipose of WT mice on HFD that was not matched in 
Tst–/– mice. Some of these results are unexpected as our lab has previously found 
greatly reduced SOD2 and PRX3 protein in adipose of WT mice after 6 weeks of HFD 
(Morton et al. 2016). As well as this, SOD activity is reduced in adipose of WT mice 
fed a HFD for 9 weeks (Furukawa et al. 2004) and PRX3 protein level is reduced in 
adipose tissue of obese humans and obese db/db mice (Huh et al. 2012; Long et al. 
2013). This could reflect a difference in HFD-mediated induction of antioxidant gene 
expression between adipose depots, with mesenteric fat used in the current work, but 
epididymal or subcutaneous used in previous studies. Also, the duration of exposure 
to HFD could impact these results, with later compensatory antioxidant programmes 
being switched on in WT mice after 20 weeks of HFD in the current investigation to 
attempt to limit severe oxidative stress due to hypertrophy. As ROS are essential for 
adipogenesis (Tormos, Anso, Hamanaka, et al. 2011), antioxidant programmes may 
be not be induced at early stages of obesity to allow for expansion of the tissue by 
hyperplasia. The lower expression of these antioxidant enzymes in adipose of Tst–/– 
compared to WT mice after 20 weeks of HFD indicates that these mice may have 
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reduced antioxidant capacity in adipose tissue, and thus be more susceptible to 
oxidative damage. However, another interpretation of these results could be that 
antioxidant gene expression fails to increase after HFD, as seen in WT mice, because 
adipose from Tst–/– mice is under less oxidative pressure due to other phenotypic 
alterations such as an increased concentration of H2S. This could potentially indicate 
a failure of the mitohormetic response, in which an oxidative trigger initiates gene 
expression of stress mechanisms such as antioxidant enzymes, and ultimate strengths 
the cells ability to deal with further stressors (Ristow and Schmeisser 2014). Future 
work using adipose-specific Tst knockout mice will help to elucidate a full 
understanding of the cause and consequences of reduced expression of these 
antioxidant genes. 
 Expression of a cytosolic and mitochondrial antioxidant enzyme, glutathione 
peroxidase 1 (Gpx1), was also measured in the adipose of Tst–/– and WT mice after 
exposure to HFD. This enzymes reduces H2O2 using glutathione as a reducing agent 
(Brigelius-Flohé and Maiorino 2013), and Gpx1 knockout protects against diet-
induced insulin resistance due to lowered quenching of insulin-stimulated H2O2 
signalling (Loh et al. 2009).  Expression of Gpx1 increased in adipose tissue of WT 
mice after 20 weeks of HFD, as has been found to occur in 6J mice after 6 weeks of 
HFD (Matsuzawa-Nagata et al. 2008), but was reduced in adipose of Tst–/– mice, and 
failed to increase after 20 weeks of HFD, as in WT mice. Consequently, reduced Gpx1 
expression in adipose tissue of Tst–/– mice may be protective against local insulin 
resistance, and indicates that local adipose insulin resistance may not be the cause of 
the overall reduction in insulin sensitivity observed during the ITT in Tst–/– mice on 
HFD. 
 Protein carbonylation is a marker of oxidative stress in adipose tissue caused 
by addition of reactive lipid aldehydes such as 4-hydroxy-2-nonenal (4-HNE) to 
protein side chains (Ruskovska and Bernlohr 2013). Carbonylation is increased in 
adipose tissue of obese humans (Grimsrud et al. 2007), and in epididymal, but not 
subcutaneous adipose of high fat fed 6J mice (Long et al. 2013). GPX4 protects against 
damaging accumulation of reactive lipid aldehyde products including 4-HNE 
(Katunga et al. 2015). Gpx4 expression was unchanged in adipose of both Tst–/– and 
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WT mice, and there was no difference in carbonylation in mesenteric adipose from 
Tst–/– or WT mice on HFD. This could be due to limitations of the method or the 
adipose depot in which this marker was measured. Future assessment of oxidative 
stress will be done using the Oxyblot protein oxidation detection kit which may be 
more efficient at measuring carbonylation than the 4-HNE antibody used here.  
 A potential confounding factor in this study is H2S which can have antioxidant 
effects at a transcriptional, post-transcriptional and molecular level. Tst–/– mice have 
increased plasma sulfide levels (Morton et al. 2016), which may influence adipose 
tissue oxidative stress through activation of NRF2-mediated transcription (Yang et al. 
2013), by direct scavenging of 4-HNE (Schreier et al. 2010), or through modulating 
SOD activity or protein (Sun et al. 2012). Expression of two NRF2 target genes, 
Hmox1 and Nqo1, was unchanged in adipose of Tst–/– mice, indicating that the 
increased ambient sulfide concentration did not cause an overt activation of NRF2-
mediated transcription in these mice. As no difference was found in carbonyl content 
between these groups of mice, the increased sulfide levels in Tst–/– mice do not appear 
to have lead to scavenging of 4-HNE, however this must be confirmed with a more 
effective measurement of carbonylation. H2S has also been shown to increase 
expression of SOD2 protein in cardiomyocytes during ischaemia/reperfusion (Sun et 
al. 2012). As discussed previously, Sod2 mRNA expression was reduced in adipose of 
Tst–/– mice, and while not confirmed at the protein level, this indicates that in this 
context H2S does not lead to a transcriptional increase in this antioxidant enzyme. In 
previous work from our lab, SOD2 protein was increased in adipose of mice with 
adipose-specific overexpression of Tst compared to WT mice on chow diet (Morton et 
al. 2016). Therefore, the reduction in Sod2 expression in Tst–/– mice found here could 
be a reciprocal phenotype, and further investigation will be required to understand this 
intriguing link between Tst and this major mitochondrial antioxidant enzyme. 
 It was hypothesised that the metabolic impairment of Tst–/– mice was due to 
increased susceptibility to HFD-induced oxidative stress in adipose tissue. I have 
confirmed that adipose tissue of Tst–/– mice has reduced expression of key antioxidant 
enzymes potentially causing an increased susceptibility to oxidative damage. No 
increase was found in carbonylation, which may be due to limitations of the method, 
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and so the full impact of Tst knockout on adipose oxidative stress cannot be confirmed. 
To address this question, it was decided to assess the in vitro response of primary 
adipocytes lacking or overexpressing TST to an oxidative challenge; work that will be 
described in Chapter 5. 
 
3.4.2.2 Inflammation 
Infiltration of pro-inflammatory macrophages is a key feature of dysfunctional adipose 
tissue and contributes to insulin resistance (Nguyen et al. 2007; Patsouris et al. 2008). 
As well as macrophages, other myeloid cell populations are also altered by HFD, with 
eosinophils number decreasing after several weeks of HFD (Wu et al. 2011). After 6 
weeks of HFD, total macrophage content was unchanged in both Tst–/– and WT mice. 
M1 macrophages, as characterised by expression of the cell surface marker CD11c 
were increased in both genotypes, indicating a normal response to HFD. However, as 
no increase in total macrophage content was found, and there was no effect of HFD on 
eosinophil count, it was concluded that 6 weeks of HFD was not long enough to induce 
adipose tissue inflammation in this model. Therefore, it was decided to repeat the 
experiment with a longer duration of high fat feeding to ensure adipose tissue 
dysfunction in the form of inflammation developed. 
After 20 weeks of high fat feeding, Tst–/– mice exhibited features of adipose 
tissue inflammation, however inflammatory markers were not different compared to 
WT mice. Immune cell populations were largely unchanged between Tst–/– and WT 
mice, in particular after HFD. This was unexpected given that Tst–/– mice exhibit an 
impaired metabolic phenotype, however the increased ambient sulfide levels in these 
mice (Morton et al. 2016) could be exerting anti-inflammatory effects on this tissue, 
such as suppressing macrophage activation (Zhang, Guo, Wu, et al. 2012). H2S is also 
known to suppress leukocyte infiltration, and while Tst–/– mice do not have reduced 
macrophage content, it is possible that this marker of inflammation is comparable to 
WT, despite increased metabolic impairment, because of the increased sulfide levels 
in Tst–/– mice (Pan et al. 2011). It was hypothesised that Tst–/– mice would be 
predisposed to increased adipose tissue inflammation leading to metabolic 
impairment. The evidence presented here shows no difference in adipose tissue 
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immune cell infiltration in Tst–/– mice on HFD, and a similar induction of pro-
inflammatory adipokine expression. Therefore, it is unlikely that Tst knockout leads 
to increased inflammation in adipose tissue, but future work with mice lacking Tst in 
adipose only will help to confirm this conclusion. 
 
Investigation of markers of adipose dysfunction in Tst–/– mice after high fat feeding 
found no change in a functional oxidative stress marker or activation of the UPR, as 
well as unchanged inflammatory responses compared to WT mice. However, some 
key aspects of adipose tissue function appear to be impaired, including induction of 
antioxidant gene expression and adiponectin release, and these may contribute to the 
increased susceptibility to metabolic impairment observed in Tst–/– mice after high fat 
feeding. However, it is likely that the effects of Tst gene knockout on tissues other than 
adipose also contribute to the metabolic impairment observed in these mice on HFD, 
and whole-body elevated sulfide may also influence adipose tissue dysfunction. 
Therefore, full interpretation of the contribution of Tst in adipose tissue will need 
further investigation in adipose tissue-specific Tst knockout mice, which will help to 
minimise the contributions of these non-adipose factors. 
 
3.4.3 Impact of increased sulfide on metabolic impairment of Tst–/– mice. 
As Tst–/– mice have a global knockout of the gene and increased plasma sulfide levels, 
metabolically important organs other than adipose tissue may also influence the 
phenotype (Morton et al. 2016). Work was carried out on these mice by M. Gibbins to 
characterise the effect of Tst knockout on liver function. Evidence was found of 
increased gluconeogenesis in Tst–/– mice, as they produced more glucose in response 
to a pyruvate bolus after fasting and had increased activity of phosphoenolpyruvate 
carboxykinase (PEPCK), a key enzyme in the pathway of glucose production (Gibbins, 
manuscript in preparation). This increase in gluconeogenesis could contribute to the 
increase in plasma glucose observed in HFD-fed Tst–/– mice during the GTT, and may 
be a result of increased sulfide, which is known to increase PEPCK activity and 
gluconeogenesis in liver (Zhang et al. 2013). Increased sulfide levels may also be 
responsible for the reduction in plasma insulin in Tst–/– mice as observed prior to and 
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during the GTT, as sulfide is known to inhibit insulin secretion in pancreatic β-cells 
through activation of KATP channels and inhibition of calcium channels (Yang, Yang, 
et al. 2005; Tang et al. 2013). Therefore, increased plasma sulfide in Tst–/– mice may 
influence the metabolic phenotype beyond the expected detrimental impact of Tst 
knockout in adipose tissue. 
 
3.4.4 Reduced fat mass in Tst–/– mice on chow diet.  
Some surprising differences were uncovered between chow-fed Tst–/– and WT mice 
that may highlight a previously unobserved effect of Tst gene knockout on adipose 
tissue which may influence susceptibility to metabolic impairment by a mechanism 
independent of, or in addition to, oxidative stress. 
 Chow-fed Tst–/– mice in the 6-week group weighed less than WT mice, with a 
similar but non-significant difference observed at 20 weeks. In the 20-week group, all 
adipose depots measured were smaller in chow-fed Tst–/– mice compared to WTs. This 
finding of reduced body and adipose tissue weight in older Tst–/– mice was confirmed 
in an extra cohort of mice maintained on chow diet until 5 months of age (see appendix, 
Figure 7.1 and Figure 7.2 on pages 211 and 212) which found them to be significantly 
lighter and have less white adipose tissue than similarly-aged WT controls. There were 
no differences in body weight at the start of the feeding regimes, indicating that Tst 
knockout may impact weight gain and fat accumulation with increasing age, an effect 
that had not previously been observed. It was not possible to measure fat mass 
longitudinally in vivo at the time of these experiments, however a Bruker Minispec 
LF50 whole body composition analyser will be used on future cohorts of Tst–/– mice 
to investigate the age at which this divergence in fat mass begins.  
This reduction in fat mass in older Tst–/– mice could be due to the impact of 
altered sulfide levels on lipid accumulation. We have previously found that SVFs from 
Tst–/– mice accumulate more lipid than WT SVFs when differentiated to adipocytes in 
vitro (Morton et al. 2016), and so this finding of reduced fat mass in vivo in older mice 
indicates that Tst gene knockout has a more complex effect on fat accumulation than 
previously thought. The previous finding of increased lipid accumulation in SVFs 
from Tst–/– mice could be due to increased H2S levels due to impaired sulfide oxidation, 
Chapter 3  
126 
 
      
      
as exposure of 3T3-L1 adipocytes to exogenous H2S increases activity and expression 
of PPARγ, and encourages glucose uptake and lipid storage (Cai et al. 2016b). 
However, the current in vivo finding in chow-fed Tst–/– mice contradicts this evidence, 
as Tst–/– mice have increased plasma sulfide (Morton et al. 2016), but reduced fat mass, 
as well as a trend for reduced SVF expression of Pparg (Morton et al. 2016). Previous 
in vitro investigation of basal and insulin-stimulated lipogenesis found that both 
processes were reduced in primary adipocytes from Tst–/– mice (Morton et al. 2016), 
which may account for the reduced fat mass in these mice on chow diet. This indicates 
that adipose from Tst–/– mice does not respond as expected to the increased plasma 
sulfide concentration, and instead may be resistant to lipid accumulation due to 
downregulation of Cse and Mpst, and a subsequent reduction in local H2S production. 
Pharmacological inhibition of CSE reduced fat mass in mice fed a high fat diet for 4 
weeks (Cai et al. 2016b). Therefore, a reduction in local H2S production due to reduced 
Cse expression in Tst–/– mice on chow diet and reduced Mpst on both chow and HFD 
may reduce lipid accumulation in adipocytes leading to the overall reduction in fat 
mass observed in these mice on chow diet. Cse expression was not significantly 
different between Tst–/–  and WT mice after 20 weeks of HFD, which may explain the 
lack of difference in fat accumulation between the two genotypes on HFD. Future work 
to assess the impact of Tst knockout on sulfide production and disposal in isolated 
adipocytes will shed light on the local sulfide environment in adipose tissue of Tst–/– 
mice and allow for a more defined hypothesis on the role of local sulfide signalling in 
lipid accumulation in adipose tissue of chow-fed mice. Mice lacking the Tst gene in 
adipose tissue only will soon be available to investigate whether this reduced fat mass 
in chow-fed knockout mice is due to local effects of Tst deficiency or a result of 
increased systemic sulfide. 
The reduction in fat mass in Tst–/– mice on chow diet may be unrelated to the 
effects of H2S on lipid accumulation, and instead be an outcome of increased activation 
of the unfolded protein response (UPR). Tst–/– mice on chow diet had increased 
expression of C/EBP homologous protein (Chop) in mesenteric adipose tissue, 
although it was not confirmed that this representation activation of the UPR. Forced 
expression of this UPR mediator was previously found to impair adipogenesis in 
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differentiating 3T3-L1 adipocytes, and mice lacking this gene gained more weight and 
fat mass on HFD compared to WT mice (Han et al. 2013). An intriguing finding from 
this paper was that 1-year-old Chop knockout mice on chow were heavier and had 
more fat mass than WTs, which indicates that upregulation of this gene in aged Tst–/– 
mice could be responsible for the reciprocal phenotype of reduced body weight and fat 
mass observed in Tst–/– mice. To understand the cause and implication of UPR 
activation in Tst–/– mice, in vitro investigation of the impact of Tst gene knockout on 
Chop expression will be carried out in the future in a newly acquired pluripotent stem 
cell line lacking the Tst gene. 
Another mechanism by which increased H2S may influence the metabolic 
phenotype of the Tst–/– mice through its potential role in mediating the beneficial 
effects of calorie restriction (CR). CR in humans leads to weight loss and improved 
metabolic parameters (Heilbronn et al. 2006), and in rodents, some of the beneficial 
effects of CR have been shown to be dependant on endogously-produced H2S (Hine et 
al. 2015). While H2S has not been directly linked to the metabolic benefits of CR, it 
has been associated with lifespan extension in fruit flies, yeast and C. elegans (Hine et 
al. 2015), therefore it’s potential benefit both health and lifespan in the Tst–/– mouse 
must be considered in future studies with this mouse. 
The discovery that Tst–/– mice on chow diet had reduced weight gain and fat 
mass, as well as reduced adiponectin without metabolic impairment was unexpected. 
Further investigation of the cause of this altered phenotype of Tst–/– mice on chow diet 
will be carried out in future to fully elucidate the role of Tst in adipose tissue.  
 
3.4.5 Limitations and future work. 
The aims of this chapter were to assess the impact of Tst gene knockout on the 
metabolic response to high fat diet, and to investigate adipose tissue dysfunction as the 
root of this metabolic response. I have confirmed that Tst–/– mice are more susceptible 
than WT mice to metabolic derangement after HFD. I also provided some evidence 
that this dysfunction is associated with changes in expression of antioxidant enzymes 
in adipose tissue. I have uncovered altered adipose tissue responses in Tst–/– mice on 
chow diet, particularly in older mice, which were previously unknown, and future 
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work will focus on understanding the impact of Tst gene knockout on sulfide 
metabolism and mitochondrial function in ageing.  
 The mice used in this chapter had a global knockout of the Tst gene and were 
on a C57BL/6 background, with a mix of substrains 6J and 6N. This could have caused 
variability in their metabolic responses to HFD. 6J mice are prone to increased weight 
gain and metabolic impairment on high fat diet compared to other inbred mouse lines 
(West et al. 1992), and 6N mice have been found to have a similar metabolic response 
to high fat diet (Podrini et al. 2013), although recent work has uncovered differences 
between the two sub-strains on low fat diet (Hull et al. 2017). This genetic 
heterogeneity could have led to variable results, and so it was decided to backcross the 
Tst–/– line with 6J mice to minimise any effect of unknown genetic variation in future 
experiments. These Tst–/– mice on a 6J background were used for experiments in 
chapter 5. Tst is expressed in tissues other than adipose, including hepatocytes and 
macrophages, as well as endothelial cells, and it is apparent that the lack of Tst in these 
other tissues could also have impacted the response to HFD. A new mouse model is 
now available which will allow for cre-mediated tissue-specific knockout of Tst, 
however due to delays in its development, it was not available for use during this PhD. 
In future, this mouse model with adipose-specific knockout of Tst will be used to 
investigate the impact of Tst gene knockout on this tissue. 
 The data from this chapter were challenging to interpret due to unexpected 
results in the WT groups. WT mice on chow diet gained a large amount of weight 
during the 20-week experiment and, by the end of the time-period, weighed an average 
of around 40g and were visibly fat. WT mice on chow also had impaired glucose 
tolerance, and did not have significantly different plasma glucose to WT mice on HFD 
at any timepoint after administration of a glucose bolus. Therefore, the use of these 
mice as a control for diet-induced metabolic impairment was not ideal, as 
interpretation of the effect of diet was confounded by the deterioration of the mice on 
chow diet. Future experiments of this diet-induced obesity model will be limited to 
shorter durations to prevent this unfortunate outcome, and a defined low-fat diet will 
be used to better maintain a healthy metabolic profile. Another unexpected finding in 
WT mice was that the expression of several key antioxidant enzymes was increased 
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by HFD, a result that contradicts certain published literature on this model (Furukawa 
et al. 2004; Huh et al. 2012; Long et al. 2013; Han et al. 2016). This contradiction 
could be due to type of adipose tissue used for this measurement. Interpretation of the 
impact of Tst gene knockout on antioxidant gene expression must be carried out with 
this caveat in mind and would benefit from clarification in future experiments with the 
Tst–/– mouse. 
 The expression of Tst in adipose of WT mice was not stable throughout the 
duration of both experiments. After 6 weeks of HFD, Tst expression had decreased to 
almost one quarter of the expression in WT mice on chow diet. Older WT mice on 
chow, that had a degree of fat accumulation and metabolic impairment, also had 
reduced adipose Tst expression, which was not further reduced in the group on HFD 
for 20 weeks. It had previously been observed that Tst mRNA in adipose tissue 
negatively correlates with fat mass, and that high fat feeding of WT mice causes a 
reduction in its expression (Morton et al. 2016). Therefore, the reduced expression of 
Tst in obese WT mice was expected. However, it was apparent that high fat feeding 
lead to convergence of body weight, fat mass, and adiponectin levels between WT and 
Tst–/– mice. The reduction in Tst expression in adipose tissue of WT mice could have 
minimised the differences between the groups, leading to the convergence of these 
phenotypes.  
 Because of these limitations, the results presented here cannot definitively 
support the hypothesis that Tst gene knockout leads to impaired metabolic health after 
a high fat challenge due to increased susceptibility to adipose oxidative stress and 
inflammation. To address the specific risk of oxidative stress, it was decided to assess 
the response of primary adipocytes lacking or overexpressing TST in vitro to an 
oxidative challenge, work that will be described in Chapter 5. 
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Chapter 4 Metabolic characterisation of a new mouse model 
with human TST expression in adipose tissue 
 
4.1 INTRODUCTION 
Overexpression of Tst in adipose tissue was previously shown to protect against the 
metabolic impairment of HFD (Morton et al. 2016). The transgenic mouse used in the 
previous study was no longer available for use during this PhD, however a new model 
was developed that was hypothesised would have a similar phenotype. The aim of this 
chapter was to characterise this new mouse model with genetic overexpression of the 
human TST gene in adipose tissue (Ad-hTST), and to investigate if the increased TST 
in adipose tissue mediates its protective effects through minimising adipose tissue 
dysfunction. Unfortunately, this new model failed to recapitulate the phenotype of the 
Adipoq-Tst mouse, raising questions about the impact of genetic differences between 
the lines. 
The previous mouse line in which a protective effect of Tst overexpression was 
first observed was called the Adipoq-Tst mouse (Morton et al. 2016). These mice had 
an extra copy of the mouse Tst gene under the control of the adiponectin promoter 
which was inserted randomly in the genome and bred to homozyosity (Figure 4.1a). 
This led to a 2-fold increase in Tst mRNA in adipose tissue. Adipoq-Tst mice were 
protected from weight gain during a high fat challenge and had improved insulin 
sensitivity compared to wild-type mice. These mice exhibited evidence for increased 
hepatic fat oxidation and adipocyte lipolysis, as well as maintaining their 
responsiveness to insulin after HFD, and having increased SOD2 protein and Prx3 
mRNA in adipose tissue. Therefore, it was hypothesised that the increase in 
antioxidant capability in adipose of Adipoq-Tst mice contributed to the improved 
metabolic phenotype through prevention of local oxidative stress in adipose tissue.  
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Figure 4.1: Schematic of genetic structure of (a) Adipoq-Tst and (b) Ad-
hTST mice. 
Adipoq: adiponectin; CAG promoter: adapted from chicken β-actin promoter; 
loxP: DNA recognition site for cre recombinase; IRES: internal ribosome entry 
site. 
 
The new mouse model used in this chapter had adipose-specific overexpression 
of the human TST gene, using cre-loxP system to tqarget expression to adipose tissue. 
This mouse was fully described in paragraph 2.1.1.3 on page 60. The parent mouse 
(Rosa26LSLhTST, Figure 2.1 on page 61) was designed to contain an expression cassette 
inserted in the constitutively active Rosa26 locus which carried the human TST (hTST) 
cDNA and mCherry fluorescent reporter gene preceded by a STOP cassette flanked 
by loxP sites (loxP-STOP-loxP: LSL). To excise the stop region and induce expression 
of human TST in adipose tissue, homozygous Rosa26LSLhTST mice were bred with 
heterozygous Adiponectin-cre (Adip-cre) mice, expressing cre recombinase in adipose 
tissue (Eguchi et al. 2011). Excision of the stop cassette allowed for transcription of 
the TST and mCherry genes, driven by the constitutively active CAG promoter (Figure 
4.1b). Cre-positive progeny from this crossing were called Ad-hTST and cre-negative 
littermates were used as controls and named wild-type-loxP-STOP-loxP (WT-LSL).  
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The aim of this chapter was to characterise the new Ad-hTST mouse, including 
ensuring expression of human TST in adipose only, and assessing the metabolic 
response to a high fat challenge. Due to time limitations, female mice were used to 
investigate the pattern of human TST expression in adipose and non-adipose tissues, 
and male mice were subjected to a high fat exposure for 6 weeks. Metabolic phenotype 
was assessed by carrying out a glucose tolerance test after 5 weeks of HFD, and by 
measuring levels of the insulin-sensitising hormone adiponectin. Adipose tissue 
dysfunction was assessed by looking at expression of antioxidant genes, as well as 
evaluating immune cell infiltration. This chapter describes the results of these 
experiments, and discusses potential problems with the new mouse model that may 
have impacted on these results. Future work to overcome these potential problems is 
also discussed. 
 
4.1.1 Hypothesis & aims 
I hypothesised that thiosulfate sulfurtransferase over-expression in adipose tissue 
protects against metabolic impairment of a high fat challenge due to increased 
antioxidant capability. 
 
To test this hypothesis, the aims of this chapter were: 
• To characterise TST expression in female Ad-hTST mice. 
• To evaluate the metabolic phenotype of Ad-hTST mice after a high fat 
challenge. 
• To assess oxidative stress and inflammation in adipose of Ad-hTST mice after 
a high fat challenge. 
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4.2 METHOD 
Ad-hTST mice in this chapter were generated by breeding the parent line 
Rosa26LSLhTST (as described in paragraph 2.1.1.3 on page 60) with Adiponectin-cre 
(Adip-cre) mice, expressing cre recombinase in adipose tissue (Eguchi et al. 2011). 
Cre-positive mice were presumed to have excision of the stop region in adiponectin-
expressing cells (see Figure 2.1 on page 61), and were called Ad-hTST. Excision of 
the stop cassette and expression of the human TST gene was confirmed using female 
mice. Cre-negative littermates were used as controls, and were called wild-type-loxP-
STOP-loxP (WT-LSL). These mice were genetically indistinguishable from the parent 
line Rosa26LSLhTST.  
Female Ad-hTST mice and WT-LSL littermates were culled at 8 weeks and 
tissues harvested to characterise human TST expression and activity in adipose and 
other tissues. At 8 weeks of age, male Ad-hTST mice and WT-LSL littermates were 
separated into two groups, one on Surwit D12328 low fat diet (LFD) and the other 
group on Surwit D12331 high fat, high sucrose diet (HFD; see Table 2.2 on page 63). 
A glucose tolerance test (GTT) was performed after 5 weeks on experimental diets. At 
the end of the study period (6 weeks), mice were culled by decapitation, and blood and 
organs were harvested. Figure 4.2 below shows the timeline of high-fat feeding for 
male Ad-hTST and control mice. 
Due to time constraints and problems with breeding, both the female and male 
cohorts were carried out in three batches containing between 4 and 16 animals. 
 
Figure 4.2: Timeline of WT-LSL and male Ad-hTST mice on LFD or HFD 
for 6 weeks. 
Glucose tolerance test (GTT) was carried out after 5 weeks on LFD/HFD. 
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4.3 RESULTS 
 
4.3.1 Expression of human and mouse TST in adipose and other tissues 
of female Ad-hTST mice. 
4.3.1.1 Expression of human TST mRNA was increased in adipose tissues of 
Ad-hTST versus WT-LSL female mice. 
Adipose depots, including gonadal (female equivalent of epididymal, also called 
parametrial), mesenteric, subcutaneous and interscapular brown adipose, were excised 
from 8-week-old female Ad-hTST mice and WT-LSL (LoxP-STOP-LoxP) controls. 
The abundance of human TST mRNA was measured using a human-specific 
Taqman® probe. Human TST was undetectable or at very low background levels in 
all WT-LSL samples (Figure 4.3). Human TST was highly expressed in all adipose 
depots from Ad-hTST mice, including interscapular brown adipose (Figure 4.3d) 
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Figure 4.3: Gene expression of human TST in adipose depots of Ad-hTST 
and WT-LSL female mice at 8 weeks of age. 
Abundance of human TST mRNA in (a) gonadal, (b) mesenteric (c) 
subcutaneous white adipose and (d) interscapular brown adipose, normalised 
to housekeeping gene Eef2. Data are mean ± SEM, analysed by Student’s t-
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4.3.1.2 Expression of mouse Tst mRNA was unchanged in adipose tissues of 
Ad-hTST versus WT-LSL female mice. 
The abundance of mouse Tst mRNA was assessed in white and brown adipose depots 
of WT-LSL and Ad-hTST female mice. Expression of the endogenous Tst gene was 
unchanged in adipose depots of Ad-hTST mice (Figure 4.4). 
 
 
Figure 4.4: Gene expression of mouse Tst in adipose depots of Ad-hTST 
and WT-LSL female mice at 8 weeks old. 
Abundance of mouse Tst mRNA in (a) gonadal, (b) mesenteric (c) 
subcutaneous white adipose and (d) interscapular brown adipose, normalised 
to housekeeping gene Eef2. Data are mean ± SEM, analysed by Student’s t-




















































































Chapter 4  
137 
 
      
      
4.3.1.3 Rhodanese activity was increased in adipose tissues of Ad-hTST 
versus WT-LSL female mice. 
Homogenates of gonadal, mesenteric and subcutaneous adipose depots from female 
Ad-hTST mice were assessed for rhodanese (TST/MPST) activity. Compared to WT-
LSL controls, rhodanese activity (expressed per milligram of protein per minute) in 
gonadal fat was significantly increased by 3.5-fold (Figure 4.5a). In mesenteric fat, 
rhodanese activity was increased by 2-fold in Ad-hTST mice compared to WT-LSL 
(Figure 4.5b). Subcutaneous fat of Ad-hTST mice exhibited a 3.3-fold increase in 
rhodanese activity compared to WT-LSL mice (Figure 4.5c). 
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Figure 4.5: Rhodanese activity in homogenates of adipose depots of Ad-
hTST and WT-LSL female mice at 8 weeks of age. 
Rhodanese activity per minute in (a) gonadal, (b) mesenteric and (c) 
subcutaneous adipose depots, normalised to protein concentration. Data are 
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4.3.1.4 TST protein was more abundant in adipose tissues of Ad-hTST versus 
WT-LSL female mice. 
TST protein content of gonadal and subcutaneous adipose depots from female Ad-
hTST and WT-LSL was measured by Western blot using an antibody with reactivity 
to both the human and mouse proteins. TST protein was very low or undetectable in 
WT-LSL samples. Both gonadal and subcutaneous depots from Ad-hTST mice had 
high TST protein content (Figure 4.6).  
 
 
Figure 4.6: TST protein in adipose depots of Ad-hTST and WT-LSL female 
mice at 8 weeks of age. 
TST protein content, relative to GAPDH endogenous control in (a) gonadal and 
(b) subcutaneous fat. Representative samples are shown below graphs. Data 
are mean ± SEM, analysed by Student’s t-test: *** P < 0.001; (n=6; except n=4 
for (b) WT-LSL due to negative values). 
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4.3.1.5 Human TST mRNA was not expressed in non-adipose tissues of Ad-
hTST and WT-LSL female mice. 
To confirm the tissue specificity of recombination by cre to adipose tissues only, 
human TST mRNA levels were measured in liver, kidney, spleen, lung and heart of 
Ad-hTST mice. Gonadal white adipose tissue (WAT) from Ad-hTST mice was used 
as a positive control and to generate a standard curve. Human TST was undetectable 
or at low background levels in liver, kidney and spleen (Figure 4.7). Lung and heart 
tissue had a low, but measurable amount of human TST, however no significant 
difference was found between Ad-hTST and WT-LSL mice, indicating that this may 
be due to amplification of a hTST sequence-related transcript in these tissues, giving 
a false positive.  
 

































Figure 4.7: Gene expression of human TST in non-adipose tissues of Ad-
hTST and WT-LSL female mice at 8 weeks of age. 
Abundance of human TST mRNA in gonadal white adipose tissue (WAT), liver, 
kidney, spleen, lung and heart, normalised to housekeeping gene Eef2. A 
standard curve for interpolation of relative concentration was created using 
mRNA from Ad-hTST WAT samples only. Data are mean ± SEM; (n=3). 
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4.3.1.6 mCherry fluorescence was present in adipose, but not in non-adipose 
tissues of Ad-hTST female mice. 
Adipose and non-adipose tissues of female Ad-hTST and WT-LSL mice were imaged 
to investigate expression of the red fluorescent marker mCherry. Explants were stained 
with DAPI to visualise nuclei. Gonadal adipose tissue from Ad-hTST showed red 
fluorescence in the cytoplasm of adipocytes, but no equivalent red fluorescence was 
observed in gonadal adipose from WT-LSL mice (Figure 4.8a). Red fluorescence was 
observed in subcutaneous adipose of Ad-hTST mice, however this was less distinct 
than in gonadal adipose, potentially due to a high background fluorescence as found 
in subcutaneous adipose from WT-LSL mice (Figure 4.8b). Explants of liver and 
quadriceps muscle from Ad-hTST mice showed no red fluorescence and were 
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Figure 4.8: mCherry fluorescence in adipose and non-adipose tissues of 
Ad-hTST and WT-LSL female mice at 8 weeks of age. 
DAPI was used to stain nuclei in explants of (a) gonadal fat, (b) subcutaneous 
fat, (c) liver and (d) quadriceps muscle. 
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4.3.2 The effects of human TST gene overexpression in adipose on 
glucose homeostasis and adipose tissue response to high fat diet 
in Ad-hTST male mice. 
4.3.2.1 Body weight was not different in Ad-hTST versus WT-LSL male mice 
on LFD or HFD for 6 weeks. 
Body weights of male Ad-hTST and WT-LSL male mice were measured after 6 weeks 
of HFD or LFD, and were found to be higher in HFD-fed mice (Figure 4.9a). Mice of 
both genotypes gained a similar amount of weight on HFD (Figure 4.9b). Ad-hTST 
and WT-LSL mice on LFD gained very little weight over the 6-week period.  
 
 
Figure 4.9: Body weight of Ad-hTST and WT-LSL mice on LFD or HFD for 
6 weeks. 
(a) Body weight at cull, and (b) weight gain from week 0 to week 6. Data are 
mean ± SEM, analysed by 2-way ANOVA: *** P < 0.001, ns = not significant; 
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4.3.2.2 Body composition was not different in Ad-hTST versus WT-LSL mice 
on LFD or HFD for 6 weeks. 
To measure changes in body composition in vivo during the 6-week feeding period, a 
Bruker Minispec LF50 whole body composition analyser was used at week 0, week 3 
and week 6. After 3 weeks on HFD, both Ad-hTST and WT-LSL mice had 
significantly increased fat mass, and reduced lean mass as a percentage of total body 
weight (Figure 4.10). By 6 weeks, fat mass was further increased and lean mass 
decreased. Ad-hTST mice gained fat mass and lost lean mass at the same rate as WT-
LSL mice on HFD. 
 
 
Figure 4.10: Whole body composition of Ad-hTST and WT-LSL mice on 
LFD or HFD for 6 weeks. 
(a) Fat mass, and (b) lean mass as a percentage of total body weight. Data 
are mean ± SEM, analysed by 2-way repeated measures ANOVA with 
Bonferroni post-hoc test comparing each group at each timepoint: LFD vs. 
HFD for both genotypes: *** P < 0.001; (n = 6-7). 
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4.3.2.3 Adipose tissue depots weights were not different in Ad-hTST versus 
WT-LSL mice on LFD or HFD for 6 weeks. 
After 6 weeks on LFD or HFD, mice were culled and three white adipose depots were 
weighed and normalised to body weight. Epididymal, mesenteric and subcutaneous 
adipose depots were increased by HFD in both Ad-hTST mice and WT-LSL, with no 
significant differences between genotypes (Figure 4.11). 
 
 
Figure 4.11: White adipose depot weights of Ad-hTST and WT-LSL mice 
on LFD or HFD for 6 weeks. 
(a) Epididymal, (b) mesenteric, and (c) subcutaneous white adipose depots, 
normalised to body weight at cull. Data are mean ± SEM, analysed by 2-way 
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4.3.2.4 Food intake and feed efficiency were not different in Ad-hTST versus 
WT-LSL mice on LFD or HFD for 6 weeks. 
Food intake was measured weekly, and feed efficiency was calculated as grams gained 
per week per kcal consumed per week. Mice on HFD consumed slightly more kcal per 
week than those on LFD, however no difference was observed in Ad-hTST mice 
compared to WT-LSL (Figure 4.12a). Consumption of HFD caused an increase in feed 
efficiency, with mice of both genotypes gaining a similar amount of weight per kcal 
consumed (Figure 4.12b).  
 
 
Figure 4.12: Food intake and feed efficiency per week in Ad-hTST and 
WT-LSL mice on LFD or HFD for 6 weeks. 
(a) Food intake (kcal per week), and (b) feed efficiency (grams gained per kcal 
consumed). Data are mean ± SEM, analysed by 2-way ANOVA: ** P <0.01, 
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4.3.2.5 Glucose tolerance was impaired after 5 weeks of HFD in Ad-hTST and 
WT-LSL mice. 
A glucose tolerance test was carried out on Ad-hTST and WT-LSL mice after 5 weeks 
of HFD. Comparison of glucose levels between genotypes at each timepoint showed 
that Ad-hTST mice on LFD had lower glucose than WT-LSL mice on LFD at 15mins 
post-injection (P < 0.05; Figure 4.13a). No differences were observed between 
genotypes on HFD. Ad-hTST mice had significantly higher glucose on HFD than on 
LFD at all timepoints after glucose administration (Figure 4.13a). WT-LSL mice had 
significantly higher glucose on HFD than LFD at later timepoints only (60 and 120 
minutes). Overall plasma glucose levels during the GTT measured by area under the 
curve were increased by HFD in both WT-LSL and Ad-hTST mice, although there 
was no significant difference between genotypes (Figure 4.13b). 
 
Plasma insulin was measured at each timepoint before and after glucose 
administration. No differences were observed between Ad-hTST and WT-LSL mice 
on either diet. Ad-hTST mice had significantly higher fasting insulin (time 0) on HFD 
than on LFD and at all timepoints after glucose administration (Figure 4.13c). WT-
LSL mice had significantly higher insulin on HFD compared to LFD at only 120 
minutes post-injection. Overall plasma insulin levels during the GTT measured by area 
under the curve were increased by HFD in both WT-LSL and Ad-hTST mice, although 
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Figure 4.13: Plasma glucose and insulin levels after administration of a 
glucose bolus to Ad-hTST and WT-LSL mice on LFD or HFD for 5 weeks. 
(a) Plasma glucose levels during a glucose tolerance test (GTT); (b) area 
under the curve (AUC) of glucose levels during GTT; (c) plasma insulin levels 
during GTT; (d) AUC of insulin levels during GTT. Data are mean ± SEM; (a) 
and (c) analysed by 2-way repeated measures ANOVA with Bonferroni post-
hoc test comparing each group at each timepoint: LFD WT-LSL vs. Ad-hTST: 
$ P < 0.05; WT-LSL LFD vs. HFD: # P < 0.05, ## P < 0.01; Ad-hTST LFD vs. 
HFD: & P < 0.05, && P < 0.01, &&& P < 0.001; (b) and (d) analysed by 2-way 
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4.3.2.6 Total plasma adiponectin was reduced in Ad-hTST versus WT-LSL 
mice on LFD diet, and total and HMW adiponectin were reduced in 
both genotypes on HFD for 6 weeks. 
Total and high molecular weight (HMW) adiponectin were measured by ELISA in the 
plasma of WT-LSL and Ad-hTST mice after 6 weeks of HFD. Total adiponectin was 
significantly reduced in Ad-hTST mice on LFD compared to WT-LSL (Figure 4.14a). 
High fat feeding caused a reduction in total and HMW adiponectin in both genotypes, 
but no significant difference was found between genotypes (Figure 4.14b). As a 
percentage of total adiponectin, HMW was reduced by HFD to the same degree in both 
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Figure 4.14: Plasma adiponectin levels of Ad-hTST and WT-LSL mice on 
LFD or HFD for 6 weeks. 
(a) Total adiponectin, (b) high molecular weight (HMW) adiponectin, and (c) 
HMW as a percentage of total adiponectin. Data are mean ± SEM, analysed 
by 2-way ANOVA: ** P <0.01, *** P < 0.001, ns = not significant; with Bonferroni 
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4.3.2.7 Plasma adiponectin was unchanged in Adip-cre versus WT mice. 
Adiponectin was measured in the plasma of Adip-cre mice and their corresponding 
cre-negative wild-type controls (6J) to ascertain if the presence of the Adip-cre gene 
impacted circulating levels of adiponectin, which could be carried through to Ad-hTST 
progeny. [Plasma samples for this measurement were provided by Dr. R. Czapiewski, 
Wellcome Trust Centre for Cell Biology, and the adiponectin ELISA was carried out 
by Rhona Aird, Molecular Metabolism Group]. Total and HMW adiponectin were 
unchanged in Adip-cre mice compared to WT mice (Figure 4.15). 
 
 
Figure 4.15: Plasma adiponectin levels of Adip-cre and WT (6J) mice. 
(a) Total adiponectin and (b) high molecular weight (HMW) adiponectin. Data 
are mean ± SEM, analysed by Student’s t-test: ns = not significant; (n=4-5). 
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4.3.2.8 Gene expression of adiponectin was unchanged in adipose tissue of 
Ad-hTST versus WT-LSL mice on LFD or HFD for 6 weeks. 
Gene expression of adiponectin (Adipoq) was measured in epididymal adipose tissue 
of WT-LSL and Ad-hTST mice after 6 weeks of HFD. There was no significant effect 























Figure 4.16: Adiponectin gene expression in epididymal white adipose 
tissue of Ad-hTST and WT-LSL mice on LFD or HFD for 6 weeks. 
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4.3.2.9 Gene expression of some key antioxidant enzymes was reduced in 
adipose tissue of Ad-hTST and WT-LSL mice on HFD for 6 weeks. 
The expression of mitochondrial and cytoplasmic antioxidant enzymes was measured 
in epididymal white adipose tissue from Ad-hTST and WT-LSL mice fed HFD or LFD 
for 6 weeks. Expression of mitochondrial antioxidant enzymes Prx3, Txn2 and Gpx4 
was reduced in mice fed HFD compared to LFD, but no differences were found in Ad-
hTST mice compared to WT-LSL (Figure 4.17). Sod2, Gpx1 and Txrnd2 were 
unchanged by increased TST expression or HFD. Sod1 and Prx1, two cytoplasmic 
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Figure 4.17: Gene expression of key antioxidant enzymes in epididymal 
adipose tissue of Ad-hTST and WT-LSL mice on LFD or HFD for 6 weeks. 
(a) Superoxide dismutase 2 (Sod2), (b)peroxiredoxin 3 (Prx3), (c) glutathione 
peroxidase 1 (Gpx1), (d) thioredoxin 2 (Txn2), (e) thioredoxin reductase 2 
(Txnrd2), (f) glutathione peroxidase 4 (Gpx4), (g) superoxide dismutase 1 
(Sod1), and (h) peroxiredoxin 1 (Prx1) mRNA abundance normalised to 
housekeeping gene Tbp. Data are mean ± SEM, analysed by 2-way ANOVA: 
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To assess activation of NRF2-mediated transcription, the expression of two NRF2-
target genes was measured. No difference was found in the expression of Hmox1 in 
Ad-hTST mice on LFD or HFD (Figure 4.18a). Expression of Nqo1 showed a 
significant interaction between genotype and diet, with lower expression in Ad-hTST 




Figure 4.18: Gene expression of NRF2-responsive antioxidant enzymes 
in epididymal adipose tissue of Ad-hTST and WT mice on LFD or HFD for 
6 weeks. 
(a) Heme oxygenase 1 (Hmox1) and (b) NAD(P)H:quinone acceptor 
oxidoreductase 1 (Nqo1) mRNA  abundance normalised to housekeeping 
gene Tbp. Data are mean ± SEM, analysed by 2-way ANOVA: * P < 0.05, ns 
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4.3.2.10 Immune cell populations in stromal vascular fraction of adipose tissue 
were not different in Ad-hTST versus WT-LSL mice on LFD or HFD 
for 6 weeks. 
Immune cell populations in SVF of epididymal adipose tissue were assessed by flow 
cytometry. Macrophage number as a percentage of total hematopoietic cell population 
(CD45+ population) was increased by HFD in both Ad-hTST and WT-LSL mice 
(Figure 4.19a). The percentage of hematopoietic cells expressing the pro-inflammatory 
macrophage marker CD11c was also increased by HFD in both genotypes (Figure 
4.19b). The percentage of eosinophils was significantly reduced by HFD in adipose 
from both Ad-hTST and WT mice (Figure 4.19c). There were no differences in 
immune cell populations between Ad-hTST and WT-LSL mice. 
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Figure 4.19: Immune cell populations in stromal vascular fraction (SVF) 
of epididymal adipose tissue of Ad-hTST and WT-LSL mice on LFD or 
HFD for 6 weeks. 
(a) Macrophages (F4/80+ CD11b+ Ly6C- MHCII+), (b) M1 macrophages 
(F4/80+ CD11b+ Ly6C- MHCII+ CD11c+), and (c) eosinophils (SiglecF+) 
measured in SVF of epididymal fat by flow cytometry. Results are expressed 
as percentage of hematopoietic population (CD45+). Data are mean ± SEM, 
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4.3.2.11 Gene expression of pro-inflammatory adipokines were not different 
in adipose tissue of Ad-hTST versus WT-LSL mice on LFD or HFD 
for 6 weeks. 
Gene expression of pro-inflammatory adipokines was measured in epididymal fat to 
assess the impact of increased TST expression on adipose tissue inflammatory markers 
after exposure to HFD. Plasminogen activator inhibitor 1 (Pai1) was significantly 
increased by HFD in both WT-LSL and Ad-hTST mice (Figure 4.20a). Monocyte 




Figure 4.20: Gene expression of pro-inflammatory adipokines in 
epididymal adipose tissue of Ad-hTST and WT mice on LFD or HFD for 6 
weeks. 
(a) Plasminogen activator inhibitor 1 (Pai1), and (b) monocyte chemotactic 
protein 1 (Mcp1) mRNA abundance normalised to housekeeping gene Tbp. 
Data are mean ± SEM, analysed by 2-way ANOVA: ** P < 0.01, ns = not 
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4.3.2.12 Gene expression of endoplasmic reticulum stress markers were 
unchanged in adipose tissue of Ad-hTST and WT-LSL mice on LFD 
or HFD for 6 weeks. 
To assess activation of the unfolded protein response, the expression of two key genes 
involved in this process was measured in epididymal fat of Ad-hTST mice after 6 
weeks of HFD. Expression of activating transcription factor 4 (Atf4) and C/EBP-




Figure 4.21: Gene expression of endoplasmic reticulum stress markers 
in epididymal adipose tissue of Ad-hTST and WT mice on LFD or HFD 
for 6 weeks. 
(a) Activating transcription factor 4 (Atf4) and (b) C/EBP-Homologous Protein 
(Chop) mRNA abundance normalised to housekeeping gene Tbp. Data are 
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4.3.2.13 Gene expression of mouse Tst was reduced in adipose of Ad-hTST 
versus WT-LSL mice on LFD diet, and in adipose of both genotypes 
on HFD for 6 weeks. 
Expression of human TST and the endogenous mouse gene was assessed in epididymal 
adipose tissue of Ad-hTST and WT-LSL mice after 6 weeks of HFD. Human TST was 
undetectable or very low in all WT-LSL samples, and highly expressed in adipose 
from Ad-hTST mice, with no change on HFD (Figure 4.22a). Endogenous mouse Tst 
expression was significantly reduced in Ad-hTST on LFD compared to WT-LSL. HFD 
caused a reduction in Tst expression in WT-LSL mice only, leading to a finding of 
significant interaction between genotype and diet (Figure 4.22b). TST protein content 
in epididymal adipose tissue was measured by Western blot. No detectable bands were 
observed for WT-LSL samples, however TST protein content was high in adipose 
from Ad-hTST mice (Figure 4.22c). 
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Figure 4.22: TST gene and protein expression in epididymal adipose 
tissue of Ad-hTST and WT mice on LFD or HFD for 6 weeks. 
Abundance of human TST, and (b) mouse Tst mRNA normalised to 
housekeeping gene Tbp; (c) TST protein abundance normalised to GAPDH, 
with representative image of Western blot. Data are mean ± SEM, analysed 
by 2-way ANOVA: ** P < 0.01, *** P < 0.001, ns = not significant; with 
Bonferroni post-hoc test comparing between genotypes for each diet: # P < 
0.05; (n=5-7; N.D. = not detected). 
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4.3.2.14 Gene expression of H2S-producing enzymes were not different in 
adipose tissue of Ad-hTST versus WT-LSL mice on LFD or HFD for 
6 weeks. 
Gene expression of two enzymes responsible for producing sulfide were measured in 
epididymal white adipose tissue. No significant difference was found in expression of 
cystathionine γ lyase (Cse) in adipose of Ad-hTST and WT-LSL mice on LFD or HFD 
(Figure 4.23a). Mercaptopyruvate sulfurtransferase (Mpst) was lower in adipose of 
mice on HFD, with no significant difference between genotypes (Figure 4.23b). 
 
Figure 4.23: Gene expression of H2S-producing enzymes in epididymal 
adipose tissue of Ad-hTST and WT-LSL mice on LFD or HFD for 6 weeks. 
(a) Cystathionine γ lyase (Cse), and (b) mercaptopyruvate sulfurtransferase 
(Mpst) mRNA abundance normalised to housekeeping gene Tbp. Data are 
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4.3.2.15 Gene expression of H2S oxidation enzymes were not different in 
adipose tissue of Ad-hTST versus WT-LSL mice on LFD or HFD for 
6 weeks. 
The gene expression of enzymes involved in the oxidation of sulfide was measured. 
Ethylmalonic encephalopathy protein 1 (Ethe1) was unchanged by increased TST 
expression or HFD (Figure 4.24a). Sulfide-quinone oxidoreductase (Sqrdl) was 
reduced by HFD in both Ad-hTST and WT-LSL mice (Figure 4.24b). 
 
Figure 4.24: Gene expression of sulfide oxidation genes in epididymal 
adipose tissue of Ad-hTST and WT-LSL mice on LFD or HFD for 6 weeks. 
(a) Ethylmalonic encephalopathy protein 1 (Ethe1), and (b) sulfide:quinone 
oxidoreductase (Sqrdl) mRNA abundance normalised to housekeeping gene 
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4.4 DISCUSSION 
Thiosulfate sulfurtransferase, when over-expressed in adipose tissue, was previously 
found to be protective against metabolic impairment due to exposure to a high fat diet 
(Morton et al. 2016). These mice, called Adipoq-Tst, expressed the mouse Tst gene 
under the control of the adiponectin promoter which led to a modest 2-fold increase in 
Tst expression in adipose tissue. For this chapter, Ad-hTST mice, with adipose-
specific over-expression of the human TST gene, were used to test the hypothesis that 
protection against metabolic impairment was due to a reduction in HFD-induced 
adipose tissue dysfunction. The mouse was designed to be used for testing potentially 
therapeutic compounds with human TST enzyme selectivity in future pre-clinical 
trials. Surprisingly the findings did not show that Ad-hTST mice were protected 
against metabolic impairment, and so did not replicate the results from previous work 
with the similar Adipoq-Tst mice. Indeed, high fat-fed Ad-hTST mice were potentially 
more prone to metabolic impairment, having mildly impaired glucose tolerance and 
elevated fasting insulin. Also, there was no clear evidence of reduced susceptibility to 
adipose tissue dysfunction, with antioxidant and endoplasmic reticulum stress gene 
expression and inflammatory cell populations comparable to controls. The lack of 
metabolic protection in this new mouse model may be due to differences between the 
mouse and human TST genes, or could highlight a hormetic effect in which a modest 
increase in TST expression is protective, as in the old Adipoq-Tst mouse, but a higher 
increase is detrimental.  
 A new mouse model was characterised for use in this study. 8-week-old female 
mice expressing cre were used to investigate expression of the human TST transgene 
and compared to female littermates lacking cre (WT-LSL). To get an accurate 
measurement of the comparable increase in active TST in adipose from Ad-hTST 
mice, rhodanese activity was measured and found to be 3.5, 2 and 3.3-fold higher in 
gonadal, mesenteric and subcutaneous fat respectively. This increase was comparable 
or greater than the increase in Tst mRNA and protein achieved in adipose of Adipoq-
Tst mice (Morton et al. 2016). Human TST mRNA was detectable at high levels in 
adipose depots of Ad-hTST mice, but it was not possible to calculate a “fold increase” 
due to its absence in adipose of controls. TST protein, detected using an antibody 
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sensitive to both human and mouse TST, was also greatly increased in adipose from 
Ad-hTST mice, however levels observed in WT-LSL were low or undetectable in 
some tissues. This was unexpected as TST protein was previously easily identifiable 
by Western blot in adipose from wild-type mice (Morton et al. 2016). This 
unexpectedly low measurement of TST protein in WT-LSL mice could indicate a 
difference in TST protein expression in adipose of female mice, which had previously 
not been assessed. Alternatively, it could be due to a preference of the currently 
available antibody for human TST over the mouse protein. However, due to time 
constraints, it was not possible to further investigate the protein levels of TST in 
adipose from WT-LSL female mice, and it the evidence was sufficient to confirm that 
TST was present in adipose of Ad-hTST mice at a greatly increased level.  
To confirm specificity of the transgene to adipose tissue, mRNA of human TST 
was measured and found to be absent in liver, kidney and spleen, and very low in lung 
and heart. As well as this, mCherry fluorescence, visible in adipose tissues from Ad-
hTST mice, was absent in liver and muscle samples. Therefore, it was concluded that 
expression of the human TST transgene was specific to adipose tissues. Human TST 
was found to be expressed in brown adipose tissue, indicating that cre-mediated 
excision of the stop cassette occurred in this tissue. The previous model, Adipoq-Tst, 
did not have overexpression of Tst in brown fat (Morton et al. 2016), and so this 
highlights another difference between these models that could account for differences 
in the metabolic phenotypes. Overexpression of TST in brown fat may impact cold-
induced thermogenesis and energy expenditure, and must be taken into account in 
future investigations with these mice. 
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4.4.1 Metabolic impairment of Ad-hTST mice on HFD. 
It was hypothesised that Ad-hTST mice would be protected against metabolic 
impairment after exposure to a high fat diet, as overexpression of TST in adipose tissue 
was protective in Adipoq-Tst mice (Morton et al. 2016). To test this hypothesis, male 
Ad-hTST mice and littermates were randomised to receive either a high fat diet (HFD: 
58% kcal from fat) or low-fat diet (LFD: 10.5% kcal from fat) for 6 weeks, at which 
point a significant increase in body weight and adipose tissue dysfunction is normally 
induced in 6N mice (Podrini et al. 2013). This feeding regime led to an increase in 
body weight and fat mass in WT-LSL mice as expected. However, Ad-hTST mice 
gained a similar amount of weight, and their increase in fat mass was indistinguishable 
from controls after 3 and 6 weeks of HFD. There was no effect of human TST 
overexpression in adipose tissue on food intake or feed efficiency, with both genotypes 
exhibiting increased feed efficiency on HFD, a well-established effect of HFD on 6J 
mice (West et al. 1992). Therefore, Ad-hTST mice do not appear to be protected from 
weight gain on HFD, as the previous model, Adipoq-Tst was. 
 Despite a similar amount of weight gain, Ad-hTST mice on HFD for 6 weeks 
were susceptible to metabolic impairment, potentially more-so than WT-LSL mice, 
challenging the hypothesis that overexpression of TST in adipose is protective. 
Glucose tolerance of WT-LSL mice deteriorated slightly with 6 weeks of HFD due to 
a failure to clear glucose as efficiently at later timepoints as mice on LFD. This 
duration of exposure to HFD does not always induce glucose intolerance in C57BL/6 
mice (Matsuzawa-Nagata et al. 2008), or may cause only a minor decline (Fisher-
Wellman et al. 2016) as observed in WT-LSL mice in the current study. Ad-hTST 
mice however, showed a more pronounced deterioration on HFD, with significantly 
higher glucose than LFD-fed Ad-hTST mice at every timepoint after administration of 
a glucose bolus. Added to this, HFD caused a significant increase in plasma insulin in 
Ad-hTST mice but not WT-LSL mice, suggesting that insulin resistance was induced 
more in Ad-hTST mice than WT-LSL mice on HFD. This does not conclusively prove 
that Ad-hTST mice are more metabolically impaired than controls, as there were no 
significant differences between the genotypes on HFD. Ad-hTST mice on LFD had a 
significantly lower glucose level than WT-LSL mice 15 minutes after administration, 
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indicating that these mice cleared glucose quicker than controls. To fully characterise 
this slight improvement in glucose tolerance in LFD-fed Ad-hTST, more sensitive 
assessment of the metabolic phenotype of these mice would be required, such as by 
hyperinsulinemic-euglycemic clamp. However, for the purposes of this investigation, 
the data do not support the hypothesis that overexpression of human TST in mouse 
adipose tissue is protective against metabolic deterioration due to HFD. This may be 
due to differences in the human and mouse TST protein sequences, which will be 
discussed below. 
 Plasma adiponectin levels were also investigated to assess the potential impact 
of overexpression of TST in adipose tissue on this key insulin-sensitising adipokine. 
High fat feeding led to a reduction in total and HMW adiponectin in both Ad-hTST 
and WT-LSL mice, a well-characterised effect of obesity in mice and humans (Hu et 
al. 1996; Ye et al. 2007). Overexpression of TST in adipose tissue of Ad-hTST mice 
did not impact this reduction of adiponectin due to high fat feeding. However, Ad-
hTST mice showed a reduction in total adiponectin in plasma on LFD, compared to 
WT-LSL. Adiponectin can be reduced due to oxidative stress (Furukawa et al. 2004), 
hypoxia and activation of the unfolded protein response in adipose tissue (Chen et al. 
2006; Hosogai et al. 2007). There was no indication that epididymal adipose tissue 
from LFD-fed Ad-hTST was under oxidative or hypoxic stress, and it also showed no 
reduction in Adipoq mRNA. Therefore, this decrease in plasma adiponectin in Ad-
hTST mice remains unexplained. Expression of human TST was not assessed in bone 
marrow adipose tissue of Ad-hTST mice, which has been shown to be a source of 
adiponectin under certain circumstances (Cawthorn et al. 2014). This should be taken 
into account in future experiments with these mice. Plasma levels of adiponectin in 
Ad-hTST mice may also have been impacted by insertion of cre recombinase into the 
adiponectin locus, as in the parent line Adip-cre (Eguchi et al. 2011). Therefore, 
adiponectin was assessed in the plasma of Adip-cre mice and found to be unchanged, 
indicating that reduced plasma adiponectin in Ad-hTST mice on LFD was a true effect 
of TST overexpression in adipose tissue. Despite this intriguing effect, it was apparent 
that Ad-hTST did not recapitulate the phenotype of Adipoq-Tst mice, which had higher 
plasma HMW adiponectin levels than controls on both chow and high fat diet (Morton 
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et al. 2016), which could potentially account for the lack of protection against 
metabolic impairment in Ad-hTST mice.  
 Based on previous work on Adipoq-Tst mice, it was hypothesised that Ad-
hTST mice would be protected against metabolic impairment due to high fat feeding. 
However, the data from this experiment do not support this hypothesis, and indicate 
that Ad-hTST mice may instead be more prone to glucose intolerance on HFD than 
controls. 
 
4.4.2 Adipose tissue dysfunction of Ad-hTST mice on HFD. 
Previous assessment of the impact of HFD on Adipoq-Tst mice indicated that the 
improved metabolic health of these mice may be due to protection against adipose 
tissue oxidative stress. Adipoq-Tst mice maintained expression of Prx3 and had higher 
SOD2 protein levels in adipose than WT mice on HFD. It was hypothesised that Ad-
hTST mice would exhibit a similar or greater protection from adipose tissue 
dysfunction due to oxidative stress. However, Ad-hTST mice failed to show protection 
against metabolic impairment, and this was reflected in the assessment of adipose 
tissue dysfunction in these mice, with no apparent improvements compared to controls.  
 Adipose tissue from Ad-hTST mice did not appear to have increased 
antioxidant capability, or protection from HFD-induced inflammation. Diet-induced 
obesity in mice leads to a reduction in expression of key antioxidant enzymes such as 
Prx3 (Huh et al. 2012) and Gpx4 (Long et al. 2013), as well as reducing gene 
expression and protein levels of the superoxide dismutase enzymes after longer 
durations of high fat feeding (Han et al. 2016; Morton et al. 2016). Ad-hTST were not 
protected against these reductions in antioxidant enzyme expression, showing a similar 
reduction to WT-LSL mice in expression of Prx3, Gpx4 and Txn2. Therefore, Ad-
hTST mice were unlike Adipoq-Tst mice, which had higher Prx3 expression in adipose 
tissue after HFD, one of the mechanisms suggested for the improvement of metabolic 
health in these mice (Morton et al. 2016). As well as the lack of evidence for protection 
against oxidative stress in adipose from Ad-hTST mice, inflammatory cell infiltration 
was also not impacted by overexpression of TST. Macrophage content, including M1 
pro-inflammatory macrophages increased with HFD in a similar manner to WT-LSL 
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mice, a well-characterised effect of high fat feeding (Lumeng et al. 2007), and numbers 
of the beneficial eosinophils were reduced (Wu et al. 2011). Expression of pro-
inflammatory adipokines, Pai1 and Mcp1 were increased by high fat feeding in Ad-
hTST and WT-LSL. Expression of two regulators of the UPR, Chop and Atf4, were 
also unchanged in adipose tissue of Ad-hTST, however a lack of increase in WT-LSL 
tissue indicates that the duration of exposure to HFD may not have been sufficient to 
cause UPR activation (Hosogai et al. 2007). Therefore, there was no indication that 
overexpression of human TST reduced adipose tissue dysfunction through minimising 
oxidative stress or inflammation, and it is likely that this underscores why Ad-hTST 
mice did not exhibit protection against metabolic impairment on HFD.  
 
4.4.3 Impact of hydrogen sulfide on adipose tissue in Ad-hTST mice. 
It was not possible to assess plasma or tissue sulfide levels in Ad-hTST mice, therefore 
interpreting the potential impact of sulfide on the phenotype of these mice is 
challenging. Overexpression of TST did not lead to changes in the expression of 
sulfide-producing or sulfide oxidation enzymes, however HFD-fed mice had reduced 
expression of both Mpst and Sqrdl. These enzymes were previously found to be 
reduced in liver after high fat feeding (Baiges et al. 2010; Peh et al. 2014), however 
their expression in mesenteric adipose tissue was not reduced after HFD in a previous 
cohort described in this thesis (Figure 3.19 and Figure 3.20 on pages 115 and 116). 
This could be due to a difference effect of HFD on mesenteric and epididymal adipose 
tissue, or differences between the WT mice in the previous chapter and WT-LSL mice 
used here. The reduction in expression of these two enzymes indicates that high fat 
feeding may impact the production and oxidation of sulfide in adipose of both WT-
LSL and Ad-hTST mice. 
Overexpression of human TST in adipose tissue has a complex effect on 
expression of the endogenous mouse Tst gene, which could impact the phenotype of 
these mice on HFD. Male Ad-hTST mice on LFD had a 45% reduction in expression 
of the endogenous Tst gene compared to WT-LSL mice, but were protected from 
further reduction due to HFD. It was not possible to measure the separate activities of 
these two homologous enzymes, and it could be possible that the functions do not fully 
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overlap due to differences in the peptide sequences. Further work will be required to 
ensure the human TST enzyme can fully substitute for the mouse enzyme, and if it is 
found that these enzymes function differently, the usefulness of the Ad-hTST mouse 
and its parent line Rosa26LSLhTST may be called into question. 
 
4.4.4 Limitations and future work. 
The aims of this chapter were to characterise human TST gene expression in a new 
mouse model (Ad-hTST), and assess the impact of this on adipose tissue dysfunction 
and metabolic impairment due to exposure to high fat diet. I have not confirmed that 
overexpression of TST in adipose tissue is protective against metabolic impairment, 
as was observed in a previous model with modest overexpression of the mouse Tst 
gene in adipose tissue. I have not uncovered evidence that overexpression of human 
TST in adipose tissue of Ad-hTST mice protects against oxidative stress and metabolic 
impairment. However, the findings presented here are not sufficient to definitively 
disprove the hypothesis that TST in adipose tissue protects against metabolic 
impairment due to limitations in our study.  
 Genetic differences between the new Ad-hTST mouse and the previously 
described Adipoq-Tst mouse may account for the phenotypic differences between 
these models. Both the gene used and the method of targeting its expression to adipose 
are different between these two lines, and these features could have influenced the 
phenotype. The Adipoq-Tst mouse was made by random insertion of the mouse Tst 
gene, allowing for seamless integration with the endogenous sulfide oxidation system. 
The Ad-hTST mouse uses the human TST gene, which produces a TST protein that 
differs from the mouse protein at twenty-seven residues, potentially causing functional 
differences despite conservation of the active site (Figure 4.25). A lysine residue (K) 
at position 219 in the mouse protein is predicted to be a potential site of post-
translational acetylation or succinylation (Farriol-Mathis et al. 2004; Park et al. 2013), 
whereas the human protein has a glutamate (E) amino acid at this residue with no 
predicted post-translational modifications. While the impact of this specific change in 
TST is unknown, alternating lysine and glutamate residues was found to dramatically 
impact the function of an enzyme in S. cerevisiae and a transcriptional regulator in V. 
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cholerae (Blanchard and Karst 1993; Singh et al. 2013). It is possible that this change, 
or any of the twenty-seven altered residues between the human and mouse peptide 
sequences, could impact protein-protein interactions, substrate preference or other 
aspects of TST function. Therefore, further characterisation of the human TST protein 
must be carried out to ensure its activity and function in mouse cells mirrors the activity 
of the mouse protein.  
  
 
Figure 4.25: Comparison of mouse and human TST protein sequence. 
Multiple sequence alignment carried out using Clustal Omega program (online 
open access tool; Sievers et al. 2014). Asterisk (*) indicates conserved 
residue; colon (:) indicates change to amino acid with strongly similar 
properties; period (.) indicates change to amino acid with weakly similar 
properties; yellow text (position 219) indicates site of potential post-translation 
modification in mouse protein; red box (position 248) indicates active site 
cysteine (Farriol-Mathis et al. 2004; Park et al. 2013). 
 
The cre-loxP system, driven by the adiponectin promoter, was used to direct 
expression of the human TST gene to adipose tissue in Ad-hTST mice. Certain 
problems associated with the cre-loxP system have been identified and may have 
impacted the efficiency of cre-mediated excision of the STOP cassette in this current 
study, and thus impacted the phenotype of these mice. The adult Adip-cre mouse is 
known to have off-target expression of cre in the skin, thyroid gland, salivary gland, 
testis, uterus and, as found here, in brown adipose tissue, as well as expression in other 
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tissues during embryonic development (Heffner et al. 2012; Blake et al. 2017). These 
off-target effects differentiate Ad-hTST from the Adipoq-Tst mouse model, and could 
influence the phenotype of these mice in unknown ways. In certain cre lines, paternal 
inheritance of the cre transgene leads to incomplete, mosaic recombination in target 
tissues (Heffner et al. 2012). All Ad-hTST mice were generated by breeding male 
Adip-cre mice with females containing the floxed transgene, potentially causing 
incomplete activation of TST expression in adipose tissues, which may explain the 
relatively modest (2 to 3.5-fold) increase in TST activity in adipose tissues of Ad-
hTST mice. Due to mouse availability, it was not possible to use Adip-cre females to 
generate mice for this study, however it will be essential to compare recombination 
efficiency of male versus female inheritance of the cre transgene in this line by 
breeding with a fluorescent reporter line (Klinger et al. 2010). Use of this reporter line 
will also allow for assessment of variation between littermates, another problem 
associated with the cre-loxP system (Heffner et al. 2012). In the current study, 
variability within groups was apparent, especially in the measurement of gene 
expression. This variability could have been due to the study being carried out with 
three separate batches of mice, or because mice are on a mixed background of 6N and 
6J substrains, but variability from cre expression may also have contributed. The cre-
loxP system has also been associated with apoptosis in developing embryos due to 
toxicity caused by cre (Naiche and Papaioannou 2007). To understand the impact of 
potential cre toxicity in Ad-hTST, Adip-cre littermates should be included as an extra 
control, but were unfortunately unavailable in this study as the Rosa26LSLhTST parents 
were homozygous. The contribution of these limitations with the cre-loxP system to 
the phenotype of Ad-hTST mice is unknown, but may account for the phenotypic 
differences between this model and the previous Adipoq-Tst mouse. It will be essential 
to confirm that efficient expression and activity of cre in adipose tissues has occurred 
in any future experiments with Ad-hTST mice.  
 The data presented in this chapter do not support the hypothesis that TST in 
adipose tissue protects against oxidative stress and adipose tissue dysfunction, and thus 
helps to maintain metabolic health during exposure to high fat diet. However, the new 
mouse model discussed here may have inherent problems that were not anticipated 
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prior to its development and use in this chapter. The human TST protein expressed in 
adipose tissue of the Ad-hTST mouse may not be functionally comparable to the 
endogenous mouse protein, and its expression within adipose depots may not be 
uniform, and could be variable between littermates. These potential problems must be 
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Chapter 5 The role of thiosulfate sulfurtransferase in the 




Several pieces of evidence from the literature and from work carried out in this lab 
suggest a potential role for TST in protecting against oxidative stress. While the results 
from chapter 3 show that mice lacking Tst may be more susceptible to metabolic 
impairment, it was not possible to show that the phenotype was due to a deteriorating 
response to oxidative stress. The aim of this chapter was to directly test the hypothesis 
that TST is involved in ROS breakdown. An inducer of oxidative stress was tested in 
vivo, but was not suitable for use due to the high risk of causing death. Therefore, 
primary adipocytes and hepatocytes were used to investigate the impact of altered Tst 
expression on ROS breakdown and mitochondrial ROS production in vitro.  
 It was hypothesised that TST may interact with ROS directly, or indirectly by 
collaboration with antioxidant enzymes. TST can be oxidised by H2O2 at its active site 
cysteine forming a sulfenic acid, which is reversible by thioredoxin, resulting in the 
oxidation of NADPH and the neutralisation of the attacking H2O2 (Nandi et al. 2000). 
This has been observed in a cell-free system, and has not been confirmed in a whole 
cell. However, previous work from our lab showed that 3T3-L1 adipocytes with si-
RNA-mediated knockdown of Tst had higher levels of mitochondrial ROS after 
exposure to H2O2 (Morton et al. 2016). As well as this in vitro evidence, mice with 
increased Tst expression in adipose tissue have increased protein levels of SOD2 and 
mRNA levels of Prx3, two key antioxidant enymes (Morton et al. 2016). In chapter 3 
of this thesis, mice lacking Tst had reduced expression of these and other antioxidant 
enzymes (see Figure 3.12 on page 105). Another mechanism by which Tst may interact 
with ROS is through modulation of H2S, which can act as an antioxidant my directly 
neutralising ROS or altering the function or transcription of antioxidant enzymes 
(discussed in paragraph 1.3.3.2 on page 49). While this evidence suggests that TST 
plays an antioxidant role in cells, it has not been shown directly that altered TST levels 
lead to altered ROS production or breakdown. One of the aims of this chapter was 
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therefore to directly test the ability of cells lacking Tst – or with overexpression of 
human TST – to breakdown and produce ROS. 
 Initially an attempt was undertaken to to induce oxidative stress in vivo using 
paraquat. Paraquat (chemical name: N,N′-dimethyl-4,4′-bipyridinium dichloride) is a 
commonly used herbicide, which when ingested in lethal amounts causes respiratory 
failure with pulmonary oedema, as its primary target organ for toxicity is the lungs 
(Lock and Wilks 2010). It is used to induce oxidative stress as it undergoes redox 
cycling in vivo. In its reduced form (PQ+), paraquat is oxidised in the presence of 
oxygen becoming PQ2+, and producing superoxide as a by-product (Figure 5.1). PQ2+ 
is then reduced by NADPH dehydrogenase or similar enzymes using NADPH present 
in cells, thus recycling the paraquat molecule. Paraquat causes cellular damage by 
producing an excess of superoxide, which when turned into H2O2 by the action of SOD 
enzymes, overwhelms the antioxidant machinery of the cell resulting in the production 
of hydroxyl radical and subsequent oxidative damage (Lock and Wilks 2010). Paraquat 
is commonly used in vivo to assess resistance to oxidative stress-induced death when 
administered at high doses of 50mg/kg or above (Luo et al. 2008; Bokov et al. 2011). 
Lower doses are used to assess the impact of oxidative stress on specific body systems 
such as dopaminergic neurons (McCormack et al. 2005) and the lungs (Zheng et al. 
2015). Therefore, to minimise the risk of death of the mice in this study, it was decided 
to carry out preliminary investigations to find the lowest dose of paraquat at which 
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Figure 5.1: Chemical structure and redox cycling mechanism of paraquat 
dichloride (PQ) in the production of superoxide in vivo. 
A: NAPH dehydrogenase or other cellular diaphorase enzyme; O2∙-: 
superoxide ion; (adapted from Dinis-Oliveira et al. 2008). 
 
 
As well as an in vivo assessment of the response to oxidative stress in mice 
with altered Tst expression, it was decided to carry out in vitro experiments to 
investigate ROS production and consumption in response to H2O2-induced oxidative 
stress. As TST has been suggested to potentially contribute to the breakdown of H2O2 
(Nandi et al. 2000), an assay was developed to test this in primary adipocytes from 
Tst–/– and Ad-hTST mice. H2O2 consumption was assessed by measuring the level of 
H2O2 remaining in the media after a short incubation period. Primary adipocytes from 
Tst–/– mice were also used to test for changes in mitochondrial ROS production in 
response to exogenous H2O2 exoposure. This model of in vitro oxidative stress was 
previously used by our group and others to induce mitochondrial superoxide 
production which can be measured using the fluorescent MitoSOX™ red 
mitochondrial superoxide indicator (Huh et al. 2012; Morton et al. 2016). 
Unfortunately, primary adipocytes were too fragile for this experiment, and it was 
difficult to accurately measure fluorescence as they floated outside the range of 
measurement. Therefore, primary hepatocytes were harvested from Tst–/– and WT, and 
used to investigate the impact of Tst loss on mitochondrial ROS production during 
oxidative stress. 
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This chapter describes the results of these experiments to uncover a potential 
role for TST in the breakdown of ROS. It was not possible to use paraquat as an inducer 
of oxidative stress in vivo under the conditions tested here. In vitro experiments, while 
not uncovering major differences in the ability of adipocytes lacking or with extra TST 
to dispose of H2O2, did uncover an unexpected finding in hepatocytes lacking Tst that 
remains to be fully eluidicated in future work. 
 
 
5.1.1 Hypothesis & Aims 
In this chapter, I hypothesised that thiosulfate sulfurtransferase protects against 
excessive damage during oxidative stress in adipose tissue. 
 
The aims of this chapter were: 
• To develop a model of induced oxidative stress in adipose tissue in vivo, and 
assess the outcome in mice with altered Tst expression. 
• To assess the impact of Tst knockout and overexpression in adipocytes on 
mitochondrial ROS levels and ROS disposal in vitro. 
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5.2 METHOD 
5.2.1 Induction of oxidative stress in vivo using paraquat 
To test the efficacy of paraquat dichloride (PQ) as an inducer of oxidative stress in 
adipose tissue in vivo, PQ (in physiological saline 0.9%) was administered to WT, Tst–
/– or heterozygous (Tst+/–) mice by intraperitoneal injection. Three preliminary studies 
were carried out, with increasing doses and time of exposure. No consistent effects of 
PQ on markers of oxidative stress in adipose tissue were observed in any of these 
studies, and so only the results from the study using the highest dose (25mg/kg) are 
included here. Results from the first and second pilot studies are included in the 
appendix (page 213). At the end of each study, mice were culled by decapitation and 
organs were harvested for analysis. 
 
5.2.2 Induction of oxidative stress in vitro 
5.2.2.1 Primary adipocyte isolation 
Male mice between 8 and 12 weeks of age were culled by CO2, followed by cervical 
dislocation and epididymal adipose tissue was harvested. This was used to isolate 
primary adipocytes by collagenase digestion as described on page 76. Tst–/– mice and 
WT (C57BL/6J) mice were used for measurement of H2O2 disposal and mitochondrial 
ROS production. Ad-hTST and WT-LSL mice were used for measurement of H2O2 
disposal only. 
 
5.2.2.2 Primary hepatocyte isolation 
Male mice around 12 weeks of age were culled by CO2, followed by cervical 
dislocation, and hepatocytes were isolated according to the protocol described on page 
77. Primary hepatocytes were cultured on a 96-well plate and were allowed to settle 
overnight before experiments were carried out to assess mitochondrial ROS 
production. 
  
Chapter 5  
180 
 
      
      
5.3 RESULTS 
5.3.1 Paraquat as an inducer of adipose tissue oxidative stress in vivo.  
5.3.1.1 PQ caused weight loss in heterozygous Tst+/– mice at 24hrs post-
injection. 
PQ (25mg/kg) or saline was administered to heterozygous Tst+/– mice, and after 24hrs, 
mice were culled and epididymal adipose tissue and lung were collected to assess for 
effects of PQ, including changes in weight, malondialdehyde content and antioxidant 
gene expression. PQ-treated mice lost significantly more weight than controls, losing 





















Figure 5.2: Weight loss of Tst+/– mice at 24hrs after administration of PQ 
(25mg/kg) or saline (0.9%). 
Weight loss expressed as percentage of starting weight. Data are mean ± 
SEM, analysed by Student’s t-test: * P < 0.05; (n=3). 
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5.3.1.2 PQ did not alter white adipose tissue weight, malondialdehyde content 
and antioxidant gene expression at 24hrs post-injection. 
The weight of epididymal, mesenteric and subcutaneous white adipose depots were 
unchanged by exposure to PQ (25mg/kg) for 24hrs (Figure 5.3a). Malondialdehyde 
(MDA), a product of lipid peroxidation and a marker of oxidative stress, was 
unchanged in epididymal adipose tissue after PQ treatment (Figure 5.3b). Expression 
of antioxidant genes Prx3, Gpx1, Sod2, Txn2, Sod1 and Prx1 in epididymal adipose 
were unaffected by PQ (Figure 5.3c). 
 
Figure 5.3: White adipose tissue response in Tst+/– mice at 24hrs after 
administration of PQ (25mg/kg) or saline (0.9%). 
(a) White adipose depot weights, (b) malondialdehyde content and (c) mRNA 
abundance of antioxidant genes normalised to housekeeping gene Tbp in 
epididymal adipose tissue. Data are mean ± SEM, analysed by Student’s t-
test: not significant; (n=3). 
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5.3.1.3 PQ does not alter lung weight or antioxidant gene expression at 24hrs 
post-injection. 
24hr exposure to PQ (25mg/kg) in Tst+/– mice did not alter the weight of the lungs 
compared to saline-treated mice (Figure 5.4a). Expression of antioxidant genes Prx3, 
Gpx1, Sod2, Txn2, Sod1 and Prx1 were unchanged in lung tissue of PQ-treated mice 
(Figure 5.4b). 
 
Figure 5.4: Lung response in Tst+/– mice at 24hrs after administration of 
PQ (25mg/kg) or saline (0.9%). 
(a) Lung weight, (b) mRNA abundance of antioxidant genes normalised to 
housekeeping gene Tbp in lung tissue. Data are mean ± SEM, analysed by 
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5.3.2 Consumption of ROS by primary adipocytes from Tst–/– and Ad-
hTST mice. 
5.3.2.1 H2O2 consumption is unchanged in primary adipocytes of Tst–/– 
compared to WT mice. 
Primary adipocytes were separated from SVF after collagenase digestion of 
epididymal adipose tissue of Tst–/– and WT mice. Adipocytes from WT and Tst–/– mice 
disposed of H2O2 at the same rate, with about 40% of H2O2 remaining after 5mins 





















Figure 5.5: Percentage of 100μM H2O2 in media after 5mins exposure of 
primary adipocytes of WT and Tst–/–  mice. 
Data are mean ± SEM, analysed by Student’s t-test: not significant; (WT n=9; 
Tst–/– n=11). 
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5.3.2.2 H2O2 consumption is unchanged in primary adipocytes of Ad-hTST 
compared to WT-LSL mice. 
H2O2 breakdown was also assessed in adipocytes from Ad-hTST mice and their 
corresponding control line, WT-LSL. There was no significant difference in the 
amount of H2O2 remaining after incubation with adipocytes from WT-LSL or Ad-























Figure 5.6: Percentage of 100μM H2O2 in media after 5mins exposure of 
primary adipocytes of WT and Ad-hTST mice. 
Data are mean ± SEM, analysed by Student’s t-test: not significant; (WT-LSL 
n=9; Ad-hTST n=11). 
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5.3.3 Mitochondrial superoxide production in primary adipocytes from 
Tst–/– mice. 
Primary adipocytes were isolated from epididymal adipose tissue of Tst–/– and WT 
mice by collagenase digestion of the tissue, and incubated in H2O2 (0.5%; 163mM) for 
2hrs prior to measurement of mitochondrial superoxide using MitoSOX. H2O2 caused 
a similar increase in mitochondrial superoxide in adipocytes from both WT and Tst–/– 
mice (Figure 5.7a). Cell death was assessed by measuring lactate dehydrogenase 
activity (LDH) in the media following pre-incubation. H2O2 led to an increase in LDH 
activity in the media of both Tst–/– and WT samples (Figure 5.7b). 
 
 
Figure 5.7: Mitochondrial superoxide and LDH activity of primary 
adipocytes of Tst–/– and WT mice exposed to H2O2 (0.5%) for 3hrs. 
(a) Mitochondrial superoxide as fluorescence of MitoSOX dye, and (b) lactate 
dehydrogenase (LDH) activity in media. Data are mean ± SEM, analysed by 
2-way ANOVA: * P <0.05, *** P < 0.001, ns = not significant; (n=2-3). 
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Measurement of fluorescence in primary adipocytes was problematic due to technical 
challenges of working with floating cells. Because of the fragility of adipocytes in 
vitro, many samples were left with too few cells to give an accurate measurement of 
fluorescence, as the floating cells gathered at the edge of the wells outside of the range 
of the fluorescent plate reader. Therefore, it was decided to change to adherent cells as 
a model of Tst knockout. SVFs were isolated from adipose of Tst–/– and WT mice, and 
differentiated into adipocytes, however there was great variability in differentiation 
efficiency between wells, making them unsuitable for this experiment. Therefore, it 
was decided to use primary hepatocytes as a model for Tst knockout, as the high 
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5.3.4 Mitochondrial superoxide production in primary hepatocytes from 
Tst–/– mice. 
5.3.4.1 Exogenous ROS exposure increases mitochondrial superoxide to a 
lesser degree in primary hepatocytes of Tst–/– compared to WT mice. 
Primary hepatocytes [collected by M. Gibbins, Molecular Metabolism group] from 
Tst–/– and WT mice were exposed to increasing concentrations of H2O2 for 2hrs 
followed by MitoSOX to measure mitochondrial superoxide levels. Hepatocytes from 
Tst–/– mice had lower mitochondrial superoxide than WT hepatocytes, especially at 
lower concentrations of H2O2 (125μM – 1mM) (Figure 5.8a). At higher concentrations 
of H2O2 (2mM and above), Tst–/– and WT hepatocytes had similar mitochondrial 
superoxide levels. No differences were observed in LDH release, an indicator of cell 
death, between Tst–/– and WT hepatocytes, although increasing H2O2 concentration 
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Figure 5.8: Mitochondrial superoxide and LDH activity of primary 
hepatocytes of Tst–/– and WT mice exposed to H2O2 for 2hrs. 
(a) Mitochondrial superoxide as fluorescence of MitoSOX dye, normalised to 
protein concentration as absorbance of sulforhodamine B (SRB), and (b) 
lactate dehydrogenase (LDH) activity in media. Data are mean ± SEM, 
analysed by 2-way ANOVA: * P <0.05, *** P < 0.001, ns = not significant; (n=8). 
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5.3.4.2 Increased mitochondrial superoxide and cell death in response to 
exogenous ROS is not impacted by pre-incubation of primary 
hepatocytes of Tst–/– and WT mice with an antioxidant. 
Primary hepatocytes were exposed to H2O2 (2mM) with or without pre-incubation with 
the antioxidant N-acetylcysteine (NAC; 1mM). Cells exposed to NAC alone had 
slightly lower MitoSOX fluorescence than control (* P <0.05), and both groups 
exposed to H2O2 had higher fluorescence than controls (Control vs. H2O2: ** P < 0.01; 
NAC vs. NAC + H2O2: *** P <0.001). There was no effect of NAC pre-treatment on 
H2O2-related MitoSOX fluorescence (Figure 5.9a). No differences were observed in 
LDH activity between hepatocytes from Tst–/– and WT mice (Figure 5.9b). 
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Figure 5.9: Mitochondrial superoxide and LDH activity of primary 
hepatocytes of Tst–/– and WT mice exposed to H2O2 for 2hrs with or 
without pre-incubation with an antioxidant. 
(a) Mitochondrial superoxide as fluorescence of MitoSOX dye, normalised to 
protein concentration as absorbance of sulforhodamine B (SRB) in 
hepatocytes pre-incubated in N-acetylcysteine (NAC: 1mM) or media for 1hr, 
followed by 2hrs in H2O2 (2mM) or media; (b) lactate dehydrogenase (LDH) 
activity in media. Data are mean ± SEM, analysed by 2-way ANOVA 
comparing genotypes and two treatments: description in text; (n=6). 
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5.3.4.3 Increased mitochondrial superoxide and cell death in response to 
exogenous ROS is not impacted by altered sulfide levels in primary 
hepatocytes of Tst–/– and WT mice. 
To assess the impact of sulfide on hepatocyte responses to exogenous ROS, primary 
hepatocytes from Tst–/– and WT mice were pre-incubated for 1hr with a sulfide donor, 
disodium sulfide (Na2S: 200μM) or DL-propargylglycine (PAG: 10mM), an inhibitor 
of the enzyme that generates H2S from cystathionine, CSE. As Na2S dissolves in water, 
it forms 2Na+, 2OH- and H2S and so sodium hydroxide was used a vehicle control at 
twice the concentration of Na2S (400μM). There were no significant differences 
between Tst–/– and WT hepatocytes in their mitochondrial superoxide response after a 
pre-exposure to increased sulfide or inhibition of CSE activity (Figure 5.10a). In the 
presence of H2O2 (2mM), fluorescence was significantly increased for each condition 
(*** P < 0.001).  LDH activity was also increased by treatment with H2O2 (*** P < 
000.1), although no differences were observed with pre-treatment with Na2S or PAG, 
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Figure 5.10: Mitochondrial superoxide and LDH activity of primary 
hepatocytes of Tst–/– and WT mice exposed to H2O2 for 2hrs with or 
without pre-incubation with a sulfide donor or CSE inhibitor. 
(a) Mitochondrial superoxide as fluorescence of MitoSOX dye, normalised to 
protein concentration as absorbance of sulforhodamine B (SRB) in 
hepatocytes pre-incubated in sodium hydroxide (vehicle: 400μM), sodium 
disulfide (Na2S: 200μM) or DL-propargylglycine (PAG: 10mM) for 1hr, followed 
by 2hrs in H2O2 (2mM) or media; (b) lactate dehydrogenase (LDH) activity in 
media. Data are mean ± SEM, analysed by 2-way ANOVA comparing 
genotypes and two treatments: description in text; (n=6). [Hepatocytes 
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5.4 DISCUSSION 
It was hypothesised that thiosulfate sulfurtransferase has antioxidant capability, and 
thus protects against adipose dysfunction and subsequent metabolic impairment 
caused by high fat diet. There is evidence that TST interacts with thioredoxin and may 
help to neutralise H2O2 in vitro (Nandi et al. 2000), and our lab showed that a reduction 
in Tst expression in 3T3-L1 adipocytes resulted in increased mitochondrial ROS levels 
(Morton et al. 2016). This chapter aimed to directly test the hypothesis that TST is 
involved in the breakdown of ROS, and thus is protective against cell dysfunction and 
death due to oxidative stress. To test this hypothesis, both in vivo and in vitro models 
of oxidative stress were used. Paraquat dichloride was chosen as an inducer of 
oxidative stress in vivo, but was found to be ineffective at inducing adipose tissue 
oxidative stress as the highest dose tolerable under these conditions. The ability of 
primary adipocytes with altered TST levels to consume H2O2 in vitro was investigated 
to test the hypothesis that TST aids in the breakdown of ROS, as previously suggested 
from experiments using a cell-free system (Nandi et al. 2000). The response of 
mitochondria to oxidative stress, and cell death was also assessed in cells lacking Tst, 
to understand if primary adipocytes from Tst–/– mice have increased mitochondrial 
ROS production, as previously observed in 3T3-L1 adipocytes with si-RNA-mediated 
knockdown of Tst (Morton et al. 2016). Primary adipocytes proved to be a challenging 
model for this investigation, and so primary hepatocytes were employed as a model of 
high Tst expression to investigate further. 
 
5.4.1 Paraquat as a model of oxidative stress in vivo 
Paraquat dichloride has been used extensively to induce oxidative stress in vivo in mice 
(McCormack et al. 2005; Qian et al. 2015; Zheng et al. 2015). The dose and length of 
exposure influence the degree of cellular damage and risk of death, with lower doses 
(10mg/kg) not usually causing death (McCormack et al. 2005), but higher doses 
(50mg/kg and above) or a longer duration of exposure after a lower dose leading to 
death (Luo et al. 2008; Zheng et al. 2015). Three cohorts of mice were used to find the 
correct dose of paraquat and exposure time that would allow for differentiation of 
susceptibility to oxidative stress in mice with altered Tst expression. Optimal 
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conditions to induce oxidative stress in vivo using paraquat were not found based on 
these three pilot experiments. In consultation with the Named Veterinary Surgeon 
(NVS) and due to limitations on the severity limit allowed by the conditions of the 
project licence, it was decided to not pursue the experiment using a higher dose of 
paraquat. A further increase in paraquat concentration or exposure time could be lethal, 
as the highest dose used here (25mg/kg) was reported in one study to cause death by 
72hrs in all mice treated by intra-gastric route (death rate confirmed by correspondence 
with author; Zheng et al. 2015).  
The results from only one pilot study, in which the highest dose was tested, 
were included in this chapter for clarity, however the results from the first two pilot 
studies are including in the appendix (section 7.2 on page 213). In the first pilot 
experiment, WT and Tst–/– mice were treated with increasing doses of paraquat up to 
a maximum of 10mg/kg for 24 hours, however no consistent differences in weight loss, 
MDA or antioxidant gene expression in white adipose tissue were found with paraquat 
treatment or between genotypes. The second experiment was undertaken in WT mice 
to investigate if exposure for up to 6 days to an increased dose of paraquat (20mg/kg 
in two injections of 10mg/kg) would lead to increased markers of oxidative stress. This 
increased exposure time did not result in consistent changes in MDA concentration in 
adipose or lung, or changes in antioxidant gene expression. These results, and those 
from the third pilot experiment included in this chapter, indicate that paraquat 
treatment is not an ideal method of inducing oxidative stress in adipose tissue in vivo. 
At the doses used here, no significant differences other than in body weight were found 
to allow investigation of the susceptibility of Tst–/– mice to oxidative stress in adipose 
tissue. Paraquat accumulates in the lung due to active transport into alveolar type I and 
II epithelial cells by an endogenous polyamine carrier system (Dinis-Oliveira et al. 
2008). However, no increase in antioxidant gene expression was found in the lung of 
mice treated with paraquat in this study, indicating that this dose and length of 
exposure was inadequate to induce oxidative stress in this tissue, despite the clinically 
significant weight loss. Paraquat has also been found in high concentrations in kidney 
after exposure in vivo as it is mostly excreted by normal glomerular filtration, however 
it has not been found to accumulate to the same extent in other organs such as brain, 
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liver or heart (Kurisaki and Hiroko 1974; Rose et al. 1976). Therefore, it is apparent 
that paraquat is unsuitable for use as an oxidative stress inducer in our investigation 
into the role of Tst in ROS metabolism in adipose tissue. It was subsequently decided 
to focus on in vitro methods to investigate the impact of altered Tst expression on the 
response to oxidative stress. 
 
5.4.2 The role of TST in the response to oxidative stress in adipocytes 
in vitro. 
It was hypothesised that overexpression of Tst in adipose tissue was protective against 
metabolic impairment after a high fat diet challenge due to the antioxidant capabilities 
of TST. To test this hypothesis, primary cells from Tst–/– and Ad-hTST mice were 
subjected to oxidative stress in vitro in the form of excess exogenous H2O2. The ability 
of adipocytes to dispose of ROS was investigated, as was the mitochondrial response 
to oxidative stress and cellular toxicity. The results described in this chapter do not 
support the hypothesis that TST protects against cellular damage due to oxidative 
stress in adipocytes. Due to the technical limitations of using adipocytes in vitro, 
primary hepatocytes were used to investigate the mitochondrial changes and cell death 
in response to oxidative stress further, highlighting some potential differences in the 
function of TST in these two cell types. 
 A role has been suggested for TST in the disposal of H2O2 through interaction 
with thioredoxin (Nandi et al. 2000). Peroxiredoxin 3, a key regulator of mitochondrial 
H2O2 levels, requires the presence of thioredoxin 2 for its recycling by reduction (Chae 
et al. 1999), and it is thought that the interaction of TST with thioredoxin may mimic 
this reaction (Nandi et al. 2000). Therefore, the disposal of H2O2 by adipocytes lacking 
and with overexpression of TST was assessed to investigate if TST influences the 
cellular breakdown of H2O2, and if so, to what degree. Under the conditions described 
in this chapter, there were no apparent differences between adipocytes lacking Tst and 
those overexpressing human TST and their respective controls in their ability to 
breakdown H2O2. This may be because TST does not interact with thioredoxin in an 
intact cell, as it was suggested to in a cell-free system (Nandi et al. 2000), or it may be 
due to greater activity of other antioxidant systems masking the impact of altered TST, 
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such as catalase and the glutathione peroxidases, as well as the peroxiredoxins 
(Gaetani et al. 1996). A large difference was observed between the two control lines, 
with about 40% of H2O2 remaining in media of WT cells, but only about 24% 
remaining in media of WT-LSL cells. This highlights a potential difference between 
the substrains of mice, as WT and Tst–/– mice were on a pure 6J background, but WT-
LSL and Ad-hTST were a mix of 6N and 6J substrains. From the current work, it 
appears unlikely that TST plays a role in the cellular breakdown of H2O2. However, 
the differences observed here in respect to control line, and the possible influence of 
substrain should be carefully considered when carrying out similar experiments in 
future.  
 At a cellular level, it is likely that TST does not impact the breakdown of H2O2, 
however it may exert antioxidant and protective effects within the mitochondria. 
Exposure of 3T3-L1 adipocytes to H2O2 causes an increase in mitochondrial 
superoxide levels (Huh et al. 2012), and si-RNA-mediated knockdown of TST leads 
to a further increase (Morton et al. 2016). Primary adipocytes from Tst–/– mice were 
used to investigate this mitochondrial response to H2O2 further, as well as assessing 
the impact of altered TST on oxidative stress-induced cell death. Results indicated that 
H2O2 induced a significant increase in mitochondrial ROS and cell death in both Tst–
/– and WT adipocytes. However, adipocytes proved to be a challenging cell model for 
this experiment as many adipocytes died during the incubation period, leaving too few 
to get an accurate fluorescence measurement as the floating cells gathered around the 
edge of wells, mostly outside the range of the measurement of the plate reader. Because 
of these technical challenges, it was decided to use primary hepatocytes from Tst–/– 
mice to investigate mitochondrial ROS production and cell death in response to 
oxidative stress, as they are a more robust cell type in culture, and adhere to the plate, 
making fluorescence measurements more accurate. However, in future this experiment 
will be repeated with differentiated SVFs grown on coverslips to allow for imaging of 
MitoSOX fluorescence. Based on the results described in this chapter, it was not 
possible to definitively discount any effect of Tst knockout in adipocytes on cell death 
and mitochondrial superoxide production in response to oxidative stress. 
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5.4.3 Primary hepatocytes lacking Tst may be protected against 
oxidative stress 
Primary hepatocytes lacking Tst proved to be a more successful cell model for the 
investigation of mitochondrial superoxide levels and cell death in response to 
exogenous oxidative stress. This more robust cell model was used to establish a basis 
for the role of TST in the response to oxidative stress that can be applied to future 
experiments using differentiated SVFs or a new induced pluripotent stem cell line 
lacking Tst. When interpreting the response to oxidative stress in primary hepatocytes, 
it must be considered that the effect of Tst knockout and potential altered sulfide levels 
could be very different in these cells compared to adipocytes (as discussed in section 
1.3.3.4 on page 53). 
Based on evidence that TST interacts with thioredoxin in the breakdown of 
H2O2 (Nandi et al. 2000), it was hypothesised that hepatocytes lacking Tst would be at 
a higher risk of cell dysfunction and death when subjected to oxidative stress. 
However, the data presented here suggest that hepatocytes from Tst–/– mice were not 
more susceptible to cell death than WT hepatocytes, and instead may be protected from 
the damaging effects of oxidative stress due to reduced mitochondrial superoxide 
production in response to H2O2. Hepatocytes lacking Tst had lower mitochondrial 
superoxide levels than WT when exposed to H2O2 concentrations lower than 2mM, 
suggesting the absence of TST may have an antioxidant effect. One possible 
explanation for this reduction in mitochondrial superoxide could be altered sulfide 
levels due to Tst gene knockout. Tst knockout leads to an increase in ambient sulfide, 
as was found in plasma of Tst–/– mice (Morton et al. 2016). Increased sulfide levels 
prevented cell death and promoted the activity of antioxidant enzymes such as the 
superoxide dismutases, catalase and glutathione peroxidases in endothelial cells 
exposed to a relatively low dose of H2O2 (600μM) (Wen et al. 2013). However, in the 
present study a sulfide donor, Na2S failed to protect against cell death in WT or Tst–/– 
primary hepatocytes exposed to a higher concentration of H2O2 (2mM). Also, PAG, 
an inhibitor of the sulfide-producing enzyme CSE, did not cause an increase in cell 
death as would have been expected if sulfide was protective. It is likely that the 
concentration of H2O2 used here (2mM) was too high, as this concentration was above 
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the point at which both mitochondrial superoxide and cell death plateaued in WT and 
Tst–/– hepatocytes (1/2mM). This reduction in mitochondrial superoxide could also be 
due to altered mitochondrial number or size, as recent work from our lab has found 
that mitochondria in liver sections analysed by electron microscopy from Tst–/– mice 
were on average larger than WT mitochondria, although the absolute number of 
mitochondria was the same [R. Carter, T. Gillingwater & N Morton unpublished]. 
Larger mitochondria would be expected to hold more fluorescent MitoSOX dye, thus 
confounding the differences between WT and Tst–/– hepatocytes. In future, this 
experiment should be repeated using a lower dose of H2O2 to probe the effect of H2S 
on cell viability and mitochondrial superoxide production in hepatocytes in response 
to oxidative stress, and a control for mitochondrial content, such as a Mitotracker dye, 
should be incorporated to account for differences in mitochondrial content between 
genotypes. Tst gene knockout in primary hepatocytes appears to reduce mitochondrial 
superoxide production in response to oxidative stress, without a subsequent reduction 
in cell death, and future work will focus on elucidating the role of sulfide in this 
antioxidant effect, and whether it occurs in adipocytes to the same degree. 
 
5.4.4 Limitations and future work. 
This chapter aimed to directly test the hypothesis that TST has antioxidant capabilities 
in adipose tissue. Unfortunately, it was not possible to induce oxidative stress in vivo 
using paraquat without an unacceptable risk of death to the mice, therefore it was not 
possible to test this hypothesis in mice. Other chemical inducers of oxidative stress 
such as TCDD (2, 3, 7, 8-tetrachlorodibenzo-p-dioxin) or arsenic may be tested in 
future (Stohs 1990; Flora 1999), and it is likely that these or paraquat may be more 
effectively targeted to adipose tissue with less systemic damage by direct injection into 
the epididymal fat pad. Also, oxidative stress in adipose tissue may be induced by 
adipose-specific genetic ablation of a key antioxidant enzyme such as peroxiredoxin 3 
(Huh et al. 2012) or overexpression of NOX4 under the control of an adipose-specific 
promoter. These transgenic mice, when crossed with mice with adipose-specific 
knockout or overexpression of Tst will be a powerful tool to understand the impact of 
altered Tst on adipose oxidative stress. 
Chapter 5  
199 
 
      
      
Using primary cells from Tst–/– and Ad-hTST mice, some aspects of the 
response of these cells to oxidative stress were assessed. Primary adipocytes are a 
challenging cell type to use in vitro as they are not adherent, and are inherently fragile. 
This led to limitations in my ability to fully characterise the response of these cells to 
oxidative stress in vitro. To successfully and accurately measure mitochondrial 
superoxide in this cell type, more cells would be needed per reaction, and so isolated 
adipocytes from separate mice would have to be pooled. This was not possible during 
this PhD due to constraints with animal numbers, but may be a possibility in future if 
a larger number of mice are available to repeat this experiment. Alternatively, 
measurement of MitoSOX fluorescence using flow cytometry instead of a plate reader 
may be a more efficient method of measuring fluorescence in this cell type (Majka et 
al. 2014). While primary hepatocytes provided a useful backup to investigate 
mitochondrial superoxide in cells lacking Tst, it would be preferable to answer this 
question using adipocytes due to the clear differences in these cells, including in the 
effect of sulfide on their activities. 
The results presented here do not support the hypothesis that TST protects 
against cellular damage due to oxidative stress. TST did not impact the ability of 
adipocytes to consume exogenous H2O2. Primary hepatocytes lacking Tst had a 
reduction in mitochondrial superoxide in response to oxidative stress compared to WT 
hepatocytes, indicating that Tst knockout may partially protect against the damage of 
exogenous oxidative stress, however this did not lead to a difference in cell death. 
Future investigations of the role of sulfide in this process, and using models of 
genetically-induced oxidative stress in adipose tissue will lead to a better 




      
      
Chapter 6 Discussion 
 
The world is in the grips of an obesity epidemic, associated with a rapid increase in 
the incidence of type two diabetes mellitus and cardiovascular disease (Wormser et al. 
2011; Zhou et al. 2016). The metabolic syndrome is a cluster of associated conditions 
that represent risk factors for increased morbidity and mortality, and its prevalence is 
increased in obese and overweight people (Park et al. 2003). Pathophysiological 
changes occur in adipose tissue in obesity, including the development of primary 
insulin resistance and altered secretion of many adipokines that link obesity with 
diabetes and cardiovascular disease. In obesity, adipose tissue exhibits oxidative stress 
due to increased production of ROS (Furukawa et al. 2004; Paglialunga et al. 2015), 
as well as chronic inflammation due to infiltration of pro-inflammatory macrophages 
and  increased expression of cytokines (Kanda et al. 2006b; Lumeng et al. 2007). 
These detrimental effects reduce the ability of adipose tissue to store excess nutrient 
as lipid in part due to impaired insulin responsiveness and increased production and 
secretion of adipokines that drive metabolic dysfunction (Yki-Jarvinen 2002; 
Furukawa et al. 2004; Patsouris et al. 2008). Understanding the progression from early 
adipose tissue dysfunction to metabolic syndrome will lead to the development of new 
interventions and therapies to prevent and treat the metabolic syndrome and diabetes. 
 Recent work from our lab showed that elevated TST in adipose tissue was 
metabolically protective during exposure to high fat diet (HFD) in mice. In response 
to HFD, Adipoq-Tst mice had reduced weight gain, elevated plasma adiponectin and 
improved glucose tolerance, as well as increased expression of antioxidant enzymes in 
adipose tissue (Morton et al. 2016). Knockdown of TST in 3T3-L1 adipocytes led to 
increased mitochondrial ROS production after exposure to H2O2 (Morton et al. 2016), 
and in vitro evidence suggested TST can interact with a key antioxidant enzyme to aid 
ROS breakdown (Nandi et al. 2000). Therefore, it was hypothesised that TST in 
adipose tissue helps to maintain metabolic health through prevention of excessive local 
ROS accumulation. To test this hypothesis, two mouse models with altered TST 
expression in adipose tissue were subjected to HFD, and metabolic impairment and 




      
      
intolerance on HFD, potentially due to reduced expression of antioxidant enzymes in 
adipose tissue, supporting the hypothesis that TST protects against metabolic 
impairment by reducing oxidative stress in adipose tissue. However, mice with 
overexpression of the human TST gene in adipose tissue did not have a reciprocal 
phenotype to the knockout mice, but instead were also potentially more prone to 
metabolic impairment on HFD than controls. Results from the Ad-hTST mice did not 
replicate previous findings using a mouse with overexpression of the mouse Tst gene 
in adipose, which was protected against weight gain and glucose intolerance on HFD 
(Morton et al. 2016), and so further characterisation of this new mouse model and the 
differences between the human and mouse protein sequences and function will be 
carried out to understand this discrepancy. 
To directly test the hypothesis that TST is involved in ROS breakdown, in vitro 
experiments were carried out to investigate the response of primary adipocytes from 
Tst–/– and Ad-hTST mice to oxidative stress. Adipocytes with altered TST showed no 
difference in their ability to breakdown H2O2, and mitochondrial superoxide 
production and cell death were unaffected by Tst knockout. However, because of the 
technical challenges of using adipocytes, primary hepatocytes from Tst–/– mice were 
employed as a more robust cell model to establish a basis for the role of TST in the 
response to oxidative stress. Hepatocytes from Tst–/– mice were not more susceptible 
to cell death than WT hepatocytes as was hypothesised, and instead had reduced 
mitochondrial superoxide production in response to H2O2. An increase in sulfide levels 
due to Tst knockout may promote the activity of antioxidant enzymes in hepatocytes, 
as observed in endothelial cells exposed to H2O2 (Wen et al. 2013). It remains unclear 
if this effect occurs in adipocytes, and whether it influences susceptibility to HFD-
induced adipose tissue dysfunction, but future work will focus on applying this finding 
in hepatocytes to adipose tissue. 
Adipose tissue dysfunction due to obesity-induced oxidative stress is a key 
factor in the link between obesity and diabetes (Furukawa et al. 2004; Paglialunga et 
al. 2015). The aim of this PhD was to investigate the antioxidant properties of TST in 
adipose tissue as a potential mechanism by which this mitochondrial enzyme may 




      
      
that Tst knockout increases the risk of metabolic impairment in HFD-fed mice, 
although it was not possible to confirm that this enzyme plays a direct antioxidant role 
in the response to oxidative stress. Summaries of the findings from chapters 3, 4 and 
5 are found in Table 6.1, Table 6.2 and Table 6.3 below. 
Table 6.1: Summary of Results - Chapter 3 
Experiment Results 
Tst–/– mouse 
- HFD for 6 weeks 
- Tst–/– lighter than WT on chow, no difference on 
HFD. 
- No difference in epididymal fat weight. 
- No difference in immune cell populations. 
Tst–/– mouse 
- HFD for 20 weeks 
- No difference in body weight on chow or HFD. 
- Tst–/– had less WAT on chow, but not HFD. 
- Glucose tolerance impaired by HFD in Tst–/– and 
WT. 
- Tst–/– had lower insulin during GTT than WT. 
- Insulin tolerance impaired by HFD in Tst–/– and 
WT. 
- Tst–/– had reduced adiponectin on chow and HFD, 
compared to reduction on HFD only for WT. 
- Tst–/– had reduced expression of antioxidant 
enzymes (Sod2, Prx3, Prx1, Gpx1, Txn2) in 
mesenteric fat. 
- Carbonyl content of adipose unaffected by HFD. 
- No differences in immune cell populations. 
- No differences in pro-inflammatory cytokine 
expression. 
- Tst–/– on chow had increased Chop expression. 
- Tst expression reduced in chow and HFD-fed WT. 






      
      
Table 6.2: Summary of Results - Chapter 4 
Experiment Results 
Female Ad-hTST mice 
- Human and mouse TST 
expression 
- Human TST mRNA was highly expressed in 
adipose, but not non-adipose tissues. 
- Mouse Tst mRNA was unchanged in adipose. 
- Rhodanese activity was increased 2 – 3.5-fold in 
adipose. 
- TST protein increased in adipose.  
Male Ad-hTST mice 
- HFD for 6 weeks 
- No differences in body weight or adipose weights. 
- No differences in food intake and feeding 
efficiency. 
- No difference in GTT on HFD. 
- Ad-hTST on LFD had lower glucose at 15min 
during GTT. 
- Ad-hTST on LFD had reduced adiponectin. 
- No differences in expression of antioxidant genes. 
- No differences in immune cell populations. 
- No differences in pro-inflammatory cytokine 
expression. 







      
      
 
Table 6.3: Summary of Results - Chapter 5 
Experiment Results 
PQ exposure in vivo in 
Tst+/–  
- 25mg/kg for 24hrs 
- PQ caused weight loss. 
- No change in adipose weight, malondialdehyde or 
antioxidant gene expression. 
- No change in lung weight or antioxidant gene 
expression. 
H2O2 disposal  
in primary adipocytes 
- Tst–/–  
- Ad-hTST 
- No change in H2O2 disposal in Tst–/– or Ad-hTST 
adipocytes compared to controls. 
- H2O2 disposal different between control lines (WT 
vs. WT-LSL). 
Tst–/– primary adipocytes 
- Mitochondrial Superoxide 
- Mitochondrial ROS increased by H2O2 exposure. 
- No difference compared to WT. 
- Technical challenges limited reliability of 
experiment. 
Tst–/– primary hepatocytes 
- Mitochondrial Superoxide 
- Mitochondrial ROS increased by H2O2, but to 
lesser extent in Tst–/– hepatocytes. 
- No effect of antioxidant (NAC), sulfide (Na2S) or 






      
      
6.1 TST AND METABOLIC IMPAIRMENT 
Evidence linking TST to metabolic protection was previously provided by 
investigation of the phenotype of transgenic mice overexpressing Tst in adipose tissue 
under the adiponectin promoter (Morton et al. 2016). These mice, in response to high 
fat diet, had reduced weight gain, elevated plasma adiponectin and improved glucose 
tolerance, as well increased expression of some antioxidant enzymes in adipose tissue 
(Morton et al. 2016). A full understanding of how TST mediated this protective effect 
was lacking, and so the Tst–/– mouse was developed to examine the impact of Tst 
knockout on the metabolic phenotype, and uncover the basis for the protection offered 
by TST in Adipoq-Tst mice. Despite exhibiting comparable gains in weight and fat 
mass on HFD, Tst–/– mice on HFD had increased plasma glucose with reduced insulin 
secretion during a glucose tolerance test, highlighting an increased risk of developing 
diabetes compared to WT mice. Tst–/– mice also had reduced expression of antioxidant 
enzymes in adipose tissue, confirming a reciprocal phenotype to the increased 
expression observed in adipose of Adipoq-Tst mice exposed to HFD (Morton et al. 
2016). Despite this reduction in antioxidant capabilities, no evidence was found for 
greatly increased adipose tissue dysfunction compared to WT mice, as a marker of 
oxidative stress was unchanged, and Tst–/– mice did not have significantly greater 
infiltration of pro-inflammatory macrophages. It is likely that the adipose tissue of Tst–
/– mice was not more discernibly affected by Tst knockout due to the reduction of TST 
in the adipose of WT mice caused by HFD and prolonged exposure to chow diet which 
promoted almost comparable fat mass gain, leading to a convergence of the adiposity 
phenotype. Also, the local deleterious effects of Tst knockout on adipose tissue may 
have been minimised due to the antioxidant and anti-inflammatory effects of H2S, 
which was increased in the plasma of Tst–/– mice (Whiteman, Li, et al. 2010; Xie et al. 
2014; Cai et al. 2016a; Morton et al. 2016). While Tst–/– mice showed increased 
metabolic impairment on HFD, as hypothesised, it is likely the phenotype was 
influenced by sulfide-mediated inhibition of insulin secretion and activation of hepatic 
gluconeogenesis (Tang et al. 2013; Zhang et al. 2013). In future, a mouse model with 
adipose-specific knockout of Tst will be available to allow for a more targeted 




      
      
Moreover, a more appropriate defined control diet rather than standard chow may help 
prevent convergence of body weight gain seen on the HFD WT mice that appeared to 
confound the comparisons between the diet and genotype effects after prolonged HFD 
regimens. 
 A new mouse model with overexpression of the human TST gene in adipose 
tissue was characterised for this thesis. Due to the use of a highly active promoter to 
drive human TST gene expression, the Ad-hTST mouse was expected to have a greater 
increase in TST compared to the previous model, Adipoq-Tst. However, despite 
increased rhodanese activity in adipose tissue, the Ad-hTST mouse failed to 
recapitulate the phenotype of the Adipoq-Tst mouse, as it was not protected from 
weight gain and glucose intolerance after a HFD (Morton et al. 2016). These results 
contradict previous findings, and potentially challenge the hypothesis that elevated 
TST in adipose tissue protects against metabolic impairment. However, the phenotype 
of Ad-hTST mice also raises questions about the ability of human TST to function in 
mouse adipose tissue, as no differences were found in any aspect of adipose tissue 
function compared to WT mice in the experiments conducted in this thesis. Instead of 
exhibiting protection against metabolic impairment, Ad-hTST mice on HFD showed 
slightly impaired glucose tolerance, which may have been due to reduced circulating 
adiponectin, rather than a direct impact of the overexpressed enzyme on oxidative 
stress in adipose tissue. Ad-hTST mice were heterozygous for adiponectin due to the 
presence of the cre gene within one adiponectin allele (Eguchi et al. 2011), however 
no difference was found in adiponectin in the plasma of the Adip-cre parents line, and 
therefore it is likely that this reduction in adiponectin is a true effect of human TST 
overexpression in adipose depots. While characterisation of the Ad-hTST mouse failed 
to support the hypothesis that TST in adipose tissue acts to prevent metabolic 
impairment, it is likely that due to differences between the human and mouse TST 
protein, this model did not function as expected and may unfortunately be unsuitable 





      
      
6.2 TST AND OXIDATIVE STRESS 
TST was thought to play a role in ROS breakdown, and thus protect adipose tissue 
from damage due to oxidative stress during exposure to HFD. As well as evidence that 
TST interacts with thioredoxin, aiding in the breakdown of H2O2 (Nandi et al. 2000), 
we had previously found that 3T3-L1 adipocytes with si-RNA-mediated knockdown 
of Tst produced more mitochondrial ROS in response to exogenous oxidative stress 
(Morton et al. 2016), highlighting a potential mechanism for TST-based metabolic 
protection. As well as these direct effects of TST, Adipoq-Tst mice had increased 
expression of key antioxidant enzymes in HFD compared to WT mice, and maintained 
higher expression after exposure to HFD (Morton et al. 2016), indicating that indirect 
transcriptional or post-translational regulation of antioxidant enzymes may also 
underscore the metabolic protection afforded by increased TST in adipose tissue.  
The data presented in this thesis do not support the hypothesis that TST is 
directly involved in the breakdown of ROS in adipocytes. Primary adipocytes from 
mice with altered TST expression were used to examine the role of TST in H2O2 
breakdown, however no difference in the degree of H2O2 breakdown was observed 
with adipocytes lacking Tst or with overexpression of human TST. Similarly, primary 
adipocytes from Tst–/– mice did not have increased mitochondrial superoxide 
production, or show a higher cell death, as might be expected if TST had antioxidant 
capabilities. However, a full understanding of the role of TST in adipocytes in response 
to oxidative stress remains unclear due to technical difficulties which rendered the 
results of these experiments inconclusive. Because of these difficulties, primary 
hepatocytes from Tst–/– mice were used as a more robust cell model to investigate the 
effect of Tst knockout on the response to oxidative stress. Unexpectedly, primary 
hepatocytes lacking Tst had reduced production of mitochondrial ROS in response to 
H2O2. This may be a result of increased accumulation of H2S or other intermediaries 
due to impaired sulfide oxidation (Libiad et al. 2014), as H2S can reduce the formation 
of ROS from mitochondria (Xie et al. 2014). The mechanism by which Tst knockout 
in hepatocytes influences mitochondrial superoxide remains unknown, however there 





      
      
6.3 FUTURE WORK 
Considerable questions remain to be answered about the impact of TST in adipose 
tissue, and how it contributes to metabolic health. To fully elucidate the effect of TST 
on the antioxidant capabilities of adipose, a genetic approach must be undertaken to 
minimise confounding factors including the effect of diet on TST expression in WT 
mice, and the potential antioxidant effects of increased plasma sulfide. New mouse 
and cell models with more precise alterations in Tst expression will soon be available, 
and compounds are under development to allow for more accurate activation of TST 
than the currently available non-specific substrate, thiosulfate. The function of TST in 
vivo must be fully elucidated before this promising anti-diabetic target can be pursued 
in a clinical setting. 
New mouse models will be available to investigate more aspects of TST 
function in adipose and other tissues. A line with cre-meditated knockout of Tst will 
be used to produce a mouse with tissue-specific knockout of the gene. It is likely that 
the phenotype of the Tst–/– mouse used in this thesis is influenced heavily by the effect 
of Tst knockout in the liver, as well as the effects of increased circulating plasma 
sulfide on the liver and other tissues (Morton et al. 2016). An adipose-specific 
knockout will be used to understand if the impact of Tst on metabolic health is 
selectively due to adipose expression of the gene, as in Adipoq-Tst mice (Morton et 
al. 2016), or due to its indirect effect on other tissues through modulation of sulfide. 
To further question the impact of TST on oxidative stress, a mouse with both Tst and 
Prx3 knocked out in adipose tissue could be a useful tool, as knockout of this key 
antioxidant enzyme leads to increased mitochondrial oxidative stress in adipocytes 
(Huh et al. 2012). High fat diet was used to induce oxidative stress in adipose tissue in 
this thesis, however this led to a reduction in Tst expression in adipose of control mice, 
thus leading to a convergence of phenotype with Tst–/– mice. A genetic approach to 
oxidative stress induction will avoid this pitfall and allow for better control of the 
effects of Tst knockout in tissues other than adipose.  
New cell lines are available to probe the effects of altered Tst expression in 
vitro. Induced pluripotent stem cells (iPSCs) with the Tst gene knocked out and 




      
      
can be differentiated into adipocytes (Tashiro et al. 2009), and will be useful to fully 
characterise the phenotype of adipocytes with altered Tst expression, including 
assessing the impact on adipogenic differentiation and function, as well as 
mitochondrial biogenesis. It will be possible to assess the response to oxidative stress 
more efficiently in these differentiated iPSCs compared to primary adipocytes, as they 
are adherent and the cell culture conditions can be manipulated more easily. 
It has become increasingly accepted that H2S is a potent anti-inflammatory 
factor, despite initial evidence that it played a role in the progression of some 
inflammatory diseases. The development of new H2S donor compounds that release 
H2S at physiological levels over a sustained period, such as GYY4137 and the 
mitochondrially-targeted AP39 (Whiteman, Li, et al. 2010; Ahmad et al. 2016), will 
allow us to experimentally induce increased sulfide levels, as found in Tst–/– mice, and 
thus elucidate the varying effects of gene knockout and increased plasma sulfide 
(Morton et al. 2016). H2S may prove to be a useful target in the fight against metabolic 
disease, due to its insulin sensitising effects in adipose tissue (Cai et al. 2016a), 
however care must be undertaken if it is to be a useful anti-diabetic target due to the 
possibility of exacerbating insulin resistance in the liver (Zhang et al. 2013), or 
reducing insulin secretion from β cells (Tang et al. 2013). Therefore, the ability to 
target the sulfide oxidation pathway in a tissue-specific manner may be an important 






      
      
6.4 CONCLUDING REMARKS 
In this thesis, I investigated the ability of TST to function as an antioxidant, and thus 
to help maintain metabolic health. I have found that Tst knockout caused metabolic 
impairment after exposure to HFD, however this was not associated with increased 
markers of adipose tissue dysfunction, despite a reduction in expression of some 
antioxidant enzymes. Future work focusing on the impact of sulfide on metabolically 
active tissues such as the liver and β cells will help to clarify the cause of this metabolic 
impairment in Tst–/– mice (Tang et al. 2013; Zhang et al. 2013). I uncovered evidence 
that TST does not impact ROS breakdown directly in adipocytes, and may not play a 
role in the response of these cells to oxidative stress, although mice with genetically-
induced oxidative stress in adipose tissue should be used to clarify this finding. I also 
characterised a new mouse model with adipose-specific overexpression of the human 
TST gene, and found that a modest increase in rhodanese activity in adipose depots did 
not lead to an improved metabolic outcome on HFD, as was hypothesised. It is possible 
that differences between the human and mouse protein sequences impacted the 
function of the human enzyme in mouse tissue, and because of this, the Ad-hTST 
mouse failed to support the hypothesis that TST in adipose tissue helps to maintain 
metabolic health, as had been previously found with Adipoq-Tst mice (Morton et al. 
2016). The findings presented in this thesis have contributed to a greater understanding 
of the role of TST in metabolic health, and the development of new mouse and cell 
models will allow us to identify potential clinical strategies to harness the potential of 






      
      
Chapter 7 Appendix 
7.1 BODY WEIGHT AND ADIPOSE TISSUE WEIGHTS OF 5-MONTH-OLD 
TST–/– VERSUS WT MICE ON CHOW DIET. 
It was observed in several cohorts that Tst–/– mice when maintained past ~5 months 
old on chow diet may be smaller and have less fat than WT mice. (A trend for smaller 
body and significantly less fat was observed after 20 weeks of chow diet, page 88 and 
89). To confirm this finding, a cohort of mice was maintained on chow diet until 5 















Figure 7.1: Body weight of at 5 months old Tst–/– and WT mice on chow 
diet. 
Data are mean ± SEM, analysed by Student’s t-test: *** P < 0.001; (n = 6). 
 
 
Three white adipose depots were weighed in 5-month-old Tst–/– and WT mice at cull 
and normalised to body weight. All three depots – (a) epididymal, (b) mesenteric and 
(c) subcutaneous – were significantly lighter relative to body weight in Tst–/– compared 





      
      
 
Figure 7.2: White adipose depot weights in 5-month-old Tst–/– versus WT 
mice on chow diet. 
(a) Epididymal, (b) mesenteric and (c) subcutaneous white adipose depots, 
normalised to body weight at cull. Data are mean ± SEM, analysed by 



























































      
      
7.2 PARAQUAT PILOT RESULTS 
7.2.1 Treatment of Tst–/– and WT mice with 1, 5 or 10mg/kg paraquat for 
24hrs. 
Paraquat (PQ; 1, 5 or 10mg/kg) or saline (0.9%) was administered to WT and Tst–/– 
mice by IP injection. After 24hrs, mice were culled and adipose tissue harvested for 
investigation of markers of oxidative stress. All mice lost weight after 24hrs, with PQ-
treated mice appearing to lose more than saline-treated (not significant potentially to 
small sample size) (Figure 7.3a). Malondialdehyde did not measurably consistently in 
mesenteric adipose tissue with PQ treatment in WT or Tst–/– mice (Figure 7.3b). 
Expression of antioxidant genes Prx3, Gpx1 in epididymal adipose were unaffected by 
PQ (Figure 7.4). Expression of Txn2, Sod2, Sod1 and Prx1 was reduced in adipose of 
Tst–/– mice compared to WT after exposure to 1mg/kg of PQ (Figure 7.4). 
 
 
Figure 7.3: Weight and adipose malondialdehyde content of Tst–/– and 
WT mice treated with 1, 5 or 10mg/kg paraquat or saline (0.9%) for 24hrs. 
(a) Weight loss, and (b) malondialdehyde in mesenteric adipose tissue. Data 






      
      
 
Figure 7.4: Antioxidant gene expression in epididymal adipose tissue of 
Tst–/– and WT mice treated with 1, 5 or 10mg/kg paraquat or saline (0.9%) 
for 24hrs. 
mRNA abundance of antioxidant genes normalised to housekeeping gene Tbp 
in epididymal adipose tissue. Data are mean ± SEM, analysed by Student’s t-







      
      
7.2.2 Treatment of WT mice with 20mg/kg paraquat for 2, 3 or 6 days. 
PQ (20mg/kg in two doses of 10mg/kg on day -1 and day 0) or saline (0.9%) was 
administered to WT mice by IP injection (timeline shown in Figure 7.5). Mice were 
culled at two, three or six days after the second injection, and adipose and lung tissue 
harvested for investigation of markers of oxidative stress and lung fibrosis. There was 
no effect of PQ treatment on body weight at any time point (Figure 7.6a). PQ did not 
cause an increased in malondialdehyde content of mesenteric fat (Figure 7.6b) at any 
time point, and expression of antioxidant enzymes was unaffected by PQ (Figure 7.6c). 
Exposure to PQ (20mg/kg) for 2, 3 or 6 days in WT mice did not alter the 
weight of the lungs compared to saline-treated mice (Figure 7.7a). Malondialdehyde 
in lung was unexpectedly higher in saline-treated mice at 2 days compared to PQ-
treated mice at any time point (Figure 7.7b). This may be due to variability in the small 
sample. Expression of fibrosis genes alpha smooth muscle actin (αSMA) and collagen 
type 1 alpha1 (Cola1a) were unaffected by PQ at all time points (Figure 7.7c). 
 
 




      
      
 
Figure 7.6: Weight and adipose response of WT mice 2, 3 or 6 days after 
administration of PQ (20mg/kg) or saline (0.9%). 
(a) Change in body weight, (b) malondialdehyde content in mesenteric fat, and 
(c) mRNA abundance of antioxidant genes normalised to housekeeping gene 
Tbp in epididymal fat. Data are mean ± SEM, analysed by Student’s t-test: not 






      
      
 
 
Figure 7.7: Lung response in WT mice 2, 3 or 6 days after administration 
of PQ (20mg/kg) or saline (0.9%). 
(a) Lung weight, (b) malondialdehyde content, and (c) mRNA abundance of 
fibrosis genes normalised to housekeeping gene Tbp in lung tissue. Data are 








      
      
7.3 ABBREVIATIONS AND MANUFACTURER’S DETAILS 





4-HNE 4-hydroxy-2-nonenal  
6J C57BL/6J 
6N C57BL/6N 
ANOVA 2-way analysis of variance 
APS Ammonium Persulfate  
ATMs Adipose tissue macrophages 
ATP Adenosine triphosphate 
AUC Area under curve 
BAT Brown adipose tissue  
BMI Body mass index 
BSA Bovine serum albumin 
CLS Crown-like structures  
CO2 Carbon Dioxide 
CRISPR Clusted regularly interspaced short palindromic repeats 
CTRP C1q/TNF-related protein  
DAPI  4',6-diamidino-2-phenylindole 
DMEM Dulbecco’s Modified Eagle Medium  
DNA Deoxyribonucleaic acid 
ECM Extracellular matrix  
EDTA Ethylenediaminetetraacetic Acid  
EGTA Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid  
ELISA Enzyme-linked immunosorbent assay 
ER Endoplasmic reticulum  
FADH Flavin adenine dinucleotide 
FSC-A Forward scatter area 
FSC-H Forward scatter height 
g Relative centrifugal force (AKA. RCF) 
GSH Glutathione  
GSH Glutathione persulfide 
GTT Glucose tolerance test  
GWAS Genome-wide associated study 




      
      
Abbreviation Meaning 
H2O2 Hydrogen peroxide  
HBSS Hank’s balanced salt solution  
HFD High fat diet 
HMW High molecular weight  
hr(s) Hour(s) 
HUVEC  Human umbilical vein endothelial cells 
IBD Inflammatory bowel disease 
ILC2 Innate lymphoid type 2 cells  
iNKT Invariant-chain natural killer T cells  
IP Intrapertioneal 
iPSC Induced pluripotent stem cell 
IRES Internal ribosome entry site 
ITT Insulin tolerance test  
KATP  ATP-sensitive postassium channel 
kcal Kilocalories 
KEAP1 Kelch-Like ECH Associated Protein 1 
kg Kilogram 
LDH Lactate dehydrogenase  
LDM Liver digestion media  
LFD Low fat diet  








MPST 3-mercaptopyruvate sulfurtransferase  
Na2S Disodium sulfide  
NAC N-acetylcysteine  
NADH Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenine dinucleotide phosphate 
NaHS Sodium hydrosulfide  
NK Natural killer cells 
nm Nanometre 
NSAID Non-steroidal anti-inflammatory drug 




      
      
Abbreviation Meaning 
NRF2 Nuclear factor (erythroid-derived 2)-like 2  
oC Degrees Celcius 
oxLDL Oxidised low density lipoprotein 
PAG DL-propargylglycine  
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline  
PolyA Polyadenosine coding sequence 
PPP Pyridoxal 5’ phosphate  
PQ Paraquat dichoride / N,N′-dimethyl-4,4′-bipyridinium dichloride 
RAS Renin-angiotensin system  
RNA Ribonucleic acid 
ROS Reactive oxygen species  
rpm Revolutions per minute 
RT Room tempterature (21oC) 
RT-PCR Real-time quantitative polymerase chain reaction 
s Seconds 
SDS Sodium dodecyl sulfate 
SEM Standard error of the mean 
siRNA Small-interfering RNA 
SNPs Single nucleotide polymorphisms  
SRB Dulforhodamine B 
SSC-A Side scatter area 
SVF Stromal vascular fraction  
TBARS Thiobarbituric acid reactive substances  
TBS (-T) Tris-buffered saline (with Tween) 
TCDD 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin 
TD-NMR Time domain nuclear magnetic resonance relaxometry 
TEMED N,N,N′,N′-Tetramethylethylenediamine  
Treg Regulatory T cells  
TST Thiosulfate sulfurtransferase (protein) 
TST Thiosulfate sulfurtransferase (human gene) 
Tst  Thiosulfate sulfurtransferase (mouse gene) 
UPR Unfolded protein response  







      
      
 
Table 7.2: Manufacturer's Details 
Item Manufacturer Address 
 AC1000 Improved Neubauer haemocytometer Hawksley Lancing, UK 
100% Acetic acid Sigma-Aldrich Dorset, UK 
100% Trichloroacetic acid Sigma-Aldrich Dorset, UK 
384-well white lightcycler plate Sarstedt Nümbrecht, 
Germany 
3-Isobutyl-1-methylxanthine (IBMX) Sigma-Aldrich Dorset, UK 
3T3-L1 cells American Type Culture 
Collection 
Middlesex, UK 
96-well plate, black Greiner Bio-One Gloucestershire, 
UK 
96-well plate, black, clear-bottom, cell culture-
treated 
Corning®  Flintshire, UK 
96-well plate, cell culture-treated Corning® Costar®  Flintshire, UK 
96-well plate, V-bottom Greiner Bio-One Gloucestershire, 
UK 
Advanced Bench pH Meter 3510 Jenway Staffordshire, UK 
Amersham hybond P 0.45 PVDF Membrane GE Healthcare Little Chalfont 
Bucks, UK 
Ammonium persulfate Sigma-Aldrich Dorset, UK 
Anti-4-hydroxynonenal antibody (rabbit, 
polyclonal, CAT #: ab46545) 
Abcam Cambridge, UK 
Anti-GAPDH antibody (mouse monocloncal, 




Anti-mouse CD11b PerCP Cy5.5 (CAT #: 45-
0112-85) 
eBioscience Altrincham, UK 
Anti-mouse CD11c Biotin (CAT #: 13-0114-85) eBioscience Altrincham, UK 
Anti-mouse CD11c Pacific Blue (CAT 
#:117321) 
Biolegend CA,USA 
Anti-mouse CD16/CD32 antibody (CAT #: 11-
0161-85) 
eBioscience Altrincham, UK 
Anti-mouse CD206 APC (CAT #:141707) Biolegend CA,USA 




      
      
Item Manufacturer Address 
Anti-mouse CD45 Pacific Blue (CAT #: 48-
0451-82) 
eBioscience Altrincham, UK 
Anti-mouse F4/80 FITC (CAT #:11-4801-81) eBioscience Altrincham, UK 
Anti-mouse F4/80 PE Cy7 (CAT #: 25-4801-82) eBioscience Altrincham, UK 
Anti-mouse Gr1 APC Cy7 (CAT #:108424) Biolegend CA,USA 
Anti-mouse Ly6C AlexaFlour700 (CAT 
#:128024) 
Biolegend CA,USA 
Anti-mouse Ly6C APC (CAT #: 17-5932-80) eBioscience Altrincham, UK 
Anti-mouse MHCII APC efluor780 (CAT #:47-
5321-82) 
eBioscience Altrincham, UK 
Anti-mouse SiglecF PE (CAT #: 552126) BD Biosciences Wokingham, UK 
Anti-TST antibody (rabbit, polyclonal, CAT #: 
16311-1-AP) 
Proteintech Manchester, UK 
BD FACSDiva™ software BD Biosciences Wokingham, UK 
BD LSRfortessa™ cell analyser BD Biosciences Wokingham, UK 
BD Micro-Fine™ Insulin syringes (0.3ml) BD Biosciences Wokingham, UK 
Bijoux, Sterile, 7ml Greiner Bio-One Gloucestershire, 
UK 
Bovine serum albumin (BSA) Sigma-Aldrich Dorset, UK 
Bruker minispec LF90II  Bruker UK Ltd. Coventry, UK 
Calcium chloride Sigma-Aldrich Dorset, UK 
Cell strainer, 100μm, 40μm Fisher Scientific Loughborough, 
UK 
Cellstar®  centrifuge tubes, 50ml Greiner Bio-One Gloucestershire, 
UK 
Centrifuge 5415R Eppendorf Stevenage, UK 
Chloroform Fisher Scientific Loughborough, 
UK 
Collagen Sigma-Aldrich Dorset, UK 
Collagenase, Type 1 Worthington Biochemical 
Corp. 
New Jersey, USA 
cOmplete ULTRA Tablet (mini) Roche LifeScience Burgess Hill, UK 
DAPI, 4',6-diamidino-2-phenylindole 
dehydrochloride 
ThermoFisher Scientific Paisley, UK 




      
      
Item Manufacturer Address 
DC™ Protein Assay Bio-Rad Laboratories Ltd Hertfordshire, 
UK 
Disodium hydrogen phosphate Sigma-Aldrich Dorset, UK 
Dulbecco’s Modified Eagle Medium powder Gibco™ Paisley, UK 
Dulbecco’s Modified Eagle Medium with high 
glucose (DMEM) 
Gibco™ Paisley, UK 
Dulbecco’s Modified Eagle Medium with low 
glucose (DMEM) 
Gibco™ Paisley, UK 
Ethanol Absolute VMR Chemicals Lutterworth, UK 
Ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA) 
Sigma-Aldrich Dorset, UK 
Ethylenediaminetetraacetic Acid (EDTA) Sigma-Aldrich Dorset, UK 
Flow cytometry tubes Gibco™ Paisley, UK 
FlowJo™ software FlowJo, LLC Ashland, OR, 
USA 
Fluorimetric Hydrogen Peroxide Assay Kit Sigma-Aldrich Dorset, UK 
Fluoromount™ Aqueous Mounting Medium Sigma-Aldrich Dorset, UK 
Glucose Sigma-Aldrich Dorset, UK 
Glutamine Gibco™ Paisley, UK 
Glycine Sigma-Aldrich Dorset, UK 
GraphPad Prism 5 software Prism CA, USA 




Hank’s balanced salt solution (HBSS) Gibco™ Paisley, UK 
HEPES Sigma-Aldrich Dorset, UK 
Heracell™ Incubator 5% CO2, 37°C ThermoFisher Scientific Paisley, UK 
Heraeus Megafuge 40R plate centrifuge ThermoFisher Scientific Paisley, UK 
Humulin® U-100, human insulin Eli Lilly Hampshire, UK 
HyClone™ foetal bovine serum, heat inactivated 
(South American Origin) 
GE Healthcare Little Chalfont 
Bucks, UK 
Hydrochloric acid Sigma-Aldrich Dorset, UK 
Hydrogen peroxide Sigma-Aldrich Dorset, UK 
Image Studio™ Lite software LI-COR Biosciences Cambridge, UK 
Infinite® M1000 PRO microplate reader TECAN Reading, UK 




      
      
Item Manufacturer Address 
IRDye® 680RD Donkey Anti-Mouse LI-COR Biosciences Cambridge, UK 
IRDye® 800RD Goat Anti-Rabbit LI-COR Biosciences Cambridge, UK 
Iron (III) nitrate Sigma-Aldrich Dorset, UK 
Isopropanol  VMR Chemicals Lutterworth, UK 
LI-COR Odyssey scanner LI-COR Biosciences Cambridge, UK 
Lightcyler® 480 Roche Applied Science Burgess Hill, UK 
Low fat corn starch diet (D12328) Research Diets Inc. New Brunswick, 
NJ, USA 
Magnesium sulfate heptahydrate Sigma-Aldrich Dorset, UK 
Methanol Fisher Scientific Loughborough, 
UK 
Microcentrifuge tubes, DNase/RNase-free, 
0.5ml 
Greiner Bio-One Gloucestershire, 
UK 
Microcentrifuge tubes, DNase/RNase-free, 
1.5ml 
Greiner Bio-One Gloucestershire, 
UK 
Microcentrifuge tubes, DNase/RNase-free, 2ml Eppendorf Stevenage, UK 
Microscope Slides Plain 1.0-1.2mm 76x26mm Scientific laboratory 
supplies Ltd. 
Lanarkshire, UK 
Microvette CB 300 tubes Sarstedt Nümbrecht, 
Germany 
Millex® Syringe Filter Units, sterile, 33mm Merck Millipore Ltd Watford, UK 
Milli-Q® Integral Water Purification System Merck Millipore Ltd Watford, UK 
Mini-PROTEAN Tetra gel electrophoresis and 
transfer system 
Bio-Rad Laboratories Ltd Hertfordshire, 
UK 
MitoSOX™ Red Mitochondrial Superoxide 
Indicator 
Life Technologies Carlsbad, CA, 
USA 
Mixer Mill MM301 homogeniser Retsch™ Haan, Germany 
Mouse HMW & Total Adiponectin ELISA Alpco Salem, NH, USA 
N,N,N′,N′-Tetramethylethylenediamine Sigma-Aldrich Dorset, UK 
NanoDrop ND-1000 ThermoFisher Scientific Wilmington, 
USA 
Newborn calf serum (NBCS) Gibco™ Paisley, UK 
Nitric acid Sigma-Aldrich Dorset, UK 





      
      
Item Manufacturer Address 
Normal rat serum ThermoFisher Scientific Wilmington, 
USA 
Nylon mesh, 500µM aperture Plastok Merseyside, UK 
Odyssey imaging system and software LI-COR Biosciences Cambridge, UK 
Olympus AX-70 Provis microscope Olympus Center Valley, 
PA, USA 
OneTough Ultra® Glucometer and test strips LifeScan Tunbridge Wells, 
UK 
Optically clear sealing tape for lightcycler plate Sarstedt Nümbrecht, 
Germany 
OxiSelect TBARS Assay Kit Cell Biolabs   
Paraformaldehyde (38%) Sigma-Aldrich Dorset, UK 
Paraquat dichloride Sigma-Aldrich Dorset, UK 
Penicillin/streptomycin (P/S) Gibco™ Paisley, UK 
Percoll Gibco™ Paisley, UK 
PerfeCTa® Fastmix II Quanta Bioscience MD, USA 
Phosphate buffered saline (PBS) Sigma-Aldrich Dorset, UK 
Pierce™ LDH Cytotoxicity assay kit ThermoFisher Scientific Paisley, UK 
Pipette tips, DNase/RNase-free, 
1000/200/20/10µl 
Greiner Bio-One Gloucestershire, 
UK 
Potassium chloride Sigma-Aldrich Dorset, UK 
Potassium cyanide Sigma-Aldrich Dorset, UK 
Potassium phosphate Sigma-Aldrich Dorset, UK 
PowerPac™ Basic Power Supply Bio-Rad Laboratories Ltd Hertfordshire, 
UK 
Precision Plus Protein Dual Colour Standards Bio-Rad Laboratories Ltd Hertfordshire, 
UK 
ProtoFLOWgel (37:5:2) Flowgen Biosciences Ltd Nottingham, UK 
QIAzol lysis reagent Qiagen West Sussex, UK 
QuantiTect Reverse Transcription Kit Qiagen West Sussex, UK 
RM1 standard chow diet Special Diet Services Essex, UK 
Rosiglitazone Sigma-Aldrich Dorset, UK 
RNAase/DNAase-free water Gibco™ Paisley, UK 
Skimmed milk powder Marvel   




      
      
Item Manufacturer Address 
SLS Coverslips 20x20mm Scientific laboratory 
supplies Ltd. 
Lanarkshire, UK 
Sodium chloride Sigma-Aldrich Dorset, UK 
Sodium dihydrogen phosphate Sigma-Aldrich Dorset, UK 
Sodium dodecyl sulfate Sigma-Aldrich Dorset, UK 
Sodium fluoride Sigma-Aldrich Dorset, UK 
Sodium orthovanadate Sigma-Aldrich Dorset, UK 
Sodium thiosulfate Sigma-Aldrich Dorset, UK 
Stainless steel grinding balls Retsch™ Haan, Germany 
Strepatvidin PE Cy7 (CAT #: 25-4317-82) eBioscience Altrincham, UK 
Sucrose Sigma-Aldrich Dorset, UK 
Surwit high fat diet (D12331) Research Diets Inc. New Brunswick, 
NJ, USA 
TaqMan® Real-Time PCR assay probes Applied Biosystems Carlsbad, CA, 
USA 
Thiobarbituric acid reactive substances 
(TBARS) assay kit 
Cayman Chemical Ann Arbor, MI, 
USA 
Tris base Sigma-Aldrich Dorset, UK 
Triton X-100 Sigma-Aldrich Dorset, UK 
Tween Sigma-Aldrich Dorset, UK 
Ultra pure ProtoFLOWgel 30% Acrylamide/ Bis 
Acrylamide 
Flowgen Bioscience Nottingham, UK 
Ultra Sensitive Mouse Insulin ELISA kit Crystal Chem Downers Grove, 
IL, USA 
Western Blotting Filter Paper, 8 cm x 10.5 cm ThermoFisher Scientific Paisley, UK 
β-glycerophosphate Sigma-Aldrich Dorset, UK 
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